Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000117242	PINK1-AS	1.33478684251809	2.47683844194158e-5	M2_vs_M1	HSALNG0001460	intronic_antisense	Not conserved	NA	-	DDOST	TIPIN
ENSG00000125462	MIR9-1HG	-7.70412311253995	2.75341853390464e-12	M2_vs_M1	HSALNG0007588	sense	Not conserved	NA	NA	MEF2D	KRT8P46
ENSG00000132832	NA	-4.95366092425525	0.0299495439148673	M2_vs_M1	HSALNG0146964	integenic	Not conserved	NA	NA	ADA	NIPAL4
ENSG00000136315	RNASE2CP	3.13296627605781	2.69602665908352e-9	M2_vs_M1	HSALNG0099840	integenic	Not conserved	NA	NA	RNASE3	ZNF252P
ENSG00000162888	C1orf147	-2.7605916665776	3.7575657988829e-11	M2_vs_M1	NA	NA	NA	NA	NA	EIF2D	IGSF22
ENSG00000163597	SNHG16	-1.80342989438965	2.14663028349977e-42	M2_vs_M1	HSALNG0118862	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Macular telangiectasia type 2,-	PRCD	GRB2
ENSG00000167912	TOX-DT	3.35531043523567	2.81627611259308e-4	M2_vs_M1	HSALNG0065583	anti_sense	Q75	hsa-miR-1237-5p,hsa-miR-4467,hsa-miR-3960,hsa-miR-1199-5p,hsa-miR-6763-5p	-	SDCBP	ENSG00000267546
ENSG00000167920	KRT10-AS1	1.87402611607667	1.8532008340827698e-40	M2_vs_M1	HSALNG0116399	anti_sense	Q75	hsa-miR-3960	Leukocyte count,-	KRTAP4-7	ENSG00000239246
ENSG00000172965	MIR4435-2HG	1.56754812695043	1.5534514130097898e-56	M2_vs_M1	HSALNG0017878	integenic	Q50	NA	NA	ANAPC1	NDUFB6
ENSG00000174370	KCNJ5-AS1	1.54377457169275	3.3577452392835797e-18	M2_vs_M1	NA	NA	NA	NA	NA	TP53AIP1	WDR76
ENSG00000174403	CRMA	-4.16518216557754	5.94969558464625e-6	M2_vs_M1	HSALNG0131539	integenic	Q50	hsa-miR-612,hsa-miR-762,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-6775-3p,hsa-miR-6810-3p,hsa-miR-6877-3p	Brain stem volume measurement; Brain volume measurement,Brain volume measurement,-	GATA5	SPATA33
ENSG00000175061	SNHG29	1.94008359409246	1.1816033575185298e-98	M2_vs_M1	HSALNG0114857	anti_sense	Q50	hsa-miR-762,hsa-miR-4520-5p,hsa-miR-6773-5p	Parental longevity,-	TRPV2	SURF6
ENSG00000175728	LINC02873	5.48344145247055	0.0092377963635174	M2_vs_M1	HSALNG0088239	integenic	Q75	NA	-	ADAMTS15	CRYAB
ENSG00000176349	NA	-4.08241181480488	2.26044618974784e-16	M2_vs_M1	NA	NA	NA	NA	NA	ELFN1	ZNF462
ENSG00000176659	LINC02910	4.78753664938987	4.6129090275430294e-42	M2_vs_M1	HSALNG0131382	integenic	Not conserved	NA	NA	CDH26	CCL21
ENSG00000176728	TTTY14	1.12990242367067	8.6946205508524e-5	M2_vs_M1	HSALNG0151340	integenic	Not conserved	hsa-miR-30b-3p	NA	HSFY2	RPL21P125
ENSG00000177335	LINC02904	-2.60463695513255	2.55248486558519e-22	M2_vs_M1	HSALNG0069224	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-326,hsa-miR-331-3p,hsa-miR-939-3p,hsa-miR-4292,hsa-miR-1343-3p,hsa-miR-6735-5p	-	LY6E	UBTD2
ENSG00000177699	NA	-1.96741076871981	3.5179993263644297e-12	M2_vs_M1	HSALNG0107519	anti_sense	Q90	NA	Rr interval,-	MORF4L1	ENSG00000230647
ENSG00000177738	ANXA2R-OT1	-1.17091286512565	1.1760770791537801e-9	M2_vs_M1	HSALNG0041489	integenic	Not conserved	hsa-miR-619-5p	Conotruncal heart malformations	ANXA2R	ENSG00000287557
ENSG00000177757	FAM87B	-4.62383197716351	0.041058378528549	M2_vs_M1	HSALNG0000041	integenic	Not conserved	NA	Unipolar depression,Circadian rhythm,-	SAMD11	FAM87B
ENSG00000177822	TENM3-AS1	-1.49471761838397	0.0119003461842784	M2_vs_M1	HSALNG0038869	integenic	Q90	NA	NA	DCTD	RLN1
ENSG00000178803	ADORA2A-AS1	-6.11180129693768	1.98878733908493e-4	M2_vs_M1	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	MIR186
ENSG00000178977	LINC00324	1.50342603975434	0.0428117002028765	M2_vs_M1	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1	KIF20A
ENSG00000179743	SPEN-AS1	1.1521898844361	1.51597815472968e-6	M2_vs_M1	HSALNG0001121	intronic_antisense	Q50	hsa-miR-30b-3p	NA	UQCRHL	MACORIS
ENSG00000180066	LINC02870	2.13738878681951	0.00177344280477368	M2_vs_M1	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B	SEPSECS-AS1
ENSG00000180539	LINC02908	1.11048994561736	3.48926086176606e-11	M2_vs_M1	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX	EDNRA
ENSG00000181577	LINC03040	2.4829528832085	7.58479613480402e-34	M2_vs_M1	NA	NA	NA	NA	NA	TMEM63B	NEDD8
ENSG00000181800	CELF2-AS1	-2.21123801127278	0.0286937643079038	M2_vs_M1	HSALNG0142713	anti_sense	Not conserved	NA	NA	USP6NL	KHDC1-AS1
ENSG00000182165	TP53TG1	1.70005442164134	1.20285768223453e-4	M2_vs_M1	HSALNG0059377	integenic	Not conserved	NA	Red blood cell distribution width,Lung carcinoma,-	ABCB4	ENSG00000289425
ENSG00000182586	LINC00334	4.67215561292046	0.0253538687860052	M2_vs_M1	HSALNG0133613	integenic	Not conserved	NA	NA	ADARB1	ENSG00000213791
ENSG00000183154	NA	2.7181676482972	2.6950733471763103e-9	M2_vs_M1	HSALNG0150383	anti_sense	Q75	NA	-	BRF2	BRICD5
ENSG00000185168	LINC00482	1.19379719936658	5.56589814879931e-8	M2_vs_M1	HSALNG0145393	integenic	Not conserved	hsa-miR-6852-5p	-	SLC38A10	CREB3L4
ENSG00000185332	TMEM105	1.65449297515105	0.0165509547399877	M2_vs_M1	HSALNG0145394	integenic	Q50	hsa-miR-619-5p,hsa-miR-761,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4472,hsa-miR-6803-5p	Sugar consumption measurement,-	SLC38A10	ENSG00000259238
ENSG00000185433	LINC00158	-5.42342268018909	1.20106855006719e-59	M2_vs_M1	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	GSAP
ENSG00000186019	ZNF225-AS1	-1.22128594948658	0.0441323497730959	M2_vs_M1	HSALNG0126426	anti_sense	Not conserved	NA	Cytokine measurement,-	ZNF235	CDC27
ENSG00000186056	MATN1-AS1	-1.16269123742316	0.00845512945424834	M2_vs_M1	HSALNG0002188	anti_sense	Q50	hsa-miR-6749-5p,hsa-miR-6791-5p,hsa-miR-6803-5p	Body height,-	ZCCHC17	NOTCH2NLC
ENSG00000186235	LINC02610	1.02362254022969	0.00179076405374912	M2_vs_M1	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	DNAH6
ENSG00000186615	KTN1-AS1	2.21275672433205	1.04027629112048e-5	M2_vs_M1	HSALNG0101474	integenic	Not conserved	NA	NA	TBPL2	TTI1
ENSG00000187013	LINC02875	3.64458802707187	0.00212170827693397	M2_vs_M1	HSALNG0145122	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-920,hsa-miR-4749-3p	Hypertension; Systolic blood pressure,-	TBX2	SHISA2
ENSG00000187185	NA	7.6902096766541	4.6405639039520605e-15	M2_vs_M1	HSALNG0111803	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6069	-	KATNB1	ACP2
ENSG00000188185	LINC00265	-5.03171093238249	2.7752369244739297e-25	M2_vs_M1	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA	ITPRIPL2
ENSG00000196696	PDXDC2P-NPIPB14P	-1.62465855647428	2.30513277074602e-5	M2_vs_M1	HSALNG0112405	integenic	Not conserved	hsa-miR-3201	Information processing speed,Vital capacity,Age at menarche,-	EXOSC6	CHIC1
ENSG00000196951	SCOC-AS1	1.23782158836633	4.86443898419374e-4	M2_vs_M1	HSALNG0037486	anti_sense	Not conserved	hsa-miR-370-3p	NA	CLGN	ZCCHC10
ENSG00000197301	HMGA2-AS1	-2.57255925104616	1.84669632039186e-30	M2_vs_M1	HSALNG0092012	anti_sense	Not conserved	NA	NA	LLPH	LPIN2
ENSG00000197503	LINC00477	-2.63429883221249	5.23889098637376e-17	M2_vs_M1	HSALNG0089868	integenic	Q50	NA	Cognitive decline measurement,Smoking status measurement,Neutrophil count,-	SOX5	MFAP3L
ENSG00000197536	IRF1-AS1	-4.1758222781296	1.4755984832656299e-123	M2_vs_M1	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	ENSG00000254287
ENSG00000197670	NA	-2.51018522463378	0.00337992934056925	M2_vs_M1	HSALNG0130935	anti_sense	Not conserved	NA	Mean reticulocyte volume; Sex hormone-binding globulin measurement; Mean corpuscular volume; Erythrocyte count,Lymphocyte count	TSHZ2	ENSG00000231563
ENSG00000198496	NBR2	-1.33376254934449	7.676284301693831e-9	M2_vs_M1	HSALNG0116616	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Age at menopause,Neutrophil count,-	NBR1	SPATA25
ENSG00000203446	SUGCT-AS1	-1.87242435115852	1.7376213385587798e-30	M2_vs_M1	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	SCOC-AS1
ENSG00000203527	SCUBE1-AS1	6.12019929559536	1.11741194652883e-5	M2_vs_M1	HSALNG0135784	anti_sense	Not conserved	NA	NA	TSPO	RGS9BP
ENSG00000203706	SERTAD4-AS1	6.69901500051253	3.95258448793901e-7	M2_vs_M1	HSALNG0010241	anti_sense	Q90	hsa-miR-1468-5p,hsa-miR-5787,hsa-miR-6085,hsa-miR-8485	-	NA	ENSG00000259871
ENSG00000203709	MIR29B2CHG	-4.02852254006644	1.34370220215411e-69	M2_vs_M1	HSALNG0010132	integenic	Q50	NA	Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34	TMEM62
ENSG00000203711	LINC02901	2.73909181138646	0.00759177554817455	M2_vs_M1	HSALNG0054705	integenic	Not conserved	hsa-miR-6089	-	SYTL3	ENSG00000271964
ENSG00000203875	SNHG5	1.218936560706	5.85721243201167e-21	M2_vs_M1	HSALNG0051708	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	C-x-c motif chemokine 10 measurement,-	NA	NHS
ENSG00000203999	LINC01270	-4.1657613802151	5.42384511320608e-6	M2_vs_M1	HSALNG0130755	integenic	Not conserved	NA	NA	CEBPB	ZNF350
ENSG00000204584	NA	1.73020189894615	2.43651290522276e-5	M2_vs_M1	HSALNG0117217	anti_sense	Q50	hsa-miR-6132	-	KAT7	OSTCP4
ENSG00000204682	MIR1915HG	1.90612314657842	1.26265494418822e-5	M2_vs_M1	HSALNG0076590	integenic	Q50	hsa-miR-619-5p	Smoking initiation; Parental longevity; Body mass index,-	SKIDA1	DLGAP4
ENSG00000204860	FAM201A	1.58089422923981	0.0277143882916827	M2_vs_M1	HSALNG0071146	anti_sense	Not conserved	hsa-miR-1205,hsa-miR-4281	Obsessive-compulsive disorder; Tourette syndrome,-	ALDH1B1	CPNE4
ENSG00000204876	NA	-3.24555803376271	8.68772696308896e-5	M2_vs_M1	NA	NA	NA	NA	NA	RBM33	SPOPL
ENSG00000205086	LINC02898	5.18280336741375	5.56178445365817e-101	M2_vs_M1	NA	NA	NA	NA	NA	COX7A2L	GPC4
ENSG00000205414	NA	-1.53682621874657	0.00226084765669577	M2_vs_M1	HSALNG0144931	anti_sense	Q50	NA	NA	SNX20	ENSG00000240036
ENSG00000205837	LINC00487	-7.03036819093382	4.46693507112056e-7	M2_vs_M1	HSALNG0012718	integenic	Q50	hsa-miR-4430	NA	CMPK2	NEUROD4
ENSG00000205853	RFPL3S	-1.97448854988	0.00216155252942299	M2_vs_M1	HSALNG0135027	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-593-3p,hsa-miR-6089	-	RTCB	ATP13A1
ENSG00000205885	C1RL-AS1	-2.08010086947014	2.02428382500325e-5	M2_vs_M1	HSALNG0088972	anti_sense	Q50	hsa-miR-4418,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6165,hsa-miR-8485	Neuritic plaque measurement,Platelet count,Platelet crit,-	CLSTN3	SARAF
ENSG00000206195	DUXAP8	-1.76818747336278	5.2873948276512505e-9	M2_vs_M1	HSALNG0133782	integenic	Not conserved	hsa-miR-5572,hsa-miR-6165	-	POTEH	PRR34-AS1
ENSG00000206337	HCP5	-3.62113864802539	1.5991773940085199e-86	M2_vs_M1	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB	XRN1
ENSG00000206344	HCG27	-2.26871336734576	5.15323288780003e-4	M2_vs_M1	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	CGN
ENSG00000206567	NA	1.59921908742566	1.9296954138721e-14	M2_vs_M1	HSALNG0024081	sense	Not conserved	hsa-miR-3620-5p,hsa-miR-3650,hsa-miR-4472,hsa-miR-4486,hsa-miR-4505,hsa-miR-1587,hsa-miR-4747-3p,hsa-miR-6089	NA	EMC3	CYB561D2
ENSG00000212719	LINC02693	-2.49734089112498	1.58978629415172e-13	M2_vs_M1	HSALNG0115274	integenic	Not conserved	hsa-miR-612,hsa-miR-4268,hsa-miR-3670,hsa-miR-4486,hsa-miR-4492,hsa-miR-4514,hsa-miR-6870-5p,hsa-miR-6879-5p	Protein measurement,-	NATD1	MARCKSL1
ENSG00000213057	C1orf220	-5.87429986667203	5.36587736297195e-4	M2_vs_M1	HSALNG0008703	sense	Q50	NA	High density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement,Serum gamma-glutamyl transferase measurement	TEX35	NCR1
ENSG00000213468	FIRRE	-4.82239997121277	8.916024702720541e-10	M2_vs_M1	HSALNG0140173	integenic	Not conserved	hsa-miR-6089	NA	IGSF1	CHRNB1
ENSG00000213904	LIPE-AS1	1.59566329469367	4.0370072209537e-4	M2_vs_M1	HSALNG0126298	anti_sense	Not conserved	hsa-miR-4463	NA	MEGF8	WAKMAR2
ENSG00000214106	PAXIP1-AS2	-1.0844965261188	0.00707422425364098	M2_vs_M1	HSALNG0062534	anti_sense	Q75	NA	Corneal endothelial cell measurement,Cognitive function measurement,-	DPP6	ENSG00000230499
ENSG00000214401	KANSL1-AS1	1.69476572775686	0.0131187338320519	M2_vs_M1	HSALNG0116913	anti_sense	Q75	hsa-miR-4665-3p,hsa-miR-9899	-	LRRC37A	ENSG00000286064
ENSG00000214783	POLR2J4	-1.55857990813912	0.0087689579265306	M2_vs_M1	HSALNG0057608	anti_sense	Not conserved	NA	NA	URGCP	RPGRIP1
ENSG00000214870	LINC02981	2.68566814348754	0.0178252339846929	M2_vs_M1	HSALNG0056819	integenic	Not conserved	NA	NA	SNX10	PIP5K1B
ENSG00000214894	LINC00243	-2.05643517187192	0.00381081145204433	M2_vs_M1	HSALNG0049199	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6744-3p	Breast carcinoma,Mean platelet volume,Sleep duration,Cutaneous lupus erythematosus,Intelligence,Angina pectoris,Bmi-adjusted waist-hip ratio,Response to vaccine,Bmi-adjusted hip circumference,Reticulocyte count,Autoimmune thyroid disease; Bipolar disorder,Age-related macular degeneration,Reaction time measurement,Decreased fine motor function,17-hydroxyprogesterone measurement,Cytokine measurement,Protein measurement; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Arterial stiffness measurement,Susceptibility to cold sores measurement,Susceptibility to plantar warts measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Serum igg glycosylation measurement,Response to candesartan,Rosacea severity measurement,Cervical carcinoma,Eosinophil count,Glomerular filtration rate,Susceptibility to urinary tract infection measurement,Tonsillectomy risk measurement,Qrs amplitude; Qrs complex,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	IER3	SNAP25
ENSG00000214922	HLA-F-AS1	-2.3624526870086	0.00116137983021429	M2_vs_M1	HSALNG0049088	anti_sense	Not conserved	hsa-miR-575,hsa-miR-8485	Age at menopause,Cytokine measurement,Psoriatic arthritis,Bmi-adjusted waist-hip ratio; Hodgkins lymphoma, mixed cellularity,Lung carcinoma,Bmi-adjusted hip circumference,Self reported educational attainment; Cognitive function measurement,Urate measurement,-	ZFP57	ENSG00000271032
ENSG00000215039	CD27-AS1	2.03632691947601	3.0686953683413597e-33	M2_vs_M1	HSALNG0088857	anti_sense	Q50	hsa-miR-642a-5p,hsa-miR-4292,hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-1587,hsa-miR-6514-3p,hsa-miR-6752-3p,hsa-miR-6784-5p,hsa-miR-6890-3p	-	VAMP1	SPPL2B
ENSG00000215067	ALOX12-AS1	-1.12136279527149	4.65847267508361e-8	M2_vs_M1	HSALNG0114242	integenic	Not conserved	hsa-miR-3944-5p	NA	SLC16A11	CCDC30
ENSG00000215068	ANXA2R-AS1	-2.49852935817292	3.6644019659793596e-28	M2_vs_M1	HSALNG0148589	integenic	Not conserved	NA	NA	ZNF131	DYRK1B
ENSG00000216863	LY86-AS1	-3.3107660911017	0.00425868433337303	M2_vs_M1	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	RAD9A
ENSG00000217825	NA	-4.96490991941217	0.0242872469319009	M2_vs_M1	HSALNG0062556	integenic	Not conserved	hsa-miR-3065-3p	NA	PAXIP1	DDX43
ENSG00000218018	RBM38-AS1	-2.2611276844488	0.0484171387963054	M2_vs_M1	HSALNG0146983	anti_sense	Q75	hsa-miR-4720-5p	Reticulocyte measurement,Myeloid white cell count,Neutrophil count,Reticulocyte count; Reticulocyte measurement,Reticulocyte count,Mean reticulocyte volume,-	HMGB1P1	LINC02006
ENSG00000221817	PPP3CB-AS1	-1.09418715499402	4.94796372073738e-5	M2_vs_M1	HSALNG0078847	anti_sense	Q90	hsa-miR-363-5p,hsa-miR-6089	-	SEC24C	ZNF493
ENSG00000222012	NA	2.39731425827713	1.18771276307624e-4	M2_vs_M1	NA	NA	NA	NA	NA	DNAJB6	PGRMC1
ENSG00000222020	HDAC4-AS1	2.38022654297263	2.09440854729899e-5	M2_vs_M1	HSALNG0023501	anti_sense	Q50	hsa-miR-4486,hsa-miR-4508,hsa-miR-6756-5p	-	TWIST2	GADL1
ENSG00000222041	CYTOR	2.55780392024139	9.701945568115558e-141	M2_vs_M1	HSALNG0016642	integenic	Not conserved	hsa-miR-519d-5p,hsa-miR-1343-3p,hsa-miR-5787,hsa-miR-6779-5p,hsa-miR-6800-3p,hsa-miR-6813-5p	Mitochondrial heteroplasmy measurement,-	PLGLB2	PSMD3
ENSG00000222047	C10orf55	2.23285390617144	0.00443313621268103	M2_vs_M1	HSALNG0078890	anti_sense,sense	Q75	NA	-	CAMK2G	CA11
ENSG00000223374	NA	-3.13342525845232	0.0107427358931653	M2_vs_M1	HSALNG0023672	anti_sense	Not conserved	NA	NA	HDLBP	DVL3
ENSG00000223478	ZDHHC12-DT	1.55815924871357	5.63107827320938e-4	M2_vs_M1	HSALNG0074656	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-6799-5p	-	PKN3	FICD
ENSG00000223511	LINC02968	-2.40265027014631	9.898396184497e-6	M2_vs_M1	HSALNG0151032	integenic	Not conserved	hsa-miR-512-5p	NA	ASMT	ENSG00000289196
ENSG00000223546	LINC00630	-3.31187956722423	0.00450813331784211	M2_vs_M1	HSALNG0139275	integenic	Not conserved	NA	NA	GPRASP3	ZNF738
ENSG00000223552	CCR5AS	-1.04301892074773	6.52677674857909e-7	M2_vs_M1	HSALNG0025681	anti_sense	Not conserved	hsa-miR-455-3p,hsa-miR-619-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Ccl4 measurement,Leukocyte count,Granulocyte percentage of myeloid white cells,Ccl2 measurement,Aids,Blood urea nitrogen measurement,Monocyte count,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	LTF	CTSL
ENSG00000223725	NA	-2.14653726315695	0.0477213796896602	M2_vs_M1	HSALNG0021871	integenic	Not conserved	NA	NA	METTL21A	ENSG00000285725
ENSG00000223764	LINC02593	4.18496258690023	9.56324334025574e-29	M2_vs_M1	HSALNG0000054	integenic	Not conserved	hsa-miR-550a-5p,hsa-miR-550a-3-5p,hsa-miR-3188,hsa-miR-3620-5p,hsa-miR-1587	-	NOC2L	IL22RA1
ENSG00000223930	NA	4.67633218926934	0.0392220051164817	M2_vs_M1	HSALNG0030914	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-920,hsa-miR-4748,hsa-miR-4753-3p,hsa-miR-6734-3p,hsa-miR-6763-5p,hsa-miR-6808-5p	Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Response to cranial radiation therapy; Body mass index,-	ZMAT3	ENSG00000223930
ENSG00000223949	ROR1-AS1	-2.72772001848602	2.69695094167123e-5	M2_vs_M1	HSALNG0004144	anti_sense	Q90	NA	Intelligence,Blood protein measurement,-	ITGB3BP	TBC1D2
ENSG00000223960	CHROMR	-4.37558208388193	9.51090687905446e-138	M2_vs_M1	HSALNG0020702	anti_sense	Q50	hsa-miR-6089	Blood protein measurement,Psoriasis; Atopic eczema,-,Oligoclonal band measurement	OSBPL6	INSR
ENSG00000224046	DMTF1-AS1	1.91290736283732	0.00201123376335986	M2_vs_M1	HSALNG0059367	anti_sense	Q75	hsa-miR-887-5p,hsa-miR-3178,hsa-miR-5787,hsa-miR-6090,hsa-miR-6726-5p,hsa-miR-6816-5p	-	TMEM243	PA2G4P1
ENSG00000224137	LINC01857	-3.35397635126179	4.7332409504697e-7	M2_vs_M1	HSALNG0021881	integenic	Q50	hsa-miR-619-5p,hsa-miR-1285-3p,hsa-miR-6089	-	CCNYL1	CLCA2
ENSG00000224165	DNAJC27-AS1	1.4128601853862	2.6428029851873e-4	M2_vs_M1	HSALNG0013632	anti_sense	Q50	hsa-miR-939-5p,hsa-miR-4297,hsa-miR-3972,hsa-miR-4638-5p,hsa-miR-6089,hsa-miR-6749-5p,hsa-miR-6895-5p,hsa-miR-1273h-5p	Body mass index,Pulse pressure measurement,Body height,Cardiovascular disease,Bmi-adjusted waist circumference; Body height; Bmi-adjusted waist-hip ratio; Systolic blood pressure,-	EFR3B	ENSG00000291266
ENSG00000224167	LINC01357	4.26301273160873	1.96696195128592e-5	M2_vs_M1	HSALNG0006142	integenic	Not conserved	hsa-miR-619-5p	NA	TAFA3	SEMA6A-AS1
ENSG00000224259	LINC01133	1.67820087214048	0.00321269673646728	M2_vs_M1	HSALNG0007801	integenic	Q50	NA	Visual perception measurement; Granulocyte count,-	KCNJ9	ENSG00000261799
ENSG00000224281	SLC25A5-AS1	1.35910747786141	0.00487528292534461	M2_vs_M1	HSALNG0139763	anti_sense	Q75	hsa-miR-6085,hsa-miR-6781-5p,hsa-miR-6803-5p,hsa-miR-7155-5p	Body height,Blood urea nitrogen measurement	STEEP1	SLC20A2
ENSG00000224307	LINC02975	2.82291846927709	0.00976444699932173	M2_vs_M1	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	LRRC77P
ENSG00000224397	PELATON	-3.00812408071375	8.68220757835192e-10	M2_vs_M1	HSALNG0130749	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4258,hsa-miR-4284,hsa-miR-4491,hsa-miR-4701-3p,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6132,hsa-miR-6748-3p,hsa-miR-6769b-5p,hsa-miR-6887-3p	Hair colour measurement,Monocyte percentage of leukocytes; Mammographic density measurement; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Gut microbiome measurement,Monocyte percentage of leukocytes,Monocyte count,-	CEBPB	ARFGAP3
ENSG00000224413	NA	5.55977627153236	2.19162588861437e-14	M2_vs_M1	HSALNG0147096	integenic	Not conserved	NA	NA	COL6A1	ENSG00000260196
ENSG00000224478	NA	-4.16856192740212	7.12186606815395e-6	M2_vs_M1	HSALNG0054727	integenic	Not conserved	hsa-miR-6089	Psoriasis vulgaris,Nicotine dependence symptom count; Depressive symptom measurement	FNDC1	ENSG00000241886
ENSG00000224536	CSRP1-AS1	1.61727489692874	1.02280617719243e-8	M2_vs_M1	HSALNG0009660	integenic	Not conserved	hsa-miR-619-5p	NA	NAV1	ZNF83
ENSG00000224614	TNK2-AS1	-4.53378845567852	1.1454551495074899e-18	M2_vs_M1	HSALNG0031857	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6089	Blood urea nitrogen measurement; Creatinine measurement	MUC20	PXT1
ENSG00000224649	NA	2.1334873287977	3.08260468780715e-4	M2_vs_M1	HSALNG0132534	integenic	Not conserved	hsa-miR-1231,hsa-miR-6073	Serum gamma-glutamyl transferase measurement,-	CCT8	RIC8A
ENSG00000224660	SH3BP5-AS1	-1.30590118633621	3.74675839817249e-10	M2_vs_M1	HSALNG0024394	anti_sense	Q90	NA	-	CAPN7	UBQLN4P1
ENSG00000224666	ETV7-AS1	-6.42283046902704	6.85827755305658e-6	M2_vs_M1	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	CIBAR1-DT
ENSG00000224945	NA	2.72416676219435	7.39211272401601e-5	M2_vs_M1	HSALNG0072581	sense	Not conserved	NA	NA	SHC3	ENSG00000285867
ENSG00000224969	NA	-4.62380293538236	0.041278692272968	M2_vs_M1	HSALNG0000070	anti_sense	Not conserved	NA	Blood protein measurement,-	HES4	KRTAP5-1
ENSG00000225138	SLC9A3-AS1	1.83594592953729	1.00054306013315e-78	M2_vs_M1	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3	STEAP2
ENSG00000225205	PDK1-AS1	1.34760388678797	9.82257301695156e-4	M2_vs_M1	HSALNG0020385	anti_sense	Q90	hsa-miR-320a-5p,hsa-miR-920,hsa-miR-6089,hsa-miR-6749-5p,hsa-miR-6784-5p,hsa-miR-6808-5p,hsa-miR-6846-5p	[pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement,Eosinophil count,-	DLX2	KIF7
ENSG00000225234	TRAPPC12-AS1	-2.44992107674782	0.00364694916349551	M2_vs_M1	HSALNG0012576	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-1587	Neurofibrillary tangles measurement,Neuritic plaque measurement; Cerebral amyloid angiopathy; Neurofibrillary tangles measurement,-	ADI1	TMEM123-DT
ENSG00000225313	NA	-1.12393242407561	0.0018029838919311	M2_vs_M1	HSALNG0002394	anti_sense	Q75	hsa-miR-3665,hsa-miR-6089	White matter volume measurement,Body mass index,Eosinophil percentage of leukocytes,Lean body mass; Body height; Risk-taking behaviour,Platelet count,Risk-taking behaviour,Susceptibility to plantar warts measurement,Attention deficit hyperactivity disorder; Smoking behavior; Smoking status measurement; Substance abuse; Body weight; Risk-taking behaviour; Antisocial behaviour measurement,-	ZNF362	ERCC5
ENSG00000225342	LRRK2-DT	-2.32880769692761	1.84818684243793e-5	M2_vs_M1	HSALNG0090483	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,Crohn's disease,Mean platelet volume,Cathepsin l1 measurement,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,-	SLC2A13	ENSG00000273355
ENSG00000225470	JPX	-1.47971941548379	4.17199952844181e-4	M2_vs_M1	HSALNG0138609	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4257,hsa-miR-1268b,hsa-miR-6089,hsa-miR-7703,hsa-miR-8485	NA	ZCCHC13	C1orf56
ENSG00000225484	NUTM2B-AS1	1.03889850749271	1.33504356168564e-4	M2_vs_M1	HSALNG0079152	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-4492,hsa-miR-3960,hsa-miR-6089,hsa-miR-1273h-5p	Hemoglobin measurement,-,Fev/fec ratio	SFTPA2	SYCE1L
ENSG00000225578	NCBP2-AS1	-3.13938283354396	0.0141086590341982	M2_vs_M1	HSALNG0031976	anti_sense	Q75	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1268b	Viral load,-	NCBP2AS2	ENSG00000286616
ENSG00000225733	FGD5-AS1	-1.05647770201558	2.49742110748985e-32	M2_vs_M1	HSALNG0024363	anti_sense	Q75	hsa-miR-6748-3p	NA	MRPS25	IFNGR2
ENSG00000225791	TRAM2-AS1	1.27194047539044	1.1737118833117e-7	M2_vs_M1	HSALNG0050617	anti_sense	Q75	hsa-miR-520a-5p,hsa-miR-525-5p,hsa-miR-500b-3p,hsa-miR-6807-3p,hsa-miR-6829-3p,hsa-miR-4433b-3p	Resistin measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Resistin measurement,Low density lipoprotein cholesterol measurement,Fasting blood glucose measurement,Oxalate measurement,Apolipoprotein b measurement,-	TMEM14A	FNDC3B
ENSG00000225792	SNX10-AS1	-4.1704276639289	9.67033153176272e-6	M2_vs_M1	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	CCDC125
ENSG00000225886	NA	-5.71391452271067	2.02158820421993e-49	M2_vs_M1	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	RIGI
ENSG00000225953	SATB2-AS1	1.41669515985719	1.36790899994652e-6	M2_vs_M1	HSALNG0021423	anti_sense	Q90	hsa-miR-3620-5p	Body height; Cortical thickness,Body height; Mathematical ability,-	C2orf69	TRIP13
ENSG00000225963	NA	-2.52001395691655	7.59544054256572e-12	M2_vs_M1	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	TSHZ2
ENSG00000225964	NRIR	-5.11887726632374	7.38125770613899e-213	M2_vs_M1	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	SECTM1
ENSG00000226004	LINC02528	-11.0415775642261	1.04280160983264e-111	M2_vs_M1	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	ENSG00000253838
ENSG00000226091	LINC00937	-8.436823338602	6.09415401221321e-22	M2_vs_M1	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	LY6E-DT
ENSG00000226137	BAIAP2-DT	1.07556407287092	2.64966112157763e-28	M2_vs_M1	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	C5AR2
ENSG00000226149	NA	3.43878745550892	4.27598119130396e-8	M2_vs_M1	HSALNG0053423	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-8485	Sporadic amyotrophic lateral sclerosis,Hypermetropia; Self reported educational attainment; Refractive error; Retinal break; Retinal detachment; Age at onset; Myopia; Axial length measurement,Abnormality of refraction,Refractive error,Cortical surface area measurement,Body height,Cortical thickness,Sleep duration,Body mass index,Periodontitis,Cytokine measurement,Response to alcohol,-	ARHGAP18	PRADC1P1
ENSG00000226179	LINC00685	1.17907785307156	0.0318816289601002	M2_vs_M1	HSALNG0136343	integenic	Not conserved	hsa-miR-619-5p	NA	PLCXD1	ENSG00000278784
ENSG00000226239	NA	-4.81099629197166	0.0247359465754828	M2_vs_M1	HSALNG0129532	anti_sense	Q50	NA	Cystatin c measurement,Cognitive decline measurement,-	PDRG1	RAD23BP1
ENSG00000226245	ZNF32-AS1	4.9268873672409	0.013496359516208	M2_vs_M1	HSALNG0077577	anti_sense	Q75	NA	-	ZNF485	GTF2H2
ENSG00000226251	LINC02608	2.01739787453061	2.79827806025319e-5	M2_vs_M1	HSALNG0010344	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-4707-3p,hsa-miR-6773-5p,hsa-miR-7843-5p	Intelligence,Monocyte count,Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Neutrophil percentage of leukocytes; Erythrocyte count,Body height,Granulocyte percentage of myeloid white cells; High density lipoprotein cholesterol measurement; Monocyte percentage of leukocytes,Hypermetropia,Astigmatism,Bmi-adjusted waist-hip ratio,Aspartate aminotransferase measurement,Basophil count; Basophil percentage of leukocytes,Basophil count,Self reported educational attainment,Reticulocyte count,Hair colour measurement,-	PACC1	SRF
ENSG00000226281	NA	2.6850160107191	0.0201640654240432	M2_vs_M1	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	FYN
ENSG00000226312	CFLAR-AS1	-7.71799547486286	3.3755216757103e-14	M2_vs_M1	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	C9orf72
ENSG00000226453	LINC02542	-1.80143821514805	0.00472831899039389	M2_vs_M1	HSALNG0051549	integenic	Not conserved	NA	Coronary artery disease,Central corneal thickness,Body height,Intraocular pressure measurement,Adolescent idiopathic scoliosis,Bell's palsy,Bone density; Heel bone mineral density,-	IBTK	SMTNL2
ENSG00000226471	NA	2.83344653087185	0.00146373240393027	M2_vs_M1	HSALNG0134787	integenic	Not conserved	NA	NA	CCDC117	ENSG00000247134
ENSG00000226519	LINC00390	3.0106293279521	0.0393484475589181	M2_vs_M1	HSALNG0096736	intronic_sense	Not conserved	NA	-	SMIM2	HDAC2-AS2
ENSG00000226571	NA	5.77595013681772	1.9761413985164e-4	M2_vs_M1	HSALNG0053886	integenic	Q90	NA	-	HECA	LPAR3
ENSG00000226674	TEX41	-1.67194630981374	4.4117597763985294e-11	M2_vs_M1	HSALNG0019370	integenic	Q90	hsa-miR-619-5p,hsa-miR-4313,hsa-miR-4257,hsa-miR-4463,hsa-miR-6089,hsa-miR-6131,hsa-miR-6512-3p,hsa-miR-7150	Retinal nerve fibre layer thickness measurement; Retinal layer thickness measurement,Pr interval,Optic disc size measurement,Central corneal thickness; Neutrophil count; Intraocular pressure measurement; Leukocyte count; Monocyte count,Smoking initiation; Intraocular pressure measurement,Neutrophil count,Crohn's disease; Inflammatory bowel disease,Platelet count,Monocyte count,Urate measurement,Intelligence,Body weight; Body mass index,Mathematical ability,Breast carcinoma,Self reported educational attainment; Body mass index,Grip strength measurement,Smoking initiation,Hematocrit; Erythrocyte count,Hemoglobin measurement,Hematocrit,Triglyceride measurement,Hematocrit; Hemoglobin measurement; Chin morphology measurement; Balding measurement,Diastolic blood pressure,Facial morphology measurement,Body height,Hemoglobin measurement; Diastolic blood pressure,Reaction time measurement,Alopecia; Smoking behavior,Risk-taking behaviour; Arterial stiffness measurement,Hematocrit; Hemoglobin measurement,Electrocardiography,Skin aging measurement,Red blood cell density measurement; Erythrocyte count,Heel bone mineral density,Mean arterial pressure,Leukocyte count,Risk-taking behaviour,Atrial fibrillation,Blood phosphate measurement,Systolic blood pressure,Cortical surface area measurement,Lobe attachment; Myeloid white cell count,Arterial stiffness measurement,Neuroimaging measurement; Myeloid white cell count; Cortical thickness,Peak expiratory flow; Fev/fec ratio,Cortical thickness,Self reported educational attainment,Fev/fec ratio,Coronary artery disease,Smoking behavior,Hemorrhoid,Aortic stenosis,Antithrombotic agent use measurement,Creatinine measurement,Lobe attachment,Diet measurement,Protein measurement,Body mass index,Hypermetropia; Myopia,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Aortic stenosis; Aortic valve calcification,Response to antihypertensive drug; Left ventricular mass,-	ARHGAP15	TMEM126B
ENSG00000226791	LINC02611	2.60326561197816	4.01527459246544e-8	M2_vs_M1	HSALNG0017221	integenic	Q50	hsa-miR-6090,hsa-miR-7113-3p	Eosinophil count; Bipolar disorder,Bipolar disorder,Myositis,-	CRACDL	VRK1
ENSG00000226950	DANCR	3.19554667498271	1.60776436019009e-66	M2_vs_M1	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	EMC10
ENSG00000227066	NA	3.60233517326259	9.05201780878196e-110	M2_vs_M1	HSALNG0001417	integenic	Not conserved	NA	NA	PLA2G2F	RPS9
ENSG00000227082	LINC02798	-1.79213781284855	1.02308109115865e-6	M2_vs_M1	HSALNG0006555	integenic	Not conserved	hsa-miR-548c-5p,hsa-miR-548d-5p,hsa-miR-548w,hsa-miR-548o-5p,hsa-miR-548ad-5p,hsa-miR-548ae-5p,hsa-miR-548ak,hsa-miR-548am-5p,hsa-miR-548ar-5p,hsa-miR-548au-5p,hsa-miR-548ay-5p	NA	SRGAP2C	RETREG2
ENSG00000227155	DOCK8-AS2	-3.15604475532218	4.27481410041402e-6	M2_vs_M1	HSALNG0069538	anti_sense	Q90	hsa-miR-4268,hsa-miR-4743-3p	Bilirubin measurement,Hair morphology measurement,-	ZNG1A	ANAPC1
ENSG00000227258	SMIM2-AS1	2.28937436497266	7.02870659954315e-8	M2_vs_M1	HSALNG0096738	integenic	Not conserved	NA	NA	NA	TMIE
ENSG00000227355	NA	-2.59579187715286	1.10791749028253e-6	M2_vs_M1	HSALNG0074175	integenic	Not conserved	hsa-miR-6089	-	GSN	NUDC
ENSG00000227398	KIF9-AS1	1.85299109956288	0.00354647508699919	M2_vs_M1	HSALNG0025756	integenic	Not conserved	hsa-miR-4259,hsa-miR-6089,hsa-miR-8485	NA	KLHL18	RBM33-DT
ENSG00000227456	LINC00310	1.38570244547097	0.0351240981311803	M2_vs_M1	HSALNG0132832	integenic	Not conserved	NA	NA	MRPS6	AGER
ENSG00000227467	LINC01537	4.08554762270586	1.20636126605766e-4	M2_vs_M1	HSALNG0141635	anti_sense	Not conserved	NA	-	ATG16L2	SKA1
ENSG00000227496	NA	5.13931515360266	0.0065680593566486	M2_vs_M1	HSALNG0011013	integenic	Q50	hsa-miR-4769-5p	Neuroticism measurement,Monocyte count,Interleukin-6 measurement,Unipolar depression,Leukocyte count,Leukocyte count; Myeloid white cell count; Monocyte count,Susceptibility to hepatitis b infection measurement,Myeloid white cell count,Cognitive inhibition measurement,Lymphocyte count,Serum gamma-glutamyl transferase measurement,-	SRP9	CNGA1
ENSG00000227502	MROCKI	-3.28087689495243	1.89026931712467e-62	M2_vs_M1	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	ANKRD1
ENSG00000227508	LINC01624	3.87154388035558	0.00281391410729483	M2_vs_M1	HSALNG0055432	integenic	Not conserved	hsa-miR-342-5p	Anti-thyroglobulin antibody measurement,Lymphocyte count; Platelet crit; Leukocyte count; Platelet count; Monocyte count,Leukocyte count; Lymphocyte count; Monocyte count,Blood protein measurement,Testosterone measurement	FAM120B	ENSG00000229407
ENSG00000227527	NA	1.97674724760832	7.24603905603689e-5	M2_vs_M1	HSALNG0002990	sense	Q50	hsa-miR-3960	NA	FOXJ3	FOXD2-AS1
ENSG00000227531	NA	-9.76546010809857	5.204772701268619e-43	M2_vs_M1	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	CD80
ENSG00000227533	SLC2A1-DT	2.91835980516836	4.6684026242871e-4	M2_vs_M1	HSALNG0003053	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Calcium measurement; Glucose measurement,Calcium measurement,Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Reticulocyte count; Reticulocyte measurement,Red blood cell distribution width,Viral load,Mean corpuscular hemoglobin concentration,Varicose veins,Mean corpuscular volume,Birth weight,Birth weight; Alcohol consumption measurement,Neutrophil count; Monocyte count,-	ZNF691	RPA2
ENSG00000227630	LINC01132	7.05896420923116	7.96082876964529e-9	M2_vs_M1	HSALNG0011630	integenic	Q50	hsa-miR-4456,hsa-miR-4717-3p,hsa-miR-6752-3p	Urate measurement,Hmg coa reductase inhibitor use measurement,-	COA6	RPA3
ENSG00000227741	NA	-2.46129348850271	1.09491193220867e-10	M2_vs_M1	HSALNG0007819	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-4483,hsa-miR-3960,hsa-miR-6846-5p,hsa-miR-7109-5p	-	DCAF8	HLA-DMB
ENSG00000227811	INKA2-AS1	4.92300849220317	0.0109290991279679	M2_vs_M1	HSALNG0006073	intronic_antisense	Q90	hsa-miR-939-3p,hsa-miR-3178	Body mass index,Multisite chronic pain,-	DDX20	ENSG00000270190
ENSG00000227896	WAPL-DT	3.35444779686145	2.37764333961249e-4	M2_vs_M1	HSALNG0079399	anti_sense	Q90	hsa-miR-4660,hsa-miR-4687-3p,hsa-miR-6089,hsa-miR-6779-5p	Parental longevity,-	OPN4	PCTP
ENSG00000228022	HCG20	-2.86607085290151	0.00197605152210233	M2_vs_M1	HSALNG0049198	integenic	Not conserved	NA	NA	TUBB	ATAD1
ENSG00000228037	NA	-4.81209567551277	0.0334035152293345	M2_vs_M1	HSALNG0000279	integenic	Not conserved	hsa-miR-4447,hsa-miR-6089,hsa-miR-6873-3p	Ulcerative colitis,Ulcerative colitis; Inflammatory bowel disease; Body mass index,Ulcerative colitis; Inflammatory bowel disease,Eosinophil count,Autoimmune disease; Rheumatoid arthritis,Eczema; Allergic rhinitis	PRXL2B	HLA-DRB9
ENSG00000228058	LINC01736	5.64349714788957	3.98829979869994e-4	M2_vs_M1	HSALNG0011359	integenic	Not conserved	NA	NA	GALNT2	ZNF548
ENSG00000228060	PABPC4-AS1	-3.01294762358106	4.62525643955752e-5	M2_vs_M1	HSALNG0002780	anti_sense	Q50	hsa-miR-619-5p	C-reactive protein measurement; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Testosterone measurement; Apolipoprotein a 1 measurement; Mean corpuscular hemoglobin; High density lipoprotein cholesterol measurement; Hdl cholesterol change measurement; Mean corpuscular volume; Physical activity,Bmi-adjusted waist circumference,High density lipoprotein cholesterol measurement; Fev/fec ratio; Mean corpuscular hemoglobin concentration; Bilirubin measurement,Mean corpuscular hemoglobin,C-reactive protein measurement; Drugs used in diabetes use measurement; Fev/fec ratio,Body mass index,-	BMP8A	NSUN6
ENSG00000228107	NA	-5.91445972833261	0.00272317095890494	M2_vs_M1	HSALNG0132942	sense	Not conserved	hsa-miR-619-5p	-	MORC3	ENSG00000263466
ENSG00000228109	MELTF-AS1	1.91331618336726	0.00204113355257719	M2_vs_M1	HSALNG0031988	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-1228-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-4701-3p,hsa-miR-4734,hsa-miR-7108-3p	-	NCBP2AS2	NCAPH2
ENSG00000228124	MDN1-AS1	-5.38052099776404	0.00698278351708131	M2_vs_M1	HSALNG0051878	anti_sense	Q90	hsa-miR-619-5p	Susceptibility to mononucleosis measurement,Eosinophil count,Response to sulfonylurea; Qrs duration,-	ANKRD6	TMEM231
ENSG00000228172	NA	1.72424725483361	0.0117306133703063	M2_vs_M1	HSALNG0001828	anti_sense	Q50	hsa-miR-6873-3p	-	AUNIP	DIABLO
ENSG00000228192	ZNF691-DT	-1.3011089157504	4.95746360244335e-4	M2_vs_M1	HSALNG0003039	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-5693	Red blood cell distribution width,-	SVBP	IKZF2
ENSG00000228221	LINC00578	7.91081041737311	1.47394354198092e-16	M2_vs_M1	HSALNG0030898	integenic	Not conserved	hsa-miR-4505	NA	KCNMB2	LINC01943
ENSG00000228315	GUSBP11	-1.85881104558167	9.87292606415229e-10	M2_vs_M1	HSALNG0134423	integenic	Not conserved	NA	Adolescent idiopathic scoliosis	DRICH1	ENSG00000258559
ENSG00000228318	NA	-6.4639277034081	1.98402023923458e-5	M2_vs_M1	HSALNG0133209	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089	Serum alanine aminotransferase measurement,3-hydroxypropylmercapturic acid measurement,Atrial fibrillation; Diastolic blood pressure; Ventricular rate measurement; Diabetes mellitus; Heart failure; Cancer; Body mass index; Stroke; Total cholesterol measurement; Systolic blood pressure; Mortality; High density lipoprotein cholesterol measurement; Triglyceride measurement; Hematocrit; Glucose measurement; Coronary artery disease,-	TMPRSS2	RFX6
ENSG00000228340	MIR646HG	4.876725362528	2.4565663787974599e-26	M2_vs_M1	HSALNG0131404	integenic	Not conserved	NA	-	CDH26	EBPL
ENSG00000228350	LINC02585	3.64202453013998	0.00293986512375008	M2_vs_M1	HSALNG0025865	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6803-5p	Intelligence; Body mass index; Bmi-adjusted waist circumference; Ccl2 measurement; Myocardial infarction,Cognitive function measurement; Mathematical ability,Anorexia nervosa; Unipolar depression,-	ATRIP	NAT10
ENSG00000228352	NA	-5.27230722681747	0.0149728254219	M2_vs_M1	HSALNG0070821	anti_sense	Q50	NA	Mean corpuscular volume,Alkaline phosphatase measurement; Daytime rest measurement,Body mass index,-	UBAP1	ENSG00000275764
ENSG00000228427	NA	1.68645762169729	5.65497281889112e-8	M2_vs_M1	HSALNG0138463	integenic	Q75	hsa-miR-30b-3p,hsa-miR-6089	Prostate carcinoma	ZMYM3	ZFP28
ENSG00000228436	RRAGC-DT	-1.67514047259446	0.0106075365171782	M2_vs_M1	HSALNG0002723	overlap_antisense,anti_sense	Q90	hsa-miR-363-5p,hsa-miR-619-5p	Protein measurement,Blood protein measurement,Kunitz-type protease inhibitor 1 measurement,Triglyceride measurement,Age at menopause,Unipolar depression,Sweet beverage consumption measurement,-	AKIRIN1	LINC02454
ENSG00000228526	MIR34AHG	-2.00967385372	0.0279606152519202	M2_vs_M1	HSALNG0000682	integenic	Q50	hsa-miR-4279,hsa-miR-500b-3p,hsa-miR-4723-3p,hsa-miR-6724-5p,hsa-miR-6744-3p,hsa-miR-7150,hsa-miR-7152-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Body height,Lean body mass,Linguistic error measurement; Specific language impairment,-	GPR157	THAP12P7
ENSG00000228544	CCDC183-AS1	-3.11318974575177	1.05248633232386e-18	M2_vs_M1	HSALNG0075303	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-1587	-	LCN15	PTMS
ENSG00000228561	NA	5.64971695835166	0.00276838021208482	M2_vs_M1	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2	SNORD3A
ENSG00000228606	DCAF8-DT	-3.1016120292489	4.45137361164792e-4	M2_vs_M1	HSALNG0007829	anti_sense	Q90	hsa-miR-4255,hsa-miR-3960,hsa-miR-4695-5p,hsa-miR-6089,hsa-miR-6125	Breast size,-	PEA15	KDSR-DT
ENSG00000228624	HDAC2-AS2	2.13058735410051	2.06008315585562e-6	M2_vs_M1	HSALNG0052943	integenic	Not conserved	NA	NA	MARCKS	LINC00390
ENSG00000228661	STIM1-AS1	-5.38079072046545	0.00812186297778316	M2_vs_M1	HSALNG0082330	anti_sense	Q90	NA	NA	RHOG	STIM1-AS1
ENSG00000228705	LINC00659	4.06439684971462	1.18120354416303e-16	M2_vs_M1	HSALNG0131561	anti_sense	Q50	hsa-miR-4505,hsa-miR-1587,hsa-miR-6732-5p	-	TCFL5	TMEM125
ENSG00000228794	LINC01128	-1.32534634040978	1.9644457465892098e-23	M2_vs_M1	HSALNG0000041	integenic	Not conserved	NA	Unipolar depression,Circadian rhythm,-	SAMD11	CADM1
ENSG00000228952	LINC02041	-6.23239061661896	6.11521685023923e-5	M2_vs_M1	HSALNG0031422	integenic	Not conserved	hsa-miR-4534	-	RTP4	ENSG00000259810
ENSG00000228956	SATB1-AS1	2.0500238097664	4.17446529265934e-20	M2_vs_M1	HSALNG0147471	integenic	Q50	NA	NA	KCNH8	SLMAP
ENSG00000229152	ANKRD10-IT1	-3.53537563410764	1.2369194826089899e-26	M2_vs_M1	HSALNG0099405	sense	Not conserved	NA	Facial emotion recognition measurement	ANKRD10	TMEM30BP1
ENSG00000229271	NA	-6.29766200808018	3.27144922247744e-5	M2_vs_M1	HSALNG0024495	sense	Not conserved	NA	Response to opioid,-	DAZL	CD5L
ENSG00000229334	TMEM44-AS2	2.60756033344033	8.43707703263478e-11	M2_vs_M1	HSALNG0031749	anti_sense	Not conserved	NA	Progranulin measurement	FAM43A	ENSG00000260086
ENSG00000229400	CNIH3-AS1	-4.83583691196562	0.0465720651372292	M2_vs_M1	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	ENSG00000290812
ENSG00000229484	LINC02766	2.60086771661029	1.68112950919254e-4	M2_vs_M1	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	MT2P1
ENSG00000229563	LINC01204	4.67277736423428	0.0365768674775849	M2_vs_M1	HSALNG0137579	integenic	Q75	NA	NA	KDM6A	OGDH
ENSG00000229618	NA	-5.94445559791091	5.88637792230197e-4	M2_vs_M1	HSALNG0056278	integenic	Q90	NA	NA	ARL4A	ENSG00000238015
ENSG00000229619	MBNL1-AS1	2.78803105157728	1.04757900403179e-34	M2_vs_M1	HSALNG0029874	anti_sense	Q50	hsa-miR-4492,hsa-miR-5587-3p	Body height,Balding measurement,Colorectal cancer,Pulse pressure measurement,Hematocrit; Hemoglobin measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Neutrophil count,Myeloid white cell count,-	IGSF10	SNRPD3
ENSG00000229873	OGFR-AS1	-2.68215075203557	4.89502376942515e-6	M2_vs_M1	HSALNG0131564	anti_sense	Q90	hsa-miR-1271-5p,hsa-miR-6800-3p	-	TCFL5	NOP14-AS1
ENSG00000229921	KIF25-AS1	1.31627255406405	5.33998399155541e-4	M2_vs_M1	HSALNG0055219	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-3652,hsa-miR-6089,hsa-miR-6826-3p	5-hiaa measurement,Nicotine dependence symptom count,Heel bone mineral density,-	FRMD1	RPL23AP7
ENSG00000229922	LINC02865	-6.07861549467881	4.4831020655392e-4	M2_vs_M1	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	LINC00487
ENSG00000229931	ATXN1-AS1	2.82698320036073	0.0014167253772447	M2_vs_M1	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	AGL
ENSG00000229953	BCAN-AS2	2.71245141989578	1.1155090572902998e-12	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	C2orf92
ENSG00000230061	TRPM2-AS	-1.87217673691797	0.0328672031639792	M2_vs_M1	HSALNG0133533	anti_sense	Q50	hsa-miR-4486,hsa-miR-6888-5p,hsa-miR-7110-5p	-	TSPEAR	ZNF528
ENSG00000230082	PRRT3-AS1	2.68624579618775	0.0207840424025232	M2_vs_M1	HSALNG0024078	anti_sense	Q50	NA	Blood protein measurement,-	CRELD1	RIC8A
ENSG00000230149	NA	-2.98831183289907	7.58306827747509e-4	M2_vs_M1	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1	NDRG4
ENSG00000230155	CEP250-AS1	1.09249099425578	4.45358486916699e-5	M2_vs_M1	HSALNG0129779	anti_sense	Q90	hsa-miR-3162-3p,hsa-miR-4478,hsa-miR-4483,hsa-miR-4492,hsa-miR-4505,hsa-miR-5787,hsa-miR-6089	Diastolic blood pressure change measurement,-	GDF5	ENSG00000230829
ENSG00000230176	LINC01433	1.84972945524322	0.00708872208323944	M2_vs_M1	HSALNG0128306	anti_sense	Q50	NA	Reticulocyte count; Reticulocyte measurement,Heel bone mineral density,Preeclampsia,Lipid measurement,Susceptibility to mononucleosis measurement,Abnormal paneth cell measurement,Pulse pressure measurement,Sensory perception of smell,-	SMOX	CT45A11P
ENSG00000230322	NA	-4.62804181817387	0.0425779514900532	M2_vs_M1	HSALNG0142712	intronic_antisense	Not conserved	NA	NA	USP6NL	H1-3
ENSG00000230325	NA	-2.44820918172862	0.0328249583484327	M2_vs_M1	HSALNG0011779	anti_sense,sense	Q75	NA	Platelet count; Platelet crit,Platelet component distribution width,Platelet count,-	HEATR1	ENSG00000223901
ENSG00000230337	EXOSC10-AS1	1.27314194073439	0.0252672437576665	M2_vs_M1	HSALNG0000845	anti_sense	Q75	NA	Waist-hip ratio,-	TARDBP	PUF60
ENSG00000230387	NA	4.66937179225962	0.0421177911625301	M2_vs_M1	HSALNG0129227	integenic	Q50	hsa-miR-151b,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-5006-5p,hsa-miR-8485	Serum alanine aminotransferase measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Venous thromboembolism	SSTR4	SLC46A1
ENSG00000230426	LINC01036	2.99560545869496	3.42537067477104e-4	M2_vs_M1	HSALNG0009116	integenic	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6802-5p	Asthma exacerbation measurement,Diet measurement,Unipolar depression,Fatty acid measurement; Fasting blood insulin measurement,Mouth morphology measurement,Non-alcoholic steatohepatitis,Protein measurement,5-hiaa measurement,Adolescent idiopathic scoliosis,Response to tenofovir,Corneal endothelial cell measurement,Interleukin 13 measurement,-	PLA2G4A	ACTR10
ENSG00000230513	THAP7-AS1	1.50469146269173	0.0493773267461162	M2_vs_M1	HSALNG0134192	anti_sense,sense	Q50	hsa-miR-3652,hsa-miR-1268b	-	P2RX6	ENSG00000286810
ENSG00000230537	LINC02937	3.46292559808168	7.272971354556361e-15	M2_vs_M1	HSALNG0072707	integenic	Not conserved	NA	Eosinophil count	AUH	ENSG00000291064
ENSG00000230551	NA	-1.05190099275628	1.6621514793461102e-15	M2_vs_M1	HSALNG0045763	sense	Q90	NA	-	CSNK1A1	PUS7L
ENSG00000230555	LINC02916	-3.67775445543388	4.28254668287023e-4	M2_vs_M1	HSALNG0077549	integenic	Q50	hsa-miR-619-5p	NA	ZNF487	ZNF404
ENSG00000230647	NA	-8.23360959592768	8.17070201305405e-18	M2_vs_M1	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	ENSG00000213172
ENSG00000230736	NA	-3.47736009003509	0.00313620439565779	M2_vs_M1	HSALNG0135029	integenic	Not conserved	NA	NA	RFPL3	ENSG00000261884
ENSG00000230896	NA	1.5098419265464	0.0483174478523214	M2_vs_M1	HSALNG0003271	sense	Q75	hsa-miR-619-5p	NA	IPP	SNORD3A
ENSG00000230943	LINC02541	-2.29509983636114	3.39070745840121e-6	M2_vs_M1	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	NAF1
ENSG00000231090	MIR4422HG	5.1326531156654	0.014742559761287	M2_vs_M1	HSALNG0003825	integenic	Not conserved	NA	NA	PCSK9	TRPC5
ENSG00000231106	LINC01436	-1.48226269665149	2.1204351568704404e-15	M2_vs_M1	HSALNG0132900	anti_sense	Q90	hsa-miR-1224-3p,hsa-miR-4478	-	CBR1	ELAC2
ENSG00000231113	LINC02976	1.57659866284023	2.81480053855501e-7	M2_vs_M1	HSALNG0050136	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	Diabetic nephropathy; Mean corpuscular hemoglobin,Apolipoprotein a 1 measurement,-	CNPY3	BTG3
ENSG00000231125	NA	-2.81889146414553	0.0436945116434901	M2_vs_M1	HSALNG0132524	sense	Not conserved	NA	-	CCT8	MED17
ENSG00000231305	NA	-1.61222602231326	0.00944910422262968	M2_vs_M1	HSALNG0147925	integenic	Not conserved	hsa-miR-6089,hsa-miR-6802-3p	-	CFAP92	GNPTG
ENSG00000231346	LINC01160	3.28994595048389	5.492371930297099e-149	M2_vs_M1	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3	MRPL20
ENSG00000231407	GORAB-AS1	-7.41088672003912	8.27818201960149e-11	M2_vs_M1	HSALNG0008377	anti_sense	Q50	hsa-miR-5011-3p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Adolescent idiopathic scoliosis,Bmi-adjusted waist circumference,Soluble triggering receptor expressed on myeloid cells 2 measurement,-,Androgenetic alopecia	KIFAP3	ACOD1
ENSG00000231426	FILNC1	3.26851890547852	5.0339439236312704e-17	M2_vs_M1	HSALNG0053896	integenic	Q50	hsa-miR-619-5p	Serum igg glycosylation measurement,Age at onset,Response to simvastatin; Pcsk9 protein measurement,-	HECA	GPX1P1
ENSG00000231453	LINC01305	-1.22458042818558	1.17464443277575e-17	M2_vs_M1	HSALNG0020489	integenic	Q90	hsa-miR-6803-5p,hsa-miR-7160-3p	-	SP9	UQCC2
ENSG00000231527	FAM27C	2.96625914445845	3.50685059431882e-5	M2_vs_M1	HSALNG0071372	integenic	Not conserved	hsa-miR-1207-3p	NA	CNTNAP3C	PYCR1
ENSG00000231528	FAM225A	-2.05633176805208	2.48366283264612e-63	M2_vs_M1	HSALNG0073810	integenic	Not conserved	NA	NA	SLC31A2	KLHL29
ENSG00000231535	LINC00278	-3.51539642432202	1.32718122138679e-37	M2_vs_M1	HSALNG0140973	integenic	Not conserved	NA	NA	ZFY	UEVLD
ENSG00000231563	NA	-2.3596273731796	0.0428202997127378	M2_vs_M1	HSALNG0011246	integenic	Not conserved	NA	NA	OBSCN	LY6G5B
ENSG00000231609	EHBP1-AS1	1.49561398041736	1.22190366602456e-7	M2_vs_M1	HSALNG0015409	anti_sense	Q90	hsa-miR-4292,hsa-miR-5698,hsa-miR-6728-3p,hsa-miR-6780a-3p	Balding measurement,Vital capacity,Low density lipoprotein cholesterol measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	WDPCP	FBXL19-AS1
ENSG00000231613	NA	5.65788586652042	1.31167729984106e-15	M2_vs_M1	HSALNG0005090	sense	Q50	hsa-miR-4505,hsa-miR-4741,hsa-miR-5787	Protein measurement,Mean platelet volume	NA	ARFGEF1
ENSG00000231638	LUARIS	-3.03206035295745	0.0207696845008824	M2_vs_M1	HSALNG0057557	anti_sense	Q90	NA	Beta-amyloid 1-42 measurement; Cerebrospinal fluid biomarker measurement,-	COA1	LINC01841
ENSG00000231652	CD109-AS1	-1.49191005587001	0.0403124832234771	M2_vs_M1	HSALNG0051248	anti_sense	Q75	hsa-miR-4677-5p,hsa-miR-4783-5p	Angina pectoris; Myocardial infarction; Heel bone mineral density,-	SLC17A5	KCTD13-DT
ENSG00000231663	COA6-AS1	1.43868234675969	2.36672722703737e-5	M2_vs_M1	HSALNG0011591	anti_sense	Q50	hsa-miR-6763-5p	-	TARBP1	UBAC2
ENSG00000231711	LINC00899	1.43446714521178	2.93939318696694e-6	M2_vs_M1	HSALNG0135993	integenic	Q50	hsa-miR-320a-5p,hsa-miR-762,hsa-miR-3178,hsa-miR-6763-3p	Birth weight,Smoking status measurement	WNT7B	CHODL
ENSG00000231721	LINC-PINT	-2.2618657937732	6.952047125097741e-61	M2_vs_M1	HSALNG0150064	integenic	Q50	NA	NA	KLF14	SERINC5
ENSG00000231731	NA	-3.7378911125226	3.12661893226614e-4	M2_vs_M1	HSALNG0018624	anti_sense	Q90	hsa-miR-591,hsa-miR-1182,hsa-miR-4478	Cardiac troponin i measurement,Self reported educational attainment,-	MYO7B	TRGV7
ENSG00000231776	LINC01611	4.66977713649336	0.0310928546916903	M2_vs_M1	HSALNG0051652	integenic	Q75	hsa-miR-1182,hsa-miR-4710	Bmi-adjusted waist-hip ratio,Breast carcinoma,Phosphatidylcholine 32:1 measurement,Synophrys measurement,Diabetic retinopathy,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Diacylglycerol 36:1 measurement; Triacylglycerol 52:1 measurement; Triacylglycerol 50:3 measurement; Diacylglycerol 34:1 measurement; Diacylglycerol 36:2 measurement,Pulse pressure measurement,Empathy measurement,Systolic blood pressure,Heel bone mineral density,Cortical surface area measurement,-	TBX18	LINC01611
ENSG00000231808	LINC01388	-3.9178878139173	4.3812056376713593e-75	M2_vs_M1	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	POLK
ENSG00000231877	NA	4.69731707211718	1.59672650680658e-7	M2_vs_M1	HSALNG0011827	integenic	Q75	hsa-miR-4308,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-2467-3p,hsa-miR-6089,hsa-miR-6510-5p,hsa-miR-6877-3p	Adolescent idiopathic scoliosis,White matter microstructure measurement,Neurofibrillary tangles measurement,Intelligence,Protein measurement,Frontal pole volume measurement,Serum selenium measurement,Economic and social preference,Dysphagia,Cognitive decline measurement,C-peptide measurement,Hippocampal volume,Serum alanine aminotransferase measurement; Response to combination chemotherapy,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	RYR2	SV2B
ENSG00000231969	MMADHC-DT	-3.38612980932384	0.00405723365472881	M2_vs_M1	HSALNG0019537	anti_sense	Q50	hsa-miR-4311	Acute lymphoblastic leukemia,Posterior cingulate cortex volume measurement,Binge eating,Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Fat body mass,Sex interaction measurement,Endometriosis,Age at menopause,Vitamin d measurement,Adolescent idiopathic scoliosis,Rheumatic heart disease,Clostridium difficile infection,Waist-hip ratio; Smoking behaviour measurement,Response to selective serotonin reuptake inhibitor; Low density lipoprotein cholesterol measurement,-	LYPD6	RBP5
ENSG00000231971	CT69	-2.9849816741634	8.13798772117353e-4	M2_vs_M1	HSALNG0053626	integenic	Q90	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4447,hsa-miR-4486,hsa-miR-6089	Mean corpuscular hemoglobin,Urate measurement,Erythrocyte count,Glomerular filtration rate,Abnormality of refraction,Mean corpuscular volume,Melanoma,Varicose veins,Hair colour measurement,Eosinophil count,Electrocardiography,Monocyte count,Platelet component distribution width; Platelet crit; Platelet count,Reticulocyte count,Leukocyte count,Platelet count,Triacylglycerol 52:5 measurement; Triacylglycerol 54:8 measurement,Calcium measurement,Platelet crit,Lymphocyte count,Coronary artery calcification,Red blood cell distribution width,Platelet-to-lymphocyte ratio,Cirrhosis of liver; Non-alcoholic fatty liver disease,Mean corpuscular hemoglobin; Erythrocyte count,Pulse pressure measurement,-	SGK1	SYVN1
ENSG00000232006	NA	-3.73936563273404	2.73915790342769e-4	M2_vs_M1	HSALNG0149924	integenic	Not conserved	hsa-miR-4691-5p	NA	NA	PRELID3B
ENSG00000232043	NA	-2.81942034398367	0.0435546452905781	M2_vs_M1	HSALNG0130783	anti_sense	Not conserved	NA	Heel bone mineral density,Duchenne muscular dystrophy; Disease progression measurement	RIPOR3	LINC02454
ENSG00000232053	NA	-4.62328308078795	0.0458259068745651	M2_vs_M1	HSALNG0061598	integenic	Q75	hsa-miR-663b	NA	STMP1	ENSG00000267501
ENSG00000232065	LINC01063	1.44173621855953	0.00187786769800672	M2_vs_M1	HSALNG0031952	anti_sense	Q50	NA	Inhalant adrenergic use measurement,Respiratory system disease,-	WDR53	DDX6
ENSG00000232082	RPS6KA2-IT1	-2.16522447803182	2.29495735058343e-5	M2_vs_M1	HSALNG0055101	sense	Not conserved	hsa-miR-4505,hsa-miR-6895-5p	NA	RPS6KA2	ENSG00000279491
ENSG00000232098	ZNF584-DT	1.38276383054067	2.01030211875365e-4	M2_vs_M1	HSALNG0127962	anti_sense	Not conserved	NA	Mean platelet volume,-	ZNF837	C2CD2
ENSG00000232104	RFX3-DT	-2.00908993715107	1.2430311734896e-10	M2_vs_M1	HSALNG0069687	integenic	Q75	NA	NA	KCNV2	CRISPLD1
ENSG00000232124	NA	1.58157916970271	0.039634483684417	M2_vs_M1	HSALNG0133503	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-6769b-5p	NA	ICOSLG	AKNAD1
ENSG00000232160	RAP2C-AS1	-1.72611756120682	0.00346133491116483	M2_vs_M1	HSALNG0140185	integenic	Not conserved	NA	NA	STK26	PYCR3
ENSG00000232197	NA	2.43756932992815	2.89352112806778e-12	M2_vs_M1	HSALNG0055420	integenic	Not conserved	hsa-miR-6883-5p,hsa-miR-6890-3p	Prostate carcinoma,-	FAM120B	EBF1
ENSG00000232442	MHENCR	1.35640010099695	1.9491709005296103e-9	M2_vs_M1	HSALNG0131657	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6786-5p	-	RTEL1	CAPN7
ENSG00000232453	LINC02777	1.82495685155187	0.0042253783136317	M2_vs_M1	HSALNG0003962	integenic	Not conserved	NA	Bmi-adjusted hip circumference,-	JUN	GHDC
ENSG00000232520	GCSIR	4.67309527622869	0.0454665799576419	M2_vs_M1	HSALNG0022903	integenic	Q50	hsa-miR-4508,hsa-miR-5011-3p,hsa-miR-7160-3p	-	ITM2C	KATNAL2
ENSG00000232533	FAM131B-AS2	3.8033352076512	1.996875367688e-209	M2_vs_M1	HSALNG0061960	integenic	Not conserved	hsa-miR-10392-3p	-	EPHA1	CD180
ENSG00000232628	NA	2.42178000085226	0.0332414355222321	M2_vs_M1	HSALNG0010945	integenic	Not conserved	NA	Ceramide measurement	NVL	AKNAD1
ENSG00000232671	ZNF687-AS1	1.89656298857966	0.0209923082517737	M2_vs_M1	HSALNG0007132	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4664-3p,hsa-miR-6803-5p	Monocyte count,-	PI4KB	C8orf82
ENSG00000232679	LINC01705	-2.4483421389045	0.0032116210060604	M2_vs_M1	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10	ENSG00000243176
ENSG00000232712	KIZ-AS1	-4.8052640670053	0.0317093205164686	M2_vs_M1	HSALNG0129095	anti_sense	Q90	hsa-miR-1285-3p,hsa-miR-4463,hsa-miR-4472,hsa-miR-6089	Lean body mass,Cystatin c measurement,Body height,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Lupus nephritis,-	NKX2-4	CEP57L1
ENSG00000232721	NA	2.83316764618774	0.0240207255824803	M2_vs_M1	HSALNG0141875	integenic	Not conserved	NA	NA	PPIAL4F	ENSG00000286615
ENSG00000232725	PLXNB3-AS1	-1.67301738421126	4.06654662607079e-4	M2_vs_M1	HSALNG0140789	anti_sense	Not conserved	hsa-miR-383-3p,hsa-miR-33b-3p,hsa-miR-4430,hsa-miR-4534,hsa-miR-5587-3p,hsa-miR-6089	Hba1c measurement,Mental or behavioural disorder,-	BCAP31	ZNF91
ENSG00000232788	ITGA6-AS1	3.31285535398051	2.24419125165449e-10	M2_vs_M1	HSALNG0020385	anti_sense	Q90	hsa-miR-320a-5p,hsa-miR-920,hsa-miR-6089,hsa-miR-6749-5p,hsa-miR-6784-5p,hsa-miR-6808-5p,hsa-miR-6846-5p	[pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement,Eosinophil count,-	DLX2	UAP1
ENSG00000232931	LINC00342	1.00620198307686	0.00216479619250385	M2_vs_M1	HSALNG0146543	integenic	Not conserved	NA	NA	ANKRD36C	LINC00623
ENSG00000232973	CYP1B1-AS1	-1.668212239979	0.0032627769994462	M2_vs_M1	HSALNG0014289	anti_sense	Q75	hsa-miR-4313,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6775-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6829-3p,hsa-miR-6872-3p	Suntan,Nevus count; Cutaneous melanoma,Cytokine measurement,Ischemic stroke; Coronary artery disease,Body height,Breast carcinoma,Non-melanoma skin carcinoma,Environmental tobacco smoke exposure measurement; Age at onset,Viral load; Hiv infection; Cd4-positive t-lymphocyte count; Disease progression measurement,-	RMDN2	KLHDC8B
ENSG00000233016	SNHG7	1.65056126136409	5.23031829615523e-53	M2_vs_M1	HSALNG0075291	anti_sense	Q90	hsa-miR-6089,hsa-miR-6829-3p	Body height,-	NA	POLD3
ENSG00000233030	NA	-4.1217499674892	3.40384316261153e-47	M2_vs_M1	HSALNG0142341	anti_sense,intronic_sense	Not conserved	NA	Monocyte count,-	H2BC18	SCG3
ENSG00000233038	PTPRN2-AS1	3.38404735893904	1.96475846733835e-9	M2_vs_M1	HSALNG0062762	anti_sense	Not conserved	hsa-miR-762,hsa-miR-3195,hsa-miR-4297,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-7113-3p	-	DNAJB6	SSBP2
ENSG00000233070	ZFY-AS1	-1.8492160697158	0.00722897036635858	M2_vs_M1	HSALNG0140969	anti_sense	Not conserved	NA	NA	SRY	RPL30-AS1
ENSG00000233073	GRM3-AS1	3.00989566486786	0.0389043161308217	M2_vs_M1	HSALNG0059352	anti_sense	Q50	hsa-miR-216a-3p,hsa-miR-4476,hsa-miR-6728-3p	Anorexia nervosa; Self reported educational attainment; Intelligence; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,-	ELAPOR2	ARHGAP44
ENSG00000233093	LINC00892	4.49587121330426	1.33062334794985e-6	M2_vs_M1	HSALNG0140334	integenic	Q50	hsa-miR-671-5p	NA	CD40LG	ZEB1-AS1
ENSG00000233098	CCDC144NL-AS1	-1.09962695016968	7.522343456083319e-36	M2_vs_M1	HSALNG0115238	integenic	Not conserved	hsa-miR-4286	NA	DHRS7B	TSPAN1
ENSG00000233117	LINC00702	1.07822783753998	3.4636410921966895e-11	M2_vs_M1	HSALNG0075773	integenic	Q50	hsa-miR-4279,hsa-miR-4710	Anti-thyroglobulin antibody measurement,Biological sex,Body height,-	KLF6	NRSN2
ENSG00000233143	DIRC3-AS1	3.05951297908683	4.19121805356285e-20	M2_vs_M1	HSALNG0022193	integenic	Not conserved	NA	-	IGFBP2	PITX1-AS1
ENSG00000233153	UBE2E2-DT	-4.80581869720149	0.0298412873991393	M2_vs_M1	HSALNG0024658	integenic	Q75	hsa-miR-486-3p,hsa-miR-1224-3p,hsa-miR-6089,hsa-miR-6891-5p	Reaction time measurement,-	NKIRAS1	IFNL1
ENSG00000233223	NA	-1.8498011553823	1.21141689589136e-14	M2_vs_M1	HSALNG0114322	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-1224-3p,hsa-miR-6089,hsa-miR-7160-3p	Testosterone measurement; Sex hormone-binding globulin measurement; Serum igm measurement,Testosterone measurement,Serum metabolite measurement,Cortical thickness,Metabolic syndrome,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-,Testosterone measurement; Sex hormone-binding globulin measurement,Protein measurement; Sex hormone-binding globulin measurement; Serum iga measurement,Red blood cell distribution width,Platelet component distribution width	SOX15	GATA5
ENSG00000233351	NA	5.90303783937314	1.33621041562922e-4	M2_vs_M1	HSALNG0053423	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-8485	Sporadic amyotrophic lateral sclerosis,Hypermetropia; Self reported educational attainment; Refractive error; Retinal break; Retinal detachment; Age at onset; Myopia; Axial length measurement,Abnormality of refraction,Refractive error,Cortical surface area measurement,Body height,Cortical thickness,Sleep duration,Body mass index,Periodontitis,Cytokine measurement,Response to alcohol,-	ARHGAP18	TMA7
ENSG00000233360	PDXP-DT	-3.04646106527047	0.0260756028728033	M2_vs_M1	HSALNG0135333	anti_sense	Q75	hsa-miR-6749-3p	-	LGALS2	ENSG00000271918
ENSG00000233384	CNIH3-AS2	3.07040343472765	1.7100149238031997e-44	M2_vs_M1	HSALNG0010968	anti_sense	Q75	hsa-miR-4467,hsa-miR-3960,hsa-miR-7156-3p	-	WDR26	CMTM7
ENSG00000233539	NA	-7.43443013226343	4.46071224679969e-11	M2_vs_M1	HSALNG0057793	integenic	Not conserved	NA	Response to diisocyanate,Glomerular filtration rate,Uric acid measurement,Lobe attachment,Igf-1 measurement,Igfbp-3 measurement; Igf-1 measurement,Glomerular filtration rate; Thyroid stimulating hormone measurement; Blood urea nitrogen measurement; Creatinine measurement; Igfbp-3 measurement; Urate measurement,Blood urea nitrogen measurement; Glomerular filtration rate,Cytokine measurement,Comparative body size at age 10, self-reported	TNS3	ENSG00000238015
ENSG00000233695	GAS6-AS1	-1.74497494757813	3.1314735910079697e-13	M2_vs_M1	HSALNG0099627	anti_sense	Not conserved	hsa-miR-6721-5p	NA	TMEM255B	ENSG00000217801
ENSG00000233705	SLC26A4-AS1	2.42082037458216	0.0152141705609235	M2_vs_M1	HSALNG0060441	anti_sense	Q50	hsa-miR-4268,hsa-miR-4486,hsa-miR-5587-3p	3-hydroxy-1-methylpropylmercapturic acid measurement,-	COG5	PRKAR2A
ENSG00000233725	NRAD1	-5.11991188837201	0.0088710618412041	M2_vs_M1	HSALNG0096726	sense	Not conserved	NA	NA	NA	ASB6
ENSG00000233828	MIR4280HG	5.97206157846302	8.818123577097709e-19	M2_vs_M1	HSALNG0043286	integenic	Q50	hsa-miR-6503-3p	NA	CCNH	PTPN3
ENSG00000233871	DLG5-AS1	4.60906371648578	3.9266832851732696e-25	M2_vs_M1	HSALNG0079068	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,-	RPS24	RTF1
ENSG00000233884	NA	3.36033275691202	0.00909804606366677	M2_vs_M1	HSALNG0072499	integenic	Not conserved	hsa-miR-6085,hsa-miR-7855-5p	-	CDK20	ZNF517
ENSG00000233975	LINC02574	-1.95007145006608	0.00100617524254929	M2_vs_M1	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	HVCN1
ENSG00000234028	EIF2AK3-DT	1.85956626851657	0.0230536301122493	M2_vs_M1	HSALNG0016705	anti_sense	Q50	NA	-	RPIA	ENSG00000277879
ENSG00000234147	NA	2.95998820395419	1.05312130107236e-207	M2_vs_M1	HSALNG0053918	integenic	Q75	hsa-miR-4281,hsa-miR-6776-5p,hsa-miR-8485	3-hydroxypropylmercapturic acid measurement,Susceptibility to bacterial meningitis measurement,Sleep quality,Facial emotion recognition measurement,Response to diisocyanate,Acute lymphoblastic leukemia,Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio,Reaction time measurement,-	NMBR	RPS5
ENSG00000234160	NA	1.44631042204341	0.00122988315318068	M2_vs_M1	HSALNG0071055	anti_sense,sense	Q90	hsa-miR-5196-5p,hsa-miR-1199-5p,hsa-miR-6089	Macrophage inflammatory protein 1b measurement,-	POLR1E	DIRC3-AS1
ENSG00000234191	LINC01283	-2.13829497667154	1.80282451049054e-32	M2_vs_M1	HSALNG0137357	integenic	Q75	NA	NA	BCOR	GFPT2
ENSG00000234263	MAP3K5-AS1	-3.19967584176396	1.32782684910879e-4	M2_vs_M1	HSALNG0053716	anti_sense	Q75	NA	Unipolar depression	PEX7	RPL22P24
ENSG00000234311	NA	2.41036933447326	1.00403770217563e-7	M2_vs_M1	HSALNG0081788	integenic	Q90	hsa-miR-574-5p,hsa-miR-6852-5p	Heel bone mineral density,Myopathy; Response to simvastatin,-	STK32C	CTSF
ENSG00000234327	ZNF232-AS1	3.162869411916	9.42737024799639e-4	M2_vs_M1	HSALNG0114103	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3162-5p,hsa-miR-1268b	-	ZFP3	CHID1
ENSG00000234390	USP27X-DT	-1.86487602554144	0.0211291734086295	M2_vs_M1	HSALNG0151200	integenic	Q90	NA	NA	PAGE1	ENSG00000255026
ENSG00000234456	MAGI2-AS3	-2.75525716607006	1.3942117594406699e-16	M2_vs_M1	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1	SYNPO2
ENSG00000234464	NA	6.55072667736581	6.8938806243966e-6	M2_vs_M1	HSALNG0142045	integenic	Not conserved	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	NA	RYR2	ERVK3-1
ENSG00000234494	SP2-AS1	1.13070295223014	0.0203222829510886	M2_vs_M1	HSALNG0117049	anti_sense	Q50	hsa-miR-7107-5p,hsa-miR-7160-3p	-	PRR15L	SMN2
ENSG00000234506	LINC01506	-6.47168551254239	8.05652191089934e-6	M2_vs_M1	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	ENSG00000290041
ENSG00000234572	LINC01800	2.39781739859513	2.06651693733264e-5	M2_vs_M1	HSALNG0015493	integenic	Q50	hsa-miR-27a-5p,hsa-miR-200c-5p,hsa-miR-7113-3p	Cholesteryl ester 22:6 measurement,Ccl2 measurement,Visceral adipose tissue measurement,Dna methylation,Epithelial cell adhesion molecule measurement,Sex hormone-binding globulin measurement,Obstructive sleep apnea; Sleep apnea measurement,Protein measurement,Monocyte percentage of leukocytes,-	SERTAD2	ZNF74
ENSG00000234608	MAPKAPK5-AS1	1.41467167523682	3.4588040824124e-27	M2_vs_M1	HSALNG0094063	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-3197,hsa-miR-3960,hsa-miR-7974	-	TMEM116	CCDC134
ENSG00000234678	ELF3-AS1	-1.631099956736	0.0041508162019608	M2_vs_M1	HSALNG0142396	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-4498	Blood protein measurement,Systemic lupus erythematosus,-	LMOD1	ZNF470-DT
ENSG00000234684	SDCBP2-AS1	-1.4496878004482	0.00156697239466132	M2_vs_M1	HSALNG0128102	anti_sense,sense	Q90	hsa-miR-30b-3p,hsa-miR-1207-5p,hsa-miR-4447	Lean body mass; Body mass index,Glomerular filtration rate,Glycocholate measurement,Sex interaction measurement; Bipolar disorder; Unipolar depression,-,Parental longevity	SNPH	AIRE
ENSG00000234694	CDC20-DT	1.64183841048328	0.00381303302093202	M2_vs_M1	HSALNG0003089	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-939-3p,hsa-miR-6798-5p,hsa-miR-6845-5p,hsa-miR-10392-3p	Platelet count,-	ELOVL1	RPS27P17
ENSG00000234717	TMEM212-AS1	-5.94269822300731	3.28669754481049e-4	M2_vs_M1	HSALNG0030700	anti_sense	Q50	hsa-miR-5004-3p,hsa-miR-6089	Sex hormone-binding globulin measurement,Body mass index,Colorectal cancer,Corneal resistance factor,White matter hyperintensity measurement; Hypertension,-	PLD1	DDX43
ENSG00000234883	MIR155HG	-1.92728927661131	5.64935008050737e-41	M2_vs_M1	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	MT1M
ENSG00000235027	PRADX	-3.58466114881836	9.55006653503436e-14	M2_vs_M1	NA	NA	NA	NA	NA	KRTAP5-6	TLR5
ENSG00000235119	NA	-3.68193841062152	6.36814375649654e-4	M2_vs_M1	HSALNG0073890	integenic	Q90	NA	-	AKNA	KDSR-DT
ENSG00000235204	NA	2.24384038150836	1.2686243225898698e-11	M2_vs_M1	HSALNG0074324	anti_sense	Q50	NA	-	PSMB7	PTBP2
ENSG00000235385	LINC02154	-6.68311600218154	1.21229844089531e-6	M2_vs_M1	HSALNG0136703	overlap_sense	Not conserved	NA	NA	ATXN3L	KLHDC7B-DT
ENSG00000235478	LINC01664	1.85272379941362	0.00470013835292125	M2_vs_M1	HSALNG0133870	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6132	Aging,Emotional symptom measurement,-	IL17RA	ENSG00000256448
ENSG00000235513	L3MBTL2-AS1	-3.07404459534604	2.38611964530782e-69	M2_vs_M1	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	SRC
ENSG00000235531	MSC-AS1	-2.2801727770828	6.15391808390073e-108	M2_vs_M1	HSALNG0066120	anti_sense	Not conserved	NA	Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2	SET
ENSG00000235560	ZNF747-DT	3.24987535196511	9.22586292624204e-7	M2_vs_M1	HSALNG0110746	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-378g	Serum gamma-glutamyl transferase measurement,Ccl5 measurement,-	ITGAL	TMEM276
ENSG00000235652	EPM2A-DT	-1.0758201002795	3.23227149740573e-5	M2_vs_M1	HSALNG0054132	anti_sense	Not conserved	hsa-miR-6089	Heel bone mineral density	GRM1	CLDN12
ENSG00000235706	DICER1-AS1	1.42061256417592	0.00302804861682504	M2_vs_M1	HSALNG0103422	anti_sense	Q90	hsa-miR-4472,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6803-5p	-	GLRX5	STX1B
ENSG00000235724	PSMD14-DT	-5.37928932868987	0.00392607573547507	M2_vs_M1	HSALNG0019993	integenic	Q90	NA	Intelligence; Unipolar depression	DPP4	FRY
ENSG00000235760	MSH2-OT1	2.14335216287177	0.00320461336090809	M2_vs_M1	HSALNG0014760	anti_sense,sense	Not conserved	NA	NA	MSH2	RBM42
ENSG00000235770	LINC00607	-2.90061096211813	3.28006248827119e-14	M2_vs_M1	HSALNG0022091	integenic	Not conserved	NA	-	MREG	VCAM1
ENSG00000235813	NA	-2.26612960723811	0.00233292206138428	M2_vs_M1	HSALNG0140236	anti_sense	Not conserved	hsa-miR-619-5p	Leukocyte count,Blood urea nitrogen measurement,Hematocrit; Creatinine measurement; Glomerular filtration rate,Creatinine measurement,Birth weight	HPRT1	ENSG00000258101
ENSG00000235823	OLMALINC	1.33966026674707	8.82045087452076e-8	M2_vs_M1	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD	ZNF274
ENSG00000235865	GSN-AS1	-1.03656847017694	0.0113918906932397	M2_vs_M1	HSALNG0074167	anti_sense	Not conserved	NA	-	STOM	LY6G5B
ENSG00000235947	EGOT	-4.79672792424628	0.0353349734759318	M2_vs_M1	HSALNG0023880	anti_sense	Q90	NA	3-hydroxy-1-methylpropylmercapturic acid measurement,-	SUMF1	STAT4-AS1
ENSG00000235978	NA	-2.13488190700124	0.032575314420792	M2_vs_M1	HSALNG0023883	anti_sense	Q75	hsa-miR-3155b	Systolic blood pressure,Serum gamma-glutamyl transferase measurement,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	SUMF1	ENSG00000275765
ENSG00000235989	MORC2-AS1	-1.65502609773187	0.0237523521615816	M2_vs_M1	HSALNG0134927	anti_sense	Q50	NA	-	OSBP2	NEK1
ENSG00000236008	LINC01814	1.82631268824949	0.00243172496080328	M2_vs_M1	HSALNG0012834	integenic	Not conserved	hsa-miR-7160-3p	NA	KIDINS220	C4orf46
ENSG00000236013	LINC02941	5.94683071155944	1.8037309923942098e-19	M2_vs_M1	HSALNG0053902	integenic	Not conserved	hsa-miR-574-5p	NA	HECA	ZNF385B
ENSG00000236021	COP1-DT	-1.45714251501663	0.00458187688281517	M2_vs_M1	HSALNG0008629	integenic	Q75	hsa-miR-619-5p,hsa-miR-6763-5p	Wellbeing measurement; Neuroticism measurement; Depressive symptom measurement,Body height,Cognitive function measurement,Bmi-adjusted hip circumference,Wellbeing measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Unipolar depression; Endometriosis,-	PAPPA2	ADGRF4
ENSG00000236069	NA	1.77270936101914	0.0239396348068003	M2_vs_M1	HSALNG0009275	integenic	Not conserved	NA	NA	RGS1	ENSG00000227304
ENSG00000236081	ELFN1-AS1	3.01674872987243	8.42250846550711e-13	M2_vs_M1	HSALNG0055679	anti_sense	Not conserved	hsa-miR-4447	NA	MAD1L1	FA2H
ENSG00000236154	NA	1.45833823276542	1.30688368993823e-5	M2_vs_M1	HSALNG0078589	anti_sense	Q75	hsa-miR-6848-5p	Body height,-	FAM241B	NDUFV1
ENSG00000236200	KDM4A-AS1	-1.15582224577497	1.47407069973815e-6	M2_vs_M1	HSALNG0003118	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4492	Attention deficit hyperactivity disorder; Upper aerodigestive tract neoplasm,Attention deficit hyperactivity disorder; Cigarettes per day measurement; Cannabis use,Handedness,Ccl2 measurement,Squamous cell lung carcinoma,-	HYI	PLEC
ENSG00000236204	LINC01376	-1.79555820643122	1.55409529135456e-4	M2_vs_M1	HSALNG0013352	integenic	Q50	hsa-miR-1208,hsa-miR-6089,hsa-miR-6510-5p	Brain volume measurement,White matter microstructure measurement,Uterine prolapse,Interleukin 2 measurement,Nose morphology measurement,Susceptibility to childhood ear infection measurement,Breast carcinoma; Mammographic density measurement,Intelligence,Breast carcinoma; Estrogen-receptor negative breast cancer,Optic disc size measurement,Cortical surface area measurement,Cup-to-disc ratio measurement,Cortical thickness,Breast carcinoma,Heel bone mineral density,Leukocyte count,Mammographic density percentage,Childhood aggressive behaviour measurement,Lower face morphology measurement,Adenosine measurement,Diastolic blood pressure,-	OSR1	CANX
ENSG00000236256	DIAPH2-AS1	5.17271015722411	5.261978167212529e-19	M2_vs_M1	HSALNG0139114	anti_sense	Q50	NA	NA	PCDH19	CD209
ENSG00000236345	SCAT8	1.22356905402175	5.23744619170446e-5	M2_vs_M1	HSALNG0050986	anti_sense	Q75	hsa-miR-6763-5p	-	PHF3	NECAB2
ENSG00000236358	NA	-4.8196419600797	0.0331504580487941	M2_vs_M1	HSALNG0011590	anti_sense,sense	Q50	NA	Response to anticonvulsant,Body height,-	COA6	MAK
ENSG00000236449	NA	1.98873201276566	7.09367276707489e-7	M2_vs_M1	HSALNG0020501	anti_sense	Q75	hsa-miR-642b-5p,hsa-miR-4488,hsa-miR-6873-3p	Mean platelet volume; Platelet component distribution width,Mean platelet volume,Pulse pressure measurement; Systolic blood pressure,Atrial fibrillation,Pulse pressure measurement; Platelet component distribution width; Systolic blood pressure,Protein measurement,Resting heart rate,Agents acting on the renin-angiotensin system use measurement,Response to radiation,Qrs amplitude; Qrs complex,Forced expiratory volume; Response to bronchodilator,-	SCRN3	NME6
ENSG00000236529	NA	-3.6184828932943	0.00123855312923401	M2_vs_M1	HSALNG0058566	integenic	Not conserved	hsa-let-7g-3p,hsa-miR-378g	NA	VKORC1L1	ENSG00000290082
ENSG00000236548	RNF217-AS1	1.2007432373563	0.00707681239748077	M2_vs_M1	HSALNG0053257	anti_sense	Q50	NA	Calcium measurement,-	HDDC2	ENSG00000227632
ENSG00000236591	UST-AS2	2.34710103242838	4.69576951300994e-7	M2_vs_M1	HSALNG0054229	anti_sense	Not conserved	hsa-miR-4284,hsa-miR-4292,hsa-miR-8485	NA	ZC3H12D	LINC01588
ENSG00000236618	PITPNA-AS1	2.13451034199526	0.00194403635996025	M2_vs_M1	HSALNG0113813	anti_sense	Q75	hsa-miR-3960,hsa-miR-4725-5p,hsa-miR-8072	-	WDR81	F8
ENSG00000236700	LINC01010	-2.02926305517967	1.3622492645221e-52	M2_vs_M1	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	RPLP0P2
ENSG00000236753	MKLN1-AS	-1.61588011701583	1.10760558419509e-14	M2_vs_M1	HSALNG0061408	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4525	Skin aging measurement,Balding measurement,Puberty onset measurement,Alopecia; Androgenetic alopecia,-	PODXL	ZNF124
ENSG00000236778	INTS6-AS1	-1.39880588189333	4.31414953787673e-11	M2_vs_M1	HSALNG0097177	anti_sense	Q75	hsa-miR-4447,hsa-miR-4516	-	WDFY2	ENSG00000275964
ENSG00000236790	LINC00299	3.5040101515821	0.00888373911484684	M2_vs_M1	HSALNG0012827	integenic	Not conserved	hsa-miR-761	NA	KIDINS220	SIX2
ENSG00000236830	CBR3-AS1	1.57464505315976	2.44202638143583e-8	M2_vs_M1	HSALNG0132929	anti_sense	Not conserved	hsa-miR-6754-5p	NA	SETD4	EVI5
ENSG00000236861	BET1-AS1	-3.24771934555908	7.53024306447998e-5	M2_vs_M1	HSALNG0059602	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3622b-5p	Eye colour measurement,Brcax breast cancer,Asparaginase hypersensitivity,Aging,Athletic endurance measurement,Circadian rhythm,-	GNG11	MAGEA4
ENSG00000236939	BAALC-AS2	-3.9999952558051	4.94591224936539e-16	M2_vs_M1	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	SMTNL1
ENSG00000236985	NA	-6.04279177463926	3.85093535413032e-4	M2_vs_M1	HSALNG0128858	integenic	Not conserved	hsa-miR-619-5p	NA	KIF16B	ABCC11
ENSG00000237017	PRPF31-AS1	-2.44271045774	0.0278685629710968	M2_vs_M1	HSALNG0127468	anti_sense	Not conserved	hsa-miR-6089	-	TFPT	NDUFV2P1
ENSG00000237036	ZEB1-AS1	2.1652271478101	2.13401988817589e-6	M2_vs_M1	HSALNG0077083	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-3178,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-7113-3p,hsa-miR-9901	Lumbar disc degeneration,Mathematical ability,Sex hormone-binding globulin measurement,Glucose homeostasis measurement; Disposition index measurement,Tinnitus; Response to cisplatin,Peripheral arterial disease; Traffic air pollution measurement,-	ZNF438	ENSG00000290357
ENSG00000237187	NR2F1-AS1	1.50894999706987	3.25784270264833e-7	M2_vs_M1	HSALNG0043533	anti_sense	Q90	NA	-	FAM172A	FBXO28
ENSG00000237220	NA	-5.60643880352677	0.00197702815515762	M2_vs_M1	HSALNG0019571	anti_sense	Q50	hsa-miR-6089	Platelet count,Arterial stiffness measurement,-	TNFAIP6	NGF
ENSG00000237232	ZNF295-AS1	2.13469283485426	1.14795885711685e-4	M2_vs_M1	HSALNG0133274	integenic	Not conserved	hsa-miR-8485	NA	UMODL1	PENK
ENSG00000237310	LINC03011	2.18232780679758	3.25954646558189e-18	M2_vs_M1	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1	SKIC3
ENSG00000237352	LINC01358	-1.5330555004046	8.28758184094316e-5	M2_vs_M1	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	CPXM1
ENSG00000237422	NA	2.91726761882285	9.83565605463557e-4	M2_vs_M1	HSALNG0072689	integenic	Q50	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-4292,hsa-miR-5001-3p,hsa-miR-6763-3p	Antisaccade response measurement,Adenosine diphosphate measurement,Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Bilirubin measurement; Aspartate aminotransferase measurement,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Hematocrit; Hemoglobin measurement; Erythrocyte count,Leukocyte count,-	AUH	TMEM143
ENSG00000237484	LINC01684	-3.4172404758373	7.8828693514218995e-50	M2_vs_M1	HSALNG0147058	integenic	Not conserved	NA	-	JAM2	ZNF804A
ENSG00000237491	LINC01409	-2.1431137723017	0.00158482018459131	M2_vs_M1	HSALNG0000038	integenic	Not conserved	hsa-miR-4267,hsa-miR-5011-3p,hsa-miR-6089	-	SAMD11	PAPOLG
ENSG00000237499	WAKMAR2	-3.28340318206703	8.63976204973149e-27	M2_vs_M1	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP	DTWD2
ENSG00000237505	PKN2-AS1	-2.43465965165848	0.0279096183391904	M2_vs_M1	HSALNG0004980	anti_sense	Q75	hsa-miR-338-3p,hsa-miR-619-5p,hsa-miR-5680,hsa-miR-6779-5p	Platelet count; Platelet crit,Platelet count,Sleep apnea measurement,Memory performance,Platelet crit,Response to tnf antagonist,Protein measurement,Educational attainment,Breast carcinoma,Autosomal dominant compelling helio-ophthalmic outburst syndrome,Diastolic blood pressure,Intraocular pressure measurement,Prostate specific antigen measurement,Prostate carcinoma,Brain volume measurement,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Cortical surface area measurement,Cognition,Open-angle glaucoma,Response to paclitaxel,Gut microbiome measurement,Clostridium difficile infection,Adolescent idiopathic scoliosis,Cytokine measurement,Cortical surface area measurement; Brain volume measurement; Neuroimaging measurement,Brain volume measurement; Cortical thickness,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Diet measurement,Microglial activation measurement,Body mass index,Body height,Periodontitis; Systolic blood pressure,Hematocrit; Hemoglobin measurement,Serum st2 measurement; Systolic blood pressure,Irritable bowel syndrome,Cannabis dependence measurement,Risk-taking behaviour,Susceptibility to childhood ear infection measurement,Neuropsychological test,Age at first sexual intercourse measurement,Age at first birth measurement,Coronary artery disease,Nicotine dependence symptom count,Self reported educational attainment,Pulse pressure measurement,Bmi-adjusted waist circumference,Abnormality of refraction,Serum gamma-glutamyl transferase measurement,Body height; Serum gamma-glutamyl transferase measurement,Serum alanine aminotransferase measurement; Bmi-adjusted waist circumference; Serum gamma-glutamyl transferase measurement; Body height; Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement; Serum gamma-glutamyl transferase measurement; Red blood cell density measurement; Aspartate aminotransferase measurement,Systolic blood pressure; Mean arterial pressure,Platelet component distribution width,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Parental genotype effect measurement; Vitamin d measurement,Peripheral arterial disease; Traffic air pollution measurement,Obsessive-compulsive disorder; Autism spectrum disorder,-	GTF2B	ZDHHC11
ENSG00000237596	NA	-7.46503130728148	6.6301485108793895e-12	M2_vs_M1	HSALNG0053689	anti_sense	Q50	hsa-miR-185-3p,hsa-miR-5572,hsa-miR-6763-5p	Hemoglobin measurement,Red blood cell distribution width,Erythrocyte count,Body height; Heel bone mineral density,Heel bone mineral density; Blood phosphate measurement,Heel bone mineral density,Age at menarche,Blood phosphate measurement,Alcoholic liver cirrhosis,Calcium measurement,Facial morphology measurement,Brcax breast cancer,Sphingomyelin 22:0 measurement,Aspartate aminotransferase measurement,Adolescent idiopathic scoliosis,Open-angle glaucoma,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Intraocular pressure measurement,Diverticulitis,Response to corticosteroid; Response to synacthen; Cortisol measurement,Bipolar disorder; Body mass index,-	MTFR2	THAP6
ENSG00000237638	LINC02245	1.36519431311632	1.0616356025853e-4	M2_vs_M1	HSALNG0015516	integenic	Not conserved	NA	NA	RAB1A	CD101-AS1
ENSG00000237753	SLC20A1-DT	2.62589394900835	1.18297253537611e-37	M2_vs_M1	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L	ZDHHC16
ENSG00000237797	MACORIS	5.49306582160751	0.00115668488734174	M2_vs_M1	HSALNG0077098	integenic	Q50	NA	Waist-hip ratio; Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	ARHGAP12	SPEN-AS1
ENSG00000237803	LINC00211	4.51264522417833	3.1097255486529096e-11	M2_vs_M1	HSALNG0146448	integenic	Not conserved	NA	NA	CDC42EP3	LEPR
ENSG00000237819	CDK6-AS1	2.92697657412678	2.0035460648341698e-29	M2_vs_M1	HSALNG0059558	anti_sense	Q90	hsa-miR-4483,hsa-miR-6085,hsa-miR-6803-5p	Lymphocyte count,Clopidogrel metabolite measurement,Protein measurement,Monocyte percentage of leukocytes,Bmi-adjusted hip circumference,-	RBM48	UBN2
ENSG00000237877	LINC01473	-2.3423161840782	2.42127562391331e-6	M2_vs_M1	HSALNG0020959	integenic	Q50	NA	NA	ZSWIM2	LSM12
ENSG00000237879	LINC00398	-5.12383136124778	0.0134535390511625	M2_vs_M1	HSALNG0096142	integenic	Q50	NA	NA	ALOX5AP	LINC00398
ENSG00000237927	NA	-8.12370663378808	8.066602002109849e-18	M2_vs_M1	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	FGF10-AS1
ENSG00000237938	NA	-2.87542289807077	1.72717264021216e-7	M2_vs_M1	HSALNG0001105	anti_sense	Q75	hsa-miR-5047	Systolic blood pressure,-	UQCRHL	ADGRB1
ENSG00000237950	LINC02918	1.349445597515	0.0072396457660865304	M2_vs_M1	HSALNG0003131	integenic	Q50	hsa-miR-619-5p,hsa-miR-1587,hsa-miR-4638-5p,hsa-miR-4695-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Intelligence; Cognitive function measurement	SLC6A9	AFAP1
ENSG00000237980	LINC02773	-2.72859677083619	3.02173477972024e-5	M2_vs_M1	HSALNG0010379	integenic	Q50	hsa-miR-4313,hsa-miR-4466	-	BATF3	ZNG1E
ENSG00000238018	SPTBN1-AS2	-6.29828589524005	1.86755963862015e-5	M2_vs_M1	HSALNG0014968	anti_sense	Q90	NA	Heel bone mineral density,Urate measurement,-	RTN4	CMTM6
ENSG00000238045	MVP-DT	-3.0633411128899	1.94565611917593e-11	M2_vs_M1	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	PTCHD3P2
ENSG00000238078	LINC01352	-1.54965940038303	1.02446724693574e-9	M2_vs_M1	HSALNG0010764	sense	Not conserved	NA	NA	NA	LRRC61
ENSG00000238133	MAP3K20-AS1	2.69689574722214	0.0372001923799505	M2_vs_M1	HSALNG0020412	anti_sense	Q75	hsa-miR-4328,hsa-miR-4430,hsa-miR-6782-5p	Serum alanine aminotransferase measurement,Smoking behaviour measurement,Chronotype measurement,Fev/fec ratio,Smoking status measurement,Lung carcinoma,Parental longevity,Adiponectin measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Hemoglobin measurement,Cognitive decline measurement,Self reported educational attainment,Gut microbiome measurement,Mathematical ability,Self reported educational attainment; Mathematical ability,Breast carcinoma,Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Mean corpuscular hemoglobin; Mean corpuscular volume; Erythrocyte count,Cancer,Lung adenocarcinoma,Mean corpuscular volume,Cup-to-disc ratio measurement; Optic disc area measurement; Optic cup area measurement,Self reported educational attainment; Cognitive function measurement; Mathematical ability,-,Apolipoprotein a 1 measurement	SP3	IFT52
ENSG00000238156	NA	6.01518457996955	1.8655028089974e-4	M2_vs_M1	HSALNG0051305	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-3667-3p	Cranial vault morphology measurement,Beta-amyloid 1-42 measurement,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference; Osteoarthritis, hip; Total hip arthroplasty; Body height,Body height,Bmi-adjusted hip circumference,-	SENP6	TSPAN7
ENSG00000238164	TNFRSF14-AS1	-1.23753326143364	9.22035131749684e-12	M2_vs_M1	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5	ECHDC3
ENSG00000238197	PAXBP1-AS1	-1.53459731250783	1.19121008554032e-5	M2_vs_M1	HSALNG0132711	anti_sense	Q90	hsa-miR-500b-3p	-	EVA1C	TBCE
ENSG00000238242	LINC02778	5.13937494761766	0.0060490050404032	M2_vs_M1	HSALNG0003993	integenic	Q90	NA	Cytokine measurement,Periodontitis,Drug-induced agranulocytosis,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	HOOK1	KCNK3
ENSG00000238279	NA	1.73145070924132	2.5469811235888503e-9	M2_vs_M1	HSALNG0007310	anti_sense	Q90	hsa-miR-4505	-	S100A1	XPO1
ENSG00000238287	EXO5-DT	1.78393361354651	7.71446727409398e-28	M2_vs_M1	HSALNG0002879	anti_sense	Q75	NA	-	RIMS3	TMEM215
ENSG00000239213	NCK1-DT	1.29929807886419	5.31409204263427e-9	M2_vs_M1	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	EXO5
ENSG00000239415	NA	2.52660198405677	0.0260614091646067	M2_vs_M1	HSALNG0133724	sense	Q50	hsa-miR-6089	-	MCM3AP	NKX3-2
ENSG00000239569	KMT2E-AS1	1.45376694584424	2.67980063561902e-4	M2_vs_M1	HSALNG0060291	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4505,hsa-miR-1587,hsa-miR-6779-3p,hsa-miR-6887-3p	Intelligence; Mathematical ability,Vital capacity,Intelligence,Risk-taking behaviour,Vitamin d measurement,Interleukin-6 measurement,Self reported educational attainment; Intelligence,-	SRPK2	LEPROT
ENSG00000239653	PSMD6-AS2	-4.29760420558283	1.32593559372423e-6	M2_vs_M1	HSALNG0026555	anti_sense	Q50	hsa-miR-619-5p	Drugs used in diabetes use measurement,Glomerular filtration rate,Neuroimaging measurement; Cortical thickness,-	ATXN7	ATP6V1E2
ENSG00000240005	STIM2-AS1	1.96113706986067	0.0471095208587006	M2_vs_M1	HSALNG0033504	anti_sense	Not conserved	hsa-miR-4508,hsa-miR-6756-5p,hsa-miR-6816-5p	NA	CCKAR	ANKMY2
ENSG00000240057	NEPRO-AS1	-2.41586331000147	7.43669046634196e-10	M2_vs_M1	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	PCBP4
ENSG00000240219	NA	-2.57271550062061	2.09897094437973e-4	M2_vs_M1	HSALNG0009887	anti_sense	Q75	hsa-miR-650,hsa-miR-1301-3p,hsa-miR-4252,hsa-miR-5047,hsa-miR-6744-3p	Body height,Neuropsychological test,Household income,Upper aerodigestive tract neoplasm,Prostate carcinoma,Mathematical ability,Self reported educational attainment; Sodium measurement,Intelligence,Biological sex,Platelet crit,Diet measurement,Self reported educational attainment,Motor function measurement; Response to levodopa; Response to zonisamide,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Self reported educational attainment; Intelligence; Household income; Mathematical ability,Social interaction measurement,-	MDM4	XACT
ENSG00000240350	SOCAR	4.08554966860921	8.12772486842249e-5	M2_vs_M1	HSALNG0017893	integenic	Not conserved	NA	NA	BCL2L11	CFAP298
ENSG00000240710	NA	-4.96942574643487	0.0164215341886497	M2_vs_M1	HSALNG0009887	anti_sense	Q75	hsa-miR-650,hsa-miR-1301-3p,hsa-miR-4252,hsa-miR-5047,hsa-miR-6744-3p	Body height,Neuropsychological test,Household income,Upper aerodigestive tract neoplasm,Prostate carcinoma,Mathematical ability,Self reported educational attainment; Sodium measurement,Intelligence,Biological sex,Platelet crit,Diet measurement,Self reported educational attainment,Motor function measurement; Response to levodopa; Response to zonisamide,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Self reported educational attainment; Intelligence; Household income; Mathematical ability,Social interaction measurement,-	MDM4	FAM78B
ENSG00000240859	LINC03014	1.29454219082505	3.03265295902031e-14	M2_vs_M1	HSALNG0055497	integenic	Not conserved	hsa-miR-4447,hsa-miR-4478,hsa-miR-6784-5p,hsa-miR-6808-5p	-	FAM20C	AFF1
ENSG00000240889	NDUFB2-AS1	1.57593763955056	0.0186990020227721	M2_vs_M1	HSALNG0061818	anti_sense	Not conserved	hsa-miR-3960,hsa-miR-6883-5p	-	DENND2A	ENSG00000272172
ENSG00000240990	HOXA11-AS	1.98534964913183	6.359733660472189e-13	M2_vs_M1	HSALNG0056865	anti_sense	Q90	hsa-miR-920,hsa-miR-4286,hsa-miR-3960,hsa-miR-4769-5p,hsa-miR-5197-3p,hsa-miR-6741-3p,hsa-miR-10394-3p	Ulcerative colitis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Bmi-adjusted waist circumference; Body fat percentage; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Aspartate aminotransferase measurement,Diuretic use measurement,-	EVX1	COG4
ENSG00000241163	LINC00877	1.9337797315008	0.00883944268053239	M2_vs_M1	HSALNG0026804	integenic	Not conserved	NA	Protein measurement	RYBP	ERCC8
ENSG00000241743	XACT	-2.00499112767351	4.588576564048211e-9	M2_vs_M1	HSALNG0139599	integenic	Not conserved	NA	NA	AMOT	RAD9B
ENSG00000241764	CBLL1-AS1	1.63242220268055	7.29404814824091e-8	M2_vs_M1	HSALNG0060448	anti_sense	Q75	NA	Lymphocyte count,-	SLC26A3	MTFP1
ENSG00000241886	NA	-4.49659307623736	1.54475987620558e-7	M2_vs_M1	HSALNG0137207	sense	Q90	NA	-	GK	ENSG00000224478
ENSG00000241990	PRR34-AS1	2.66537006461471	1.4873231174663e-11	M2_vs_M1	HSALNG0135994	integenic	Q50	hsa-miR-920,hsa-miR-939-5p,hsa-miR-3620-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-5589-5p,hsa-miR-6775-3p	Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder,-	PPARA	ARFIP1
ENSG00000242125	SNHG3	1.54217591406079	7.12795270367406e-38	M2_vs_M1	HSALNG0002066	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-4492,hsa-miR-5787,hsa-miR-6890-5p	Systolic blood pressure,Nighttime rest measurement,-	RCC1	QSOX1
ENSG00000242258	LINC00996	-5.17909599585198	1.0603129574581199e-103	M2_vs_M1	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	KCNA3
ENSG00000242516	LINC00960	1.2587275781681	9.7685747187534e-7	M2_vs_M1	HSALNG0026938	anti_sense	Not conserved	hsa-miR-619-5p	NA	FRG2C	LINC02454
ENSG00000242588	NA	-1.2898516400244	1.19706098121538e-40	M2_vs_M1	HSALNG0061221	integenic	Not conserved	NA	NA	GARIN1A	PIKFYVE
ENSG00000242759	LINC00882	2.23928867361304	0.00793908833780053	M2_vs_M1	HSALNG0147877	integenic	Not conserved	hsa-miR-619-5p	Body mass index,-	CBLB	ENSG00000218631
ENSG00000243055	GK-AS1	-7.54664286488304	6.40985717225449e-13	M2_vs_M1	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	SLC9A8
ENSG00000243176	NA	-1.3084660222546	3.92165090164296e-6	M2_vs_M1	HSALNG0030112	anti_sense	Q75	NA	NA	PTX3	PMP22
ENSG00000243701	DUBR	2.05932447335295	2.19377392039098e-5	M2_vs_M1	HSALNG0027862	integenic	Q50	NA	NA	CCDC54	SHROOM4
ENSG00000243799	PEX5L-AS1	5.14305025004127	0.00600533087897246	M2_vs_M1	HSALNG0030989	anti_sense	Not conserved	NA	-	USP13	TRIL
ENSG00000243926	TIPARP-AS1	3.28710763760924	1.9205990809124e-5	M2_vs_M1	HSALNG0030062	anti_sense	Q75	hsa-miR-6727-5p	-	SSR3	PABPC4
ENSG00000243960	NA	3.0099022632354	0.038946543871611	M2_vs_M1	HSALNG0006050	sense	Q90	hsa-miR-3620-5p	-	WDR77	DDX31
ENSG00000244124	ATP1B3-AS1	-5.60155275114215	0.00189132121337695	M2_vs_M1	HSALNG0029431	anti_sense	Q50	NA	Pulse pressure measurement; Mean corpuscular hemoglobin,Red blood cell distribution width,Hair color,Hair colour measurement,Thyroid preparation use measurement,-	TFDP2	H1-3
ENSG00000244459	NA	1.04523794662965	0.0394328476974013	M2_vs_M1	HSALNG0032293	integenic	Q90	hsa-miR-6836-3p	-	FAM53A	ENSG00000272338
ENSG00000244513	EOGT-DT	-1.80819772682569	0.0452883273495841	M2_vs_M1	HSALNG0026692	anti_sense	Q90	NA	Blood urea nitrogen measurement,Parental longevity,Mean corpuscular hemoglobin,Urate measurement,-	ARL6IP5	ENSG00000278730
ENSG00000244586	WNT5A-AS1	-6.16721582692443	1.26034526597127e-4	M2_vs_M1	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3	MAPK10
ENSG00000244998	NA	5.13741026485959	0.00642400964479261	M2_vs_M1	HSALNG0150503	anti_sense	Not conserved	NA	-	GPR20	METTL21A
ENSG00000245025	NA	-1.2318581292691	0.00400611809180623	M2_vs_M1	HSALNG0063952	anti_sense	Not conserved	hsa-miR-6805-5p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Renal cell carcinoma,Basal cell carcinoma,-	PEBP4	ENSG00000279277
ENSG00000245105	A2M-AS1	3.8079457698943	1.03029559073828e-11	M2_vs_M1	HSALNG0089113	anti_sense	Not conserved	hsa-miR-1228-5p,hsa-miR-4307,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-6090	-	KLRG1	ENSG00000233351
ENSG00000245148	ARAP1-AS2	-5.87016787257136	2.32996212314212e-4	M2_vs_M1	HSALNG0085578	anti_sense	Not conserved	NA	NA	ATG16L2	RTRAFP2
ENSG00000245248	USP2-AS1	1.96286904635484	7.7740828972114695e-22	M2_vs_M1	HSALNG0143088	integenic	Not conserved	NA	-	RNF26	LRRC73
ENSG00000245275	SAP30L-AS1	-1.88741635896983	2.49142183266185e-4	M2_vs_M1	HSALNG0046004	anti_sense	Q50	hsa-miR-1178-3p,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6781-5p	Systolic blood pressure,Nicotine use; Alcohol drinking; Generational effect measurement; Non-substance related disinhibited behaviour; Illegal drug consumption,Triglyceride measurement,-	HAND1	ENSG00000227496
ENSG00000245468	LINC02447	2.07284463971671	0.00222035283374883	M2_vs_M1	HSALNG0032671	integenic	Q50	NA	-	GRPEL1	SVIP
ENSG00000245532	NEAT1	-1.83911872109175	1.4817280585993098e-70	M2_vs_M1	HSALNG0084892	integenic	Q50	hsa-miR-4308,hsa-miR-4710,hsa-miR-6724-5p,hsa-miR-6747-3p,hsa-miR-8485	Bmi-adjusted hip circumference,Hemoglobin a1 measurement,-	FRMD8	TCF12-DT
ENSG00000245556	SCAMP1-AS1	-1.32670501876463	1.39822030158313e-10	M2_vs_M1	HSALNG0042878	integenic	Q50	hsa-miR-619-5p	NA	AP3B1	MAN1C1
ENSG00000245571	FAM111A-DT	-1.62301140292043	1.59614623569489e-10	M2_vs_M1	HSALNG0084388	anti_sense	Not conserved	hsa-miR-532-3p,hsa-miR-6089	Prostate carcinoma	MPEG1	PELI2
ENSG00000245648	KLRK1-AS1	5.13710097745054	0.00734436854784933	M2_vs_M1	HSALNG0089224	anti_sense	Q50	NA	Maximal oxygen uptake measurement,Nkg2-d type ii integral membrane protein measurement,-	KLRD1	INTS1
ENSG00000245910	SNHG6	2.04571637367089	5.60502582421087e-134	M2_vs_M1	HSALNG0065926	anti_sense	Q75	NA	-	TCF24	EIF2B3
ENSG00000245928	SDAD1-AS1	-7.01732770758154	3.37581554601929e-8	M2_vs_M1	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	CLEC4E
ENSG00000245937	SLC12A2-DT	1.5133596688372	9.009005311730849e-11	M2_vs_M1	HSALNG0044716	anti_sense	Q50	hsa-miR-140-3p,hsa-miR-4691-3p	Facial hair thickness measurement,Red blood cell distribution width; Apolipoprotein a 1 measurement; Myeloid white cell count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Skin and soft tissue staphylococcus aureus infection,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Waist-hip ratio; Total blood protein measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Vital capacity; Aspartate aminotransferase measurement,Lean body mass,Systolic blood pressure,Varicose veins; Sex hormone-binding globulin measurement; Fev/fec ratio; High density lipoprotein cholesterol measurement; Serum albumin measurement,Red blood cell distribution width,Body height,Lymphocyte percentage of leukocytes; Lymphocyte count; Bmi-adjusted waist circumference; Nicotine dependence symptom count; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Serum alanine aminotransferase measurement; Appendicular lean mass,Bmi-adjusted waist-hip ratio,Body fat distribution; Lymphocyte count; Red blood cell distribution width,Calcium measurement; Sex hormone-binding globulin measurement; Serum albumin measurement; Red blood cell distribution width,Breast carcinoma,-	FBN2	SPTSSB
ENSG00000245954	LINC02273	5.7800858584817	6.68270948235246e-4	M2_vs_M1	HSALNG0037887	integenic	Q75	hsa-miR-504-3p,hsa-miR-6089	Systemic lupus erythematosus,Reaction time measurement,Smoking status measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Body mass index,-	FHIP1A	FAM118A
ENSG00000245975	MINDY2-DT	2.64183312775108	0.00364585305166782	M2_vs_M1	HSALNG0106254	anti_sense	Q90	NA	Parental longevity,-	ADAM10	LINC02296
ENSG00000246095	LINC01096	-1.61181967133302	0.00913004579392743	M2_vs_M1	HSALNG0033002	integenic	Not conserved	hsa-miR-6886-3p,hsa-miR-9899	NA	NKX3-2	AFMID
ENSG00000246100	LINC00900	-1.72929395988363	4.75511150254903e-23	M2_vs_M1	HSALNG0087365	integenic	Q75	hsa-miR-665,hsa-miR-4281,hsa-miR-1268b,hsa-miR-3960	NA	CADM1	GTF2E1
ENSG00000246250	NA	-5.8555676608242	8.78349398650951e-4	M2_vs_M1	HSALNG0083840	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4487	Body mass index,Chronotype measurement,-	ALX4	RNA5SP219
ENSG00000246263	UBR5-DT	-1.77048438364573	6.69376204054216e-5	M2_vs_M1	HSALNG0067415	anti_sense	Q90	hsa-miR-8485	-	ODF1	SNRPEP4
ENSG00000246273	SBF2-AS1	1.18420015132508	2.0144288376063e-8	M2_vs_M1	HSALNG0082633	integenic	Not conserved	NA	Platelet count	SWAP70	SUGT1
ENSG00000246331	NA	4.67003857486957	0.0261679209348059	M2_vs_M1	HSALNG0090149	integenic	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-10392-3p	Macrophage inflammatory protein 1a measurement,Macrophage colony stimulating factor measurement,Optic disc size measurement,Parental genotype effect measurement; Birth weight,Colorectal cancer,-	TSPAN11	HPCAL4
ENSG00000246334	PRR7-AS1	2.21517877649533	0.00189559221653741	M2_vs_M1	HSALNG0046927	anti_sense	Q75	hsa-miR-4763-3p,hsa-miR-6089,hsa-miR-7160-5p	Chronotype measurement,-	DBN1	LINC01060
ENSG00000246363	LINC02458	1.95318840959566	3.13449843326353e-22	M2_vs_M1	HSALNG0092935	integenic	Not conserved	NA	NA	DUSP6	CAPRIN1
ENSG00000246375	PPM1K-DT	-7.38724294758269	3.03507635082334e-10	M2_vs_M1	HSALNG0035747	anti_sense	Q50	hsa-miR-6089	Urate measurement,Serum metabolite measurement,Metabolite measurement; Blood metabolite measurement; Coronary artery calcification; Amino acid measurement,Bipolar disorder,Serum metabolite measurement; Amino acid measurement,Gout; Urate measurement,Blood metabolite measurement; Breast carcinoma,Gout,Protein measurement; Blood metabolite measurement; Amino acid measurement,-	HERC6	FAM107A
ENSG00000246430	LINC00968	-2.10980584842633	4.96585552105364e-5	M2_vs_M1	HSALNG0065481	integenic	Q75	hsa-miR-6791-5p	NA	PENK	RAB18
ENSG00000246451	KLC1-AS1	-1.64044789593821	3.24038497863651e-6	M2_vs_M1	HSALNG0104020	anti_sense	Not conserved	hsa-miR-6089	Body mass index	XRCC3	SNRK
ENSG00000246662	CIBAR1-DT	-5.95449282129657	1.77685343079608e-4	M2_vs_M1	HSALNG0066967	integenic	Q50	NA	-	RBM12B	TAC3
ENSG00000246859	STARD4-AS1	-2.31377248792024	1.9855188517844902e-10	M2_vs_M1	HSALNG0044138	integenic	Not conserved	NA	NA	CAMK4	FRMD8
ENSG00000246898	LINC00920	2.4743083770853	0.00267975080288822	M2_vs_M1	HSALNG0112089	integenic	Not conserved	hsa-miR-5003-3p	NA	CDH5	ABCB11
ENSG00000247092	SNHG10	2.4417026980264	2.2649226129474097e-28	M2_vs_M1	HSALNG0103440	anti_sense	Q50	hsa-miR-6089,hsa-miR-6779-5p,hsa-miR-6780a-3p	Corneal endothelial cell measurement,Erythrocyte count,-	SYNE3	IL17RA
ENSG00000247095	MIR210HG	3.82361958156903	6.930487664563479e-100	M2_vs_M1	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	TMEM160
ENSG00000247121	NA	-1.01790115779689	0.00388509978671603	M2_vs_M1	HSALNG0043661	anti_sense	Q50	hsa-miR-500b-3p,hsa-miR-6085,hsa-miR-6813-5p	Intelligence,Blood protein measurement,Protein measurement,Cardiovascular disease,Systolic blood pressure,Endoplasmic reticulum aminopeptidase 1 measurement,Systolic blood pressure; Mean arterial pressure,Diastolic blood pressure change measurement,Leukocyte count; Juvenile idiopathic arthritis; Neutrophil count,Diastolic blood pressure,Diastolic blood pressure; Crohn's disease; Systolic blood pressure,Aspartate aminotransferase measurement,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Neutrophil count; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Neutrophil percentage of leukocytes,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body mass index; Urate measurement,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	ERAP1	SSUH2
ENSG00000247134	NA	1.21387048379751	3.62051409793998e-8	M2_vs_M1	HSALNG0064447	integenic	Q50	hsa-miR-4441,hsa-miR-4463,hsa-miR-6069,hsa-miR-6803-5p	Airway imaging measurement,Protein measurement,-	NRG1	ENSG00000226471
ENSG00000247240	UBL7-DT	1.01951696109521	0.0434579826293324	M2_vs_M1	HSALNG0107191	integenic	Q50	hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-1227-5p,hsa-miR-6763-5p,hsa-miR-8072	Mean corpuscular volume,Caffeine metabolite measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	ARID3B	MUC4
ENSG00000247271	ZBED5-AS1	1.11669149435248	1.07248528443097e-15	M2_vs_M1	HSALNG0082661	anti_sense	Q90	hsa-miR-4489	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	CTR9	ZNF429
ENSG00000247317	LY6E-DT	-6.53577514380973	9.18125900912922e-30	M2_vs_M1	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	LINC00937
ENSG00000247473	CARS1-AS1	-4.79320616248577	0.0426753127319518	M2_vs_M1	HSALNG0082262	anti_sense	Not conserved	NA	-	SLC22A18	GJB5
ENSG00000247774	PCED1B-AS1	3.43159978625868	1.0214192471624899e-182	M2_vs_M1	HSALNG0090741	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6089	Antihypertensive use measurement,Body height,-	AMIGO2	RPL7A
ENSG00000247934	NA	-1.89662697648797	8.11553840511455e-6	M2_vs_M1	HSALNG0090059	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3529-5p,hsa-miR-6089	Serum igg glycosylation measurement,Seasonal allergic rhinitis,Bmi-adjusted waist circumference,Balding measurement,Open-angle glaucoma,Gut microbiome measurement,Attention deficit hyperactivity disorder; Behavior,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Blood protein measurement,Brain volume measurement,Cortical surface area measurement; Facial morphology measurement,Forced expiratory volume; Vital capacity,Reticulocyte measurement,Bmi-adjusted hip circumference,Volumetric bone mineral density,Chronic obstructive pulmonary disease,Body height,Neuroimaging measurement; Cortical thickness,Forced expiratory volume; Response to bronchodilator,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	PTHLH	UBLCP1
ENSG00000247982	LINC00926	-3.16331329126913	1.2493105165744598e-97	M2_vs_M1	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12	NFKBIZ
ENSG00000248019	FAM13A-AS1	-1.1005006217583	0.0294040287092801	M2_vs_M1	HSALNG0035768	anti_sense	Q75	NA	Fev/fec ratio,-	HERC3	RASL10A
ENSG00000248187	NA	7.33361646586278	0	M2_vs_M1	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p	NA	PGRMC2	PLA2G5
ENSG00000248206	NA	-4.79299842731018	0.0431762722679899	M2_vs_M1	HSALNG0038988	intronic_sense	Q50	NA	-	STOX2	SOCS2
ENSG00000248275	TRIM52-AS1	1.16810570776331	0.0031184137588229	M2_vs_M1	HSALNG0047244	anti_sense	Q50	hsa-miR-596,hsa-miR-619-5p,hsa-miR-4486,hsa-miR-4710,hsa-miR-5004-5p,hsa-miR-6085,hsa-miR-6129	-	TRIM41	TANGO2
ENSG00000248309	MEF2C-AS1	2.56690760862111	1.27928530536422e-20	M2_vs_M1	HSALNG0043388	integenic	Not conserved	NA	NA	POLR3G	EMC10
ENSG00000248445	SEMA6A-AS1	-1.60319946618244	0.0332515848196554	M2_vs_M1	HSALNG0044316	anti_sense	Q90	hsa-miR-8485	Biological sex,Cytokine measurement,Cortical surface area measurement,-	COMMD10	LINC01357
ENSG00000248464	FGF10-AS1	-5.49299840811578	0.00204086788798873	M2_vs_M1	HSALNG0041545	anti_sense	Q90	hsa-miR-3622a-5p	Keratinocyte carcinoma; Basal cell carcinoma; Non-melanoma skin carcinoma,Balding measurement,Alopecia,Forced expiratory volume,Breast carcinoma,Lip morphology measurement,Dental caries; Dentures,-	MRPS30	LINC02100
ENSG00000248473	LINC01962	6.09492971598236	3.5816413496100795e-20	M2_vs_M1	HSALNG0047230	integenic	Q75	hsa-miR-1268b,hsa-miR-4497,hsa-miR-6089,hsa-miR-8072	-	TRIM7	RPL8P3
ENSG00000248538	PPP1R3B-DT	4.42339917898169	6.92331071806854e-6	M2_vs_M1	HSALNG0063318	integenic	Q50	hsa-miR-6803-5p	NA	ERI1	RECQL5
ENSG00000248673	LINC01331	5.77767893966317	1.24833646179887e-4	M2_vs_M1	HSALNG0042682	integenic	Q50	NA	-	ENC1	CENPW
ENSG00000248677	LINC02102	-2.68008733581369	0.0113274571791997	M2_vs_M1	HSALNG0039917	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7160-3p	Body height,-	NSUN2	SLC22A1
ENSG00000248693	LINC02100	-5.49502986888569	0.00311751244060253	M2_vs_M1	HSALNG0040483	integenic	Not conserved	NA	NA	CDH18	LINC02100
ENSG00000248727	LINC01948	-3.04331452243933	4.68583561847179e-4	M2_vs_M1	HSALNG0041950	integenic	Not conserved	NA	Macula measurement,High density lipoprotein cholesterol measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Glucose measurement,Glaucoma; Open-angle glaucoma,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,-	ANKRD55	ZNF524
ENSG00000248927	NA	-1.94776491120806	2.71605660331741e-10	M2_vs_M1	HSALNG0044434	sense	Q90	NA	Self reported educational attainment,Mathematical ability,Fev/fec ratio,-	PRR16	TBX1
ENSG00000249001	NA	5.26105195165747	1.16436441052797e-96	M2_vs_M1	HSALNG0035715	anti_sense	Q50	hsa-miR-4281,hsa-miR-4486	Urate measurement,Sparc-like protein 1 measurement,Idiopathic dilated cardiomyopathy,Body weight,Gout; Urate measurement,Bmi-adjusted hip circumference,Mental or behavioural disorder,Heel bone mineral density,Body height,-,Omega-6:omega-3 polyunsaturated fatty acid ratio; Omega-3 polyunsaturated fatty acid measurement; Docosahexaenoic acid measurement	SPARCL1	GFI1
ENSG00000249096	LINC02362	-2.63082211689191	5.8522322630766e-10	M2_vs_M1	HSALNG0039015	integenic	Not conserved	hsa-miR-6089,hsa-miR-6127,hsa-miR-6129	NA	IRF2	ASAH2B
ENSG00000249207	NA	-3.02555561188026	0.0287642346096893	M2_vs_M1	HSALNG0033933	integenic	Not conserved	hsa-miR-6090,hsa-miR-1273h-5p	NA	TMEM156	ENSG00000246250
ENSG00000249249	TICAM2-AS1	-2.2663731033457	0.0115775200402295	M2_vs_M1	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	TCEAL1
ENSG00000249307	LINC01088	3.91661598393777	2.95443010952259e-14	M2_vs_M1	HSALNG0035427	integenic	Not conserved	hsa-miR-619-5p	NA	BMP2K	TBRG1
ENSG00000249502	MED28-DT	-4.4350360928176	5.2186475285195e-50	M2_vs_M1	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	MARCHF3
ENSG00000249572	TARS1-DT	-1.09975022393065	0.00253129078717056	M2_vs_M1	HSALNG0041037	anti_sense	Q50	hsa-miR-7703	Systolic blood pressure,-	ADAMTS12	DNAH12
ENSG00000249639	NA	1.78766990418598	0.009185392691113	M2_vs_M1	HSALNG0045032	overlap_antisense,anti_sense	Q90	hsa-miR-612,hsa-miR-4507,hsa-miR-6860	Heel bone mineral density,-	SLC25A48	ATG9B
ENSG00000249669	CARMN	2.65054543226261	0.0188595349667724	M2_vs_M1	HSALNG0045753	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-5787,hsa-miR-6751-3p,hsa-miR-6769a-3p	Antipsychotic drug related weight gain,Heel bone mineral density,3-hydroxypropylmercapturic acid measurement,Diet measurement; Bilirubin measurement,-	PCYOX1L	A1BG-AS1
ENSG00000249685	NA	-1.58414658789087	0.00331235648853992	M2_vs_M1	HSALNG0033928	integenic	Q50	NA	Acute lymphoblastic leukemia	KLHL5	CCDC30
ENSG00000249740	OSMR-DT	3.3802272189217	1.05325059428724e-14	M2_vs_M1	HSALNG0041294	anti_sense	Not conserved	hsa-miR-6873-3p	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Gut microbiome measurement,Bmi-adjusted waist circumference,Reticulocyte count,Hemoglobin measurement,Colorectal adenoma,Retinal vasculature measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Response to selective serotonin reuptake inhibitor,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hematocrit,Erythrocyte count,Heart rate variability measurement; Response to antipsychotic drug,-	LIFR	NDUFB9P2
ENSG00000249771	NA	-2.80143973887364	0.00361696885612255	M2_vs_M1	HSALNG0034072	integenic	Q90	hsa-miR-619-5p,hsa-miR-4258	-	PHOX2B	GLIS2
ENSG00000249917	LINC00536	-8.23275766387731	2.58690303464902e-18	M2_vs_M1	HSALNG0067917	integenic	Not conserved	NA	NA	TRPS1	ENSG00000253207
ENSG00000249923	LINC02891	1.10618413949435	0.0312697897650293	M2_vs_M1	HSALNG0134112	integenic	Q50	hsa-miR-6803-5p	-	RTN4R	COIL
ENSG00000249937	LINC02223	-4.53306855862435	4.78444472584772e-19	M2_vs_M1	HSALNG0040447	integenic	Q50	NA	NA	TAF11L14	GIPR
ENSG00000249942	NA	5.48878851185894	8.19430409691155e-14	M2_vs_M1	HSALNG0148381	integenic	Not conserved	hsa-miR-6728-3p	Breast size,Susceptibility to pneumonia measurement,Dense area measurement; Mammographic density measurement	BTC	FCER2
ENSG00000250033	SLC7A11-AS1	-5.2551164051226	0.00525403408552037	M2_vs_M1	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT	MOV10L1
ENSG00000250041	NA	1.9365785499167	1.2262316751451401e-9	M2_vs_M1	HSALNG0082662	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6165	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	ZBED5	THUMPD3
ENSG00000250073	ESAM-AS1	2.93510885361796	5.34028793925731e-7	M2_vs_M1	HSALNG0087909	anti_sense	Q50	hsa-miR-4447	-	NRGN	ARPC1AP4
ENSG00000250091	DNAH10OS	1.09323459968803	8.40694227464491e-4	M2_vs_M1	HSALNG0143752	anti_sense,sense	Q75	NA	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Leukocyte count; Grip strength measurement,Hip circumference; Tourette syndrome; Appendicular lean mass,-,Body mass index,Lymphocyte count; Myeloid white cell count; Leukocyte count; Red blood cell density measurement; Erythrocyte count,Bmi-adjusted waist circumference; Apolipoprotein b measurement,Atrial fibrillation,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	CCDC92	CLCA4
ENSG00000250116	RHOQ-AS1	-6.87586329047768	1.0887612221889e-6	M2_vs_M1	HSALNG0014691	anti_sense	Q75	NA	-	PIGF	ENSG00000236985
ENSG00000250126	NA	3.64690876780483	0.00286190352663403	M2_vs_M1	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	PDE3A
ENSG00000250240	NA	-1.4203561283923	6.41127155247572e-6	M2_vs_M1	HSALNG0043615	anti_sense	Q75	NA	-	SPATA9	ZNF432
ENSG00000250274	NA	-3.89076539438351	3.30478146551527e-8	M2_vs_M1	NA	NA	NA	NA	NA	LCP2	FKRP
ENSG00000250497	NA	-3.03306181644544	0.00114229305221887	M2_vs_M1	HSALNG0033009	integenic	Q50	hsa-miR-181d-3p,hsa-miR-3158-3p,hsa-miR-3960,hsa-miR-5047	Facial morphology measurement,Erythrocyte count,-	BOD1L1	HS2ST1
ENSG00000250509	NA	-7.93501495960651	1.14526496526284e-14	M2_vs_M1	HSALNG0047167	integenic	Q75	hsa-miR-619-5p,hsa-miR-6086	Joint damage measurement,-	CNOT6	PCNX1
ENSG00000250657	NA	7.15340872076397	3.3087594138764895e-35	M2_vs_M1	HSALNG0034131	integenic	Q50	hsa-miR-4516	Mhpg measurement; 5-hiaa measurement,-	GRXCR1	LDHB
ENSG00000250748	MSRB3-AS1	2.81734894378368	0.0187937245793263	M2_vs_M1	HSALNG0091992	integenic	Not conserved	hsa-miR-6089	Creatinine measurement	WIF1	MDFI
ENSG00000250777	NA	3.06218462127469	0.00322140526960536	M2_vs_M1	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	CHRM5
ENSG00000250831	NA	3.93002580391176	1.7361127426001e-12	M2_vs_M1	HSALNG0148928	integenic	Q75	NA	NA	MEF2C	SGF29
ENSG00000250893	NA	-5.80209469883622	0.00112466724314638	M2_vs_M1	HSALNG0034014	anti_sense	Not conserved	NA	-	CHRNA9	ENSG00000234622
ENSG00000250929	LINC01181	-8.92526492911649	1.20308115123119e-21	M2_vs_M1	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	CFHR4
ENSG00000251136	RIPK2-DT	-2.82094802509189	4.190807264419399e-140	M2_vs_M1	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	UGDH
ENSG00000251141	MRPS30-DT	-2.68182871209406	1.50367749884718e-4	M2_vs_M1	HSALNG0041549	anti_sense	Q50	hsa-miR-6878-3p	Balding measurement,Lip morphology measurement,Dental caries; Dentures,Breast carcinoma,Gut microbiome measurement,Breast carcinoma; Cancer,Creatinine measurement,Protein measurement,Glomerular filtration rate,Response to cetuximab; Skin disease,Depressive symptom measurement; Response to antidepressant,Upper face morphology measurement,-	FGF10	ENSG00000254165
ENSG00000251230	MIR3945HG	-4.726017903067	2.58543506118527e-38	M2_vs_M1	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	ETS2
ENSG00000251293	NA	-5.77122796477875	0.00134621764552486	M2_vs_M1	HSALNG0044415	integenic	Q75	hsa-miR-8485	Age at onset,Body mass index,Cognitive decline measurement,Response to carboplatin,Adolescent idiopathic scoliosis,Aging,Gut microbiome measurement,Body height; Fev/fec ratio; Body mass index,-	DTWD2	ENSG00000282988
ENSG00000251301	LINC02384	-7.57464570445775	4.99516291838503e-12	M2_vs_M1	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	FCGR3B
ENSG00000251363	LINC02315	1.45145428867018	0.0227903810802764	M2_vs_M1	HSALNG0100823	integenic	Not conserved	hsa-miR-619-5p	NA	LRFN5	ZNF528-AS1
ENSG00000251393	NA	-2.15493370697336	3.3499574571018397e-18	M2_vs_M1	HSALNG0102349	anti_sense	Q75	hsa-miR-619-5p	Self reported educational attainment,Platelet component distribution width,Platelet crit,-	RIOX1	MIR3945HG
ENSG00000251414	NA	-5.27018020468696	0.0118379118224415	M2_vs_M1	HSALNG0046852	anti_sense	Q75	hsa-miR-6845-3p	-	SIMC1	ENSG00000285679
ENSG00000251442	LINC01094	-1.75091639527968	1.0887612221889e-6	M2_vs_M1	HSALNG0035402	integenic	Q50	hsa-miR-7150	Mean platelet volume,Total blood protein measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Monocyte count,Creatine kinase measurement; Serum non-albumin protein measurement,Protein measurement,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,-	ANXA3	INPP4A
ENSG00000251580	LINC02482	1.95940486155934	0.0297858839675683	M2_vs_M1	HSALNG0032638	anti_sense	Not conserved	hsa-miR-432-3p,hsa-miR-663b,hsa-miR-6089,hsa-miR-1273h-5p	NA	MRFAP1L1	ZBTB20
ENSG00000253106	NA	-1.83773169307897	1.7436511121854e-5	M2_vs_M1	HSALNG0068272	anti_sense	Q50	hsa-miR-5787,hsa-miR-6089	Colorectal health,-	RNF139	CD247
ENSG00000253147	LINC03023	-5.59695311446213	0.00164146438130764	M2_vs_M1	HSALNG0063824	integenic	Q50	hsa-miR-6779-5p,hsa-miR-6889-3p	Sphingomyelin measurement,Cervical carcinoma,Response to tamsulosin,Body height; Body mass index,Body mass index,Attention function measurement,Cholesteryl ester 18:0 measurement; Sphingomyelin 16:1 measurement,Beta-amyloid 1-42 measurement,Sphingomyelin 18:1 measurement,Microglial activation measurement,Diabetes mellitus biomarker,Interleukin-6 measurement,Entorhinal cortical volume,Visceral adipose tissue measurement,Influenza a (h1n1),Protein measurement,Cognitive inhibition measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Irritable bowel syndrome,Mathematical ability,Diastolic blood pressure; Sodium measurement,Squamous cell lung carcinoma; Family history of lung cancer,Preterm premature rupture of the membranes; Spontaneous preterm birth,-	ATP6V1B2	NME8
ENSG00000253161	LINC01605	6.90307896839008	3.2563128729959198e-31	M2_vs_M1	HSALNG0150382	integenic	Q90	hsa-miR-149-3p,hsa-miR-4486	Body height,Endometriosis,-	BRF2	ZXDB
ENSG00000253167	WASHC5-AS1	-5.69873710377368	0.00219244837692467	M2_vs_M1	HSALNG0068302	anti_sense	Q75	NA	-	SQLE	ZBTB5
ENSG00000253177	NA	3.77631749227551	6.17371029630161e-13	M2_vs_M1	HSALNG0066950	integenic	Q50	NA	-	CIBAR1	PFAS
ENSG00000253199	LINC02153	-6.29679919308755	1.59457336837158e-5	M2_vs_M1	HSALNG0063824	integenic	Q50	hsa-miR-6779-5p,hsa-miR-6889-3p	Sphingomyelin measurement,Cervical carcinoma,Response to tamsulosin,Body height; Body mass index,Body mass index,Attention function measurement,Cholesteryl ester 18:0 measurement; Sphingomyelin 16:1 measurement,Beta-amyloid 1-42 measurement,Sphingomyelin 18:1 measurement,Microglial activation measurement,Diabetes mellitus biomarker,Interleukin-6 measurement,Entorhinal cortical volume,Visceral adipose tissue measurement,Influenza a (h1n1),Protein measurement,Cognitive inhibition measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Irritable bowel syndrome,Mathematical ability,Diastolic blood pressure; Sodium measurement,Squamous cell lung carcinoma; Family history of lung cancer,Preterm premature rupture of the membranes; Spontaneous preterm birth,-	ATP6V1B2	KRT8P26
ENSG00000253200	NA	-3.38655343367548	5.36321325269309e-20	M2_vs_M1	NA	NA	NA	NA	NA	BIN3	RPL18AP3
ENSG00000253207	NA	-6.47114700450943	3.84168253398235e-6	M2_vs_M1	HSALNG0067821	integenic	Not conserved	NA	-	UTP23	IFITM3P4
ENSG00000253286	NA	-5.24913613456228	1.8538191838896998e-13	M2_vs_M1	HSALNG0068229	anti_sense	Q50	hsa-miR-6829-5p	Electrocardiography; Pr interval; Atrial fibrillation,Qrs duration,Systolic blood pressure,Electrocardiography,-	FAM91A1	PTX3
ENSG00000253320	MAILR	-1.25067616922876	2.97766976892519e-6	M2_vs_M1	HSALNG0067488	integenic	Q50	NA	NA	ATP6V1C1	PHF8
ENSG00000253414	LINC01605	5.38989364154323	2.29214677521719e-96	M2_vs_M1	HSALNG0150382	integenic	Q90	hsa-miR-149-3p,hsa-miR-4486	Body height,Endometriosis,-	BRF2	UCP2
ENSG00000253474	NA	-1.3853733079254	6.07674744367725e-5	M2_vs_M1	HSALNG0065166	integenic	Not conserved	hsa-miR-6089,hsa-miR-6760-5p	Blood metabolite measurement,Cognitive function measurement,Memory performance,Fat body mass,-	PPDPFL	ENSG00000288817
ENSG00000253477	NA	-3.77178927146564	2.13375425014412e-10	M2_vs_M1	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	FAM151B
ENSG00000253507	NA	3.58978116210833	2.65909835011378e-23	M2_vs_M1	HSALNG0068646	integenic	Q75	NA	Serum igg glycosylation measurement	EFR3A	XRN2
ENSG00000253508	NA	2.83143897692795	0.00134725718357715	M2_vs_M1	HSALNG0056867	integenic	Q75	NA	Ulcerative colitis,Heel bone mineral density,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Bmi-adjusted waist circumference; Body fat percentage; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Aspartate aminotransferase measurement,Diuretic use measurement,-	HOXA13	ENSG00000280254
ENSG00000253522	MIR3142HG	-4.9622223677943	5.94988139303756e-101	M2_vs_M1	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	ADAMDEC1
ENSG00000253535	ADAM7-AS1	-8.57915875650325	5.4187231817152e-24	M2_vs_M1	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	TAF5LP1
ENSG00000253549	CA3-AS1	2.61866268239731	8.64624687288468e-7	M2_vs_M1	HSALNG0066709	anti_sense	Q50	hsa-miR-491-5p,hsa-miR-4482-5p,hsa-miR-4707-5p,hsa-miR-6810-5p	Glomerular filtration rate,-	CA1	CDCA3
ENSG00000253557	NA	2.33235707090835	9.70629415641642e-4	M2_vs_M1	HSALNG0063737	integenic	Q50	hsa-miR-7155-5p	Bone quantitative ultrasound measurement,Platelet count,Mean platelet volume,Gout,Smooth surface dental caries,Urate measurement,Intelligence,Insulin measurement,Telomere length,-	PSD3	TSPAN9
ENSG00000253633	LINC03047	4.66972799315564	0.0321666389814213	M2_vs_M1	HSALNG0067441	integenic	Q50	NA	Mean platelet volume,Iga glomerulonephritis,Platelet component distribution width,-	ODF1	SBNO1-AS1
ENSG00000253636	NA	-1.87366073625135	0.0317193088626042	M2_vs_M1	HSALNG0066155	integenic	Not conserved	NA	NA	TERF1	IFNAR2
ENSG00000253671	NA	3.60398950660632	9.93763954180202e-35	M2_vs_M1	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	ENSG00000289050
ENSG00000253716	MINCR	1.82053029457299	1.0471393813918998e-12	M2_vs_M1	HSALNG0069266	integenic	Not conserved	hsa-miR-4312,hsa-miR-4492	NA	TOP1MT	HECTD4
ENSG00000253738	OTUD6B-AS1	1.20926274330097	9.632780720485759e-25	M2_vs_M1	HSALNG0066885	anti_sense	Q50	NA	-	PIP4P2	PITHD1
ENSG00000253746	NA	6.62512622020722	1.49369721167761e-6	M2_vs_M1	HSALNG0064563	integenic	Q50	hsa-miR-4447,hsa-miR-4508,hsa-miR-4539,hsa-miR-3960,hsa-miR-6501-3p,hsa-miR-6780a-3p,hsa-miR-8072	Mathematical ability,Adolescent idiopathic scoliosis,Interleukin-6 measurement,Body height,Endometriosis,Sex hormone-binding globulin measurement,Triglyceride measurement,Empathy measurement,Leukocyte count; Lymphocyte count,Body mass index,-	BRF2	BCL10
ENSG00000253775	NA	4.92470087094319	0.0131556831342631	M2_vs_M1	HSALNG0063788	integenic	Not conserved	hsa-miR-4695-5p,hsa-miR-6855-3p	High density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,Reticulocyte count; Reticulocyte measurement,Coronary artery disease,Triglyceride measurement; High density lipoprotein cholesterol measurement; Sleep duration,Red blood cell distribution width,Mean corpuscular volume,Triglyceride measurement; High density lipoprotein cholesterol measurement; 3-hydroxypropylmercapturic acid measurement,Triglyceride measurement; Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Gut microbiome measurement,Triglyceride measurement; Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,Triglyceride measurement,Sleep duration; High density lipoprotein cholesterol measurement,Selenium measurement; Response to dietary selenium supplementation,-	ATP6V1B2	TBR1
ENSG00000253821	NA	-1.17295127096365	2.98045051872127e-27	M2_vs_M1	HSALNG0065531	integenic	Not conserved	NA	NA	FAM110B	PIDD1
ENSG00000253838	NA	-8.98939013255113	8.761950102526719e-34	M2_vs_M1	HSALNG0150187	sense	Q50	NA	-	IDO1	SIMALR
ENSG00000253854	NA	-3.50724833089622	5.08405480942542e-6	M2_vs_M1	HSALNG0066977	sense	Not conserved	NA	NA	CIBAR1	MAT2B
ENSG00000253891	NA	-6.94360227039601	8.59872009598323e-8	M2_vs_M1	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	EFCAB3
ENSG00000253944	MTUS1-DT	3.25924606159446	5.58346178695867e-4	M2_vs_M1	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	FEZ1
ENSG00000253948	VPS13B-DT	1.02647700082719	0.0397604157158759	M2_vs_M1	HSALNG0067239	integenic	Not conserved	NA	-	STK3	OTOGL
ENSG00000253968	NA	-2.4198493377696	1.09246906267196e-4	M2_vs_M1	HSALNG0046692	integenic	Q50	hsa-miR-198,hsa-miR-665,hsa-miR-4435,hsa-miR-4446-3p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6728-3p	Antipsychotic drug related weight gain,Stroke,Cognitive function measurement,Prostate carcinoma; Cytokine measurement,Peripheral arterial disease; Traffic air pollution measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Oral cleft,Cleft lip; Cleft palate,Body height,Bmi-adjusted hip circumference,Adiponectin measurement,-	BNIP1	PDCD6IPP2
ENSG00000253982	CLN8-AS1	1.06127335336	8.862448327507349e-25	M2_vs_M1	HSALNG0062950	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1225-3p,hsa-miR-6165,hsa-miR-6727-3p	NA	ERICH1	NUDT16
ENSG00000254006	NA	1.91501760025449	0.00184523845085972	M2_vs_M1	HSALNG0065805	integenic	Q90	NA	NA	CYP7B1	GYG2
ENSG00000254054	NA	7.28585320557686	1.0824997847018e-126	M2_vs_M1	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	NUDT18
ENSG00000254092	NA	-5.29467994112527	0.0187937245793263	M2_vs_M1	HSALNG0063843	integenic	Q75	NA	-	GFRA2	ENSG00000280852
ENSG00000254154	CRYZL2P-SEC16B	-6.90402890171732	5.46495391491517e-8	M2_vs_M1	HSALNG0008675	integenic	Q90	NA	Body mass index,Total blood protein measurement; Insomnia,-	SEC16B	HERC2P10
ENSG00000254287	NA	-8.95100721690948	2.15475434448966e-32	M2_vs_M1	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	OTOF
ENSG00000254330	NA	-5.40482218518341	0.00877813576054136	M2_vs_M1	HSALNG0065798	sense	Q75	NA	Hiv-1 infection; Susceptibility to viral and mycobacterial infections	CYP7B1	KCNS2
ENSG00000254349	MIR2052HG	-2.58757069020312	0.0160528252183259	M2_vs_M1	HSALNG0066240	integenic	Not conserved	NA	Myoglobin measurement,Adolescent idiopathic scoliosis,Abnormality of refraction,-	PI15	AMT
ENSG00000254416	LINC02732	-4.80468952394146	0.0338008706417107	M2_vs_M1	HSALNG0087054	integenic	Q75	hsa-miR-4505	Cognition,Serum metabolite measurement; Coronary artery disease,Angina pectoris; Antithrombotic agent use measurement; Aspirin use measurement; Myocardial infarction,Angina pectoris; Vasodilators used in cardiac diseases use measurement; Aspirin use measurement,Body height,Coronary artery disease,-	FDX1	IFNL1
ENSG00000254428	NA	-7.12925496199745	2.0902573242443703e-9	M2_vs_M1	HSALNG0087596	anti_sense	Not conserved	hsa-miR-1260b	NA	RPS25	CHTF8
ENSG00000254433	NA	-4.62305125826054	0.0481974263429251	M2_vs_M1	HSALNG0086911	anti_sense	Q90	NA	-	KBTBD3	ENSG00000254433
ENSG00000254473	UBQLN1-AS1	1.50270869217893	8.08416564606162e-6	M2_vs_M1	HSALNG0150655	integenic	Q50	hsa-miR-8485	NA	IDNK	ZKSCAN1
ENSG00000254480	LINC02749	3.0106318411165	0.0393578248035222	M2_vs_M1	HSALNG0082346	integenic	Not conserved	NA	Mean reticulocyte volume,-	SSU72P5	IGFBP7
ENSG00000254510	NA	3.88316723605853	0.00264727735268922	M2_vs_M1	HSALNG0085021	integenic	Q90	hsa-miR-637,hsa-miR-1237-5p,hsa-miR-4472	Bmi-adjusted waist circumference; Attention deficit hyperactivity disorder; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,Vital capacity,Bmi-adjusted waist-hip ratio,-	NPAS4	CD101
ENSG00000254531	FLJ20021	2.54191497246731	4.97257767967528e-35	M2_vs_M1	HSALNG0148159	anti_sense	Not conserved	hsa-miR-6780a-3p	-	BANK1	MORC3
ENSG00000254545	NA	2.80050003049033	1.2101138136712599e-11	M2_vs_M1	HSALNG0002264	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-4498	-	HCRTR1	PEMT
ENSG00000254554	ADM-DT	-5.1554702019739604	0.0229936261534206	M2_vs_M1	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2	ADM-DT
ENSG00000254602	MIR130AHG	-6.23821906073245	3.66245642701026e-5	M2_vs_M1	HSALNG0084300	overlap_antisense,sense	Q90	hsa-miR-619-5p,hsa-miR-6880-5p	Alcohol use disorder measurement; Mean corpuscular hemoglobin; Mean corpuscular volume,Glomerular filtration rate,-	CLP1	NME8
ENSG00000254614	CAPN1-AS1	1.79097784425548	0.00760245202148587	M2_vs_M1	HSALNG0084866	anti_sense	Not conserved	hsa-miR-4505,hsa-miR-5787	Bmi-adjusted hip circumference,-	SYVN1	GCOM1
ENSG00000254639	NA	1.58582030380366	0.0403590861219694	M2_vs_M1	HSALNG0083976	integenic	Q90	hsa-miR-8077	Agents acting on the renin-angiotensin system use measurement	CREB3L1	VAV1
ENSG00000254659	LINC02715	-4.80518969171788	0.031965296429361	M2_vs_M1	HSALNG0087023	overlap_antisense,sense	Q50	hsa-miR-4447	Self reported educational attainment,Mathematical ability,Antibody measurement,Late-onset alzheimers disease,Vision disorder,Self reported educational attainment; Intelligence,Forced expiratory volume; Smoking status measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	RDX	IFNL1
ENSG00000254682	NA	2.61682024530555	7.77104231248801e-4	M2_vs_M1	HSALNG0085472	anti_sense	Not conserved	NA	Vitamin d measurement,-	NADSYN1	ENSG00000234775
ENSG00000254694	NA	-4.79135304609497	0.0476122182994066	M2_vs_M1	HSALNG0088010	sense	Not conserved	hsa-miR-1303	NA	RPUSD4	ENSG00000254694
ENSG00000254703	SENCR	3.15860657277529	2.0722112360512298e-19	M2_vs_M1	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1	GPN1
ENSG00000254777	NA	6.55700865486617	1.26413310886745e-6	M2_vs_M1	HSALNG0150218	integenic	Not conserved	hsa-miR-574-5p	NA	CHD7	ENSG00000286333
ENSG00000254860	TMEM9B-AS1	-1.47529636265638	7.84266901876979e-4	M2_vs_M1	HSALNG0082585	anti_sense	Q75	hsa-miR-6808-5p	-	AKIP1	GAPDHP1
ENSG00000255028	NA	-4.81161865238526	0.0290808572187422	M2_vs_M1	HSALNG0087023	overlap_antisense,sense	Q50	hsa-miR-4447	Self reported educational attainment,Mathematical ability,Antibody measurement,Late-onset alzheimers disease,Vision disorder,Self reported educational attainment; Intelligence,Forced expiratory volume; Smoking status measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	RDX	NME8
ENSG00000255031	NA	-1.46379077264583	1.29063775905013e-4	M2_vs_M1	HSALNG0085213	anti_sense,sense	Q75	hsa-miR-1249-5p	-	TCIRG1	ENSG00000255893
ENSG00000255045	NA	5.14067313278183	0.00355265610734724	M2_vs_M1	HSALNG0087906	anti_sense	Q50	hsa-miR-593-5p,hsa-miR-1237-3p,hsa-miR-6792-3p	Anorexia nervosa; Self reported educational attainment; Intelligence; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Smoking status measurement,-	VSIG2	LINC02861
ENSG00000255046	NA	-6.42653258202004	2.48861246810642e-5	M2_vs_M1	HSALNG0063460	anti_sense	Q50	hsa-miR-619-5p	Alkaline phosphatase measurement,C-reactive protein measurement; Alkaline phosphatase measurement; Serum non-albumin protein measurement,Triglyceride measurement; Mean reticulocyte volume; Mean corpuscular volume,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Monocyte count; Ejection fraction measurement; Neuroticism measurement,Non-melanoma skin carcinoma,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	CTSB	FAM120C
ENSG00000255050	NA	-4.62299668413664	0.0487906101149492	M2_vs_M1	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD	ASAP2
ENSG00000255135	EMSY-DT	1.66066916154368	8.41550413859965e-7	M2_vs_M1	HSALNG0085855	anti_sense	Q90	hsa-miR-30c-2-3p,hsa-miR-619-5p	Microglial activation measurement,-	THAP12	ENSG00000254545
ENSG00000255139	NA	-2.38403554036744	0.00682565544637111	M2_vs_M1	HSALNG0084419	anti_sense	Q90	hsa-miR-4447,hsa-miR-3960,hsa-miR-6085	Protein measurement,-,Igf-1 measurement	OR4D9	ENSG00000290124
ENSG00000255153	TOLLIP-DT	1.93007331828245	0.00673159354616513	M2_vs_M1	HSALNG0082091	integenic	Not conserved	hsa-miR-6069	NA	MUC5B	ZNF45
ENSG00000255198	SNHG9	1.82461510742099	1.43470776351742e-27	M2_vs_M1	HSALNG0108960	integenic	Q50	hsa-miR-3612,hsa-miR-5739,hsa-miR-6793-3p	-	RNF151	SNRPE
ENSG00000255284	GATD1-DT	1.07254140460844	9.85251651774659e-6	M2_vs_M1	HSALNG0082025	integenic	Q75	hsa-miR-4472	NA	PANO1	HSP90AA2P
ENSG00000255299	NA	-2.18711704527113	0.00114106148484207	M2_vs_M1	HSALNG0084342	sense	Q50	NA	Chronotype measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	OR5B21	DHX16
ENSG00000255306	NA	-1.85757719185954	0.0134667262701553	M2_vs_M1	HSALNG0085208	anti_sense	Not conserved	NA	Uric acid measurement,-	UNC93B1	ARRDC3-AS1
ENSG00000255310	NA	-2.03722865607811	2.90984799715907e-16	M2_vs_M1	HSALNG0063412	sense	Q50	hsa-miR-370-3p	-	XKR6	GAS5
ENSG00000255337	TMEM123-DT	-5.06775348879584	3.30233371807092e-11	M2_vs_M1	HSALNG0086787	anti_sense	Not conserved	hsa-miR-7113-3p	-	BIRC2	PLEKHA7
ENSG00000255345	NA	-2.43848054177021	0.0212159572933568	M2_vs_M1	HSALNG0085998	anti_sense	Q50	hsa-miR-4261	Lung carcinoma,-	USP35	DTWD2
ENSG00000255355	PATL1-DT	-5.17616250123167	0.0386777157142344	M2_vs_M1	HSALNG0084422	integenic	Not conserved	hsa-miR-619-5p	NA	STX3	ADGRF2
ENSG00000255422	NA	1.67390512799435	0.0334648468858619	M2_vs_M1	HSALNG0087571	anti_sense	Q90	NA	-	PHLDB1	PKP3
ENSG00000255443	CD44-AS1	-4.98048279897809	0.0231124149562612	M2_vs_M1	HSALNG0083610	anti_sense	Q50	NA	-	SLC1A2	PARP4P1
ENSG00000255491	NA	1.13479208719345	9.42862795288965e-10	M2_vs_M1	HSALNG0068289	integenic	Q50	hsa-miR-363-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6754-5p	Platelet component distribution width,Triacylglycerol 58:6 measurement,Left ventricular ejection fraction measurement; Dilated cardiomyopathy; Left ventricular structural measurement; Left ventricular systolic function measurement; Hematocrit; Heart function measurement,Reticulocyte measurement,Hematocrit; Hemoglobin measurement; Pr interval,Pr interval; Left ventricular structural measurement; Atrial fibrillation,Left ventricular systolic function measurement,Platelet crit; Heart relative wall thickness; Left ventricular ejection fraction measurement; Fractional shortening; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Electrocardiography; Ejection fraction measurement,-	MTSS1	PBXIP1
ENSG00000255553	LINC02733	-3.82834204177498	8.49677931558421e-8	M2_vs_M1	HSALNG0084581	integenic	Not conserved	NA	Alkaline phosphatase measurement,Phosphatidylcholine measurement,-	FTH1	PRMT2
ENSG00000255666	LINC02700	-1.07345500670055	0.0275998370318823	M2_vs_M1	HSALNG0086530	integenic	Not conserved	hsa-miR-382-5p	Allantoin measurement	PIWIL4	FAM227A
ENSG00000255680	NA	2.94785827775533	0.00572616651851978	M2_vs_M1	HSALNG0082458	anti_sense	Q90	NA	-	ILK	ENSG00000267940
ENSG00000255857	PXN-AS1	1.52189235341291	1.9230947966378e-5	M2_vs_M1	HSALNG0094500	anti_sense	Q90	hsa-miR-3183,hsa-miR-3925-3p,hsa-miR-4497,hsa-miR-6089,hsa-miR-6769a-3p,hsa-miR-7843-5p,hsa-miR-10392-3p	C-reactive protein measurement,-	SIRT4	SMARCD1
ENSG00000255874	PRECSIT	-2.50169319775093	1.20486307370637e-7	M2_vs_M1	HSALNG0141617	integenic	Not conserved	NA	Sitting height ratio	ANKRD10	CGGBP1
ENSG00000255893	NA	-3.15514930857311	3.47035686416656e-4	M2_vs_M1	HSALNG0086522	sense	Q50	NA	NA	MRE11	ENSG00000254936
ENSG00000255921	NA	-5.25339924655551	2.17111706488859e-44	M2_vs_M1	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	CYGB
ENSG00000255980	LINC02953	1.54164441247887	8.30400752184671e-17	M2_vs_M1	HSALNG0143008	integenic	Q50	NA	NA	MYEOV	CRY1
ENSG00000256073	URB1-AS1	1.57595252586859	2.8763788650161203e-9	M2_vs_M1	HSALNG0132674	integenic	Not conserved	hsa-miR-1237-5p,hsa-miR-3194-5p,hsa-miR-6819-5p	NA	EVA1C	MED17
ENSG00000256262	USP30-AS1	-5.99933784792265	1.28590498519096e-21	M2_vs_M1	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	LINC01050
ENSG00000256268	LINC02454	1.52739465010284	2.96271841833477e-7	M2_vs_M1	HSALNG0091990	integenic	Q75	NA	Differentiated thyroid carcinoma; Papillary thyroid carcinoma,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-	MSRB3	ENSG00000232043
ENSG00000256443	NA	5.32776050705699	0.00144287085038083	M2_vs_M1	HSALNG0143189	sense	Q50	NA	NA	SYT7	SMIM2
ENSG00000256448	NA	2.53536932488783	0.0453159282133339	M2_vs_M1	HSALNG0085636	anti_sense	Q90	NA	-	RELT	LINC01664
ENSG00000256481	NA	3.98882470003131	1.56815742579941e-4	M2_vs_M1	HSALNG0084742	anti_sense,sense	Q90	hsa-miR-760,hsa-miR-3960,hsa-miR-4695-5p,hsa-miR-8072	Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to hepatitis a infection measurement,Uric acid measurement,Bmi-adjusted waist-hip ratio,Intelligence; Cognitive function measurement,Bmi-adjusted waist-hip ratio; Urate measurement,Bmi-adjusted waist circumference,Urate measurement,Reticulocyte count,Insulin measurement; Body mass index; Total cholesterol measurement; Waist-hip ratio; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Bmi-adjusted hip circumference,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio; Smoking behavior,High density lipoprotein cholesterol measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,-	FLRT1	EXOC5P1
ENSG00000256546	LINC02985	1.1764409556971	0.0280800937967727	M2_vs_M1	HSALNG0094625	integenic	Q75	NA	Serum alanine aminotransferase measurement,Uric acid measurement; Body weight	BCL7A	SAMD13
ENSG00000256633	PDE2A-AS2	1.57172524212226	0.0139018854763915	M2_vs_M1	HSALNG0143016	anti_sense	Q90	hsa-miR-6749-5p,hsa-miR-6763-5p	-	ATG16L2	MAFA-AS1
ENSG00000256915	NA	2.03683926239274	0.0426378508064917	M2_vs_M1	HSALNG0091991	integenic	Q75	hsa-miR-4763-3p	Creatinine measurement,Goiter,Brain volume measurement,Heel bone mineral density,Body height,-	MSRB3	GANC
ENSG00000256940	PPP1R14B-AS1	1.23429373089127	7.01808276485421e-8	M2_vs_M1	HSALNG0084765	anti_sense	Q90	hsa-miR-505-5p,hsa-miR-920,hsa-miR-1237-5p,hsa-miR-3178,hsa-miR-1587	-	NA	INTS2
ENSG00000256967	NA	-5.49294860897312	0.00202174061875415	M2_vs_M1	HSALNG0088974	anti_sense	Q50	hsa-miR-146b-3p	-	RBP5	DAZAP2
ENSG00000257027	NA	-1.26242461043746	1.36606565151476e-7	M2_vs_M1	HSALNG0089164	integenic	Not conserved	NA	NA	CLEC2D	SDAD1
ENSG00000257219	LNCOG	5.49283114337456	0.00202898249511423	M2_vs_M1	HSALNG0092540	integenic	Q50	hsa-miR-619-5p,hsa-miR-1227-5p,hsa-miR-1233-5p,hsa-miR-4270,hsa-miR-5685,hsa-miR-6763-5p	Triacylglycerol 46:0 measurement,Triacylglycerol 48:0 measurement,-	ZDHHC17	RPL21P16
ENSG00000257258	NA	2.81113735571559	2.5163434888583e-17	M2_vs_M1	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	SPC25
ENSG00000257270	NA	-2.39014306293671	3.51185065379969e-4	M2_vs_M1	HSALNG0104222	anti_sense	Q90	NA	-	BRF1	TMCO2
ENSG00000257285	PRMT5-DT	-2.13054134326136	5.38519728574761e-4	M2_vs_M1	HSALNG0099989	anti_sense	Q50	NA	Self reported educational attainment; Household income,Self reported educational attainment; Cognitive function measurement,Self reported educational attainment,Fev/fec ratio,Hypertension,Intelligence,-	REM2	TIMM9
ENSG00000257433	RPAP3-DT	-1.52011608184496	1.27122076919319e-6	M2_vs_M1	HSALNG0090786	anti_sense	Q90	hsa-miR-4478,hsa-miR-4505,hsa-miR-1587,hsa-miR-4717-5p,hsa-miR-6744-3p,hsa-miR-6763-5p,hsa-miR-6855-5p,hsa-miR-8485	Cup-to-disc ratio measurement,Periodontitis,Blood protein measurement,-	SLC48A1	SH2D4B
ENSG00000257477	LINC01154	5.64053177002412	0.00170160157990978	M2_vs_M1	HSALNG0091365	overlap_antisense,anti_sense	Q90	hsa-miR-210-5p,hsa-miR-6086,hsa-miR-6510-5p,hsa-miR-6749-3p,hsa-miR-6788-5p,hsa-miR-6791-5p,hsa-miR-6803-5p	Hematocrit,Hemoglobin measurement,Bmi-adjusted waist circumference,Fear of severe pain measurement,-	NCKAP1L	LINC01611
ENSG00000257551	HLX-AS1	-2.94478461307784	1.1223703938103e-10	M2_vs_M1	HSALNG0010765	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-6735-3p	Heart failure,Body height,Heel bone mineral density,Apolipoprotein b measurement,Urate measurement,Serum albumin measurement,Monocyte count,Neutrophil percentage of leukocytes,Leukocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Eosinophil count; Basophil count,Lymphocyte count,Neutrophil count,Fetal hemoglobin measurement,C-reactive protein measurement; Vital capacity,C-reactive protein measurement; Total cholesterol measurement,-	RAB3GAP2	PDE8A
ENSG00000257557	PPP1R12A-AS1	-2.1560959593565	5.01368689313718e-7	M2_vs_M1	HSALNG0092662	anti_sense	Q50	hsa-miR-619-5p	Platelet count,Reticulocyte count; Reticulocyte measurement,-	OTOGL	BPNT1
ENSG00000257595	LINC02356	4.82714271217849	2.4935506076871003e-25	M2_vs_M1	HSALNG0094035	integenic	Q75	hsa-miR-30b-3p,hsa-miR-3194-5p	Platelet count,Lean body mass,Eosinophil count; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Parental genotype effect measurement; Eosinophil count; Protein measurement; Intraocular pressure measurement; Systolic blood pressure; C-x-c motif chemokine 10 measurement; Hba1c measurement; Monokine induced by gamma interferon measurement; Preeclampsia; Rheumatoid arthritis; Peripheral arterial disease; Vitiligo,Triglyceride measurement; Epilepsy; Alcohol dependence measurement; Alcohol consumption measurement,Lymphocyte count,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,-	SH2B3	DCTN6-DT
ENSG00000257599	OVCH1-AS1	-2.48811811419933	5.18726686347171e-5	M2_vs_M1	HSALNG0090102	anti_sense	Q90	hsa-miR-517-5p,hsa-miR-619-5p,hsa-miR-6071	Age at onset,Protein measurement,Gut microbiome measurement,-	FAR2	FTH1P4
ENSG00000257605	MYG1-AS1	3.19766071711669	0.0186195358554996	M2_vs_M1	HSALNG0091261	anti_sense	Q75	hsa-miR-6089	-	AAAS	ENSG00000223390
ENSG00000257698	GIHCG	1.20474912185365	2.89216081332443e-5	M2_vs_M1	HSALNG0091676	intronic_antisense	Q75	hsa-miR-619-5p,hsa-miR-4505	-	CTDSP2	MBL1P
ENSG00000257718	CPNE8-AS1	1.32611197546594	1.69951822440143e-4	M2_vs_M1	HSALNG0090432	anti_sense	Q50	hsa-miR-6763-3p,hsa-miR-6878-3p	NA	ALG10B	KRT17
ENSG00000257913	DDN-AS1	-4.62839726880007	0.0436316391164218	M2_vs_M1	HSALNG0090908	anti_sense	Q90	hsa-miR-939-3p,hsa-miR-4463,hsa-miR-4722-5p,hsa-miR-6721-5p,hsa-miR-6746-3p,hsa-miR-6810-3p	Chronotype measurement; Heel bone mineral density,Pulse pressure measurement; Red blood cell distribution width; Bmi-adjusted waist circumference; Body mass index; Systolic blood pressure; Body height; Hba1c measurement; High density lipoprotein cholesterol measurement,Self reported educational attainment,Verbal-numerical reasoning measurement,Blood protein measurement,Intelligence,Mathematical ability,-	WNT1	ENSG00000258824
ENSG00000257924	LINC02416	-4.80665512825468	0.0274218218459933	M2_vs_M1	HSALNG0090757	integenic	Not conserved	hsa-miR-619-5p	-	PCED1B	IFNL1
ENSG00000258082	NA	1.72298564210342	0.0120418211952202	M2_vs_M1	HSALNG0011660	integenic	Q50	hsa-miR-6089,hsa-miR-6769b-3p	Serum gamma-glutamyl transferase measurement,Platelet count,Monocyte percentage of leukocytes; Monocyte count,Apolipoprotein a 1 measurement,Low density lipoprotein cholesterol measurement,Response to vaccine; Cytokine measurement,Cognitive function measurement,-	TOMM20	PABPC4L
ENSG00000258137	GPR84-AS1	2.41863699050511	4.67046067727978e-10	M2_vs_M1	HSALNG0091365	overlap_antisense,anti_sense	Q90	hsa-miR-210-5p,hsa-miR-6086,hsa-miR-6510-5p,hsa-miR-6749-3p,hsa-miR-6788-5p,hsa-miR-6791-5p,hsa-miR-6803-5p	Hematocrit,Hemoglobin measurement,Bmi-adjusted waist circumference,Fear of severe pain measurement,-	NCKAP1L	ANKRD18DP
ENSG00000258168	NA	-1.35052730245116	8.965280353362449e-30	M2_vs_M1	HSALNG0092318	anti_sense	Q50	hsa-miR-4312,hsa-miR-4455,hsa-miR-5787	Leukocyte count,Hiv-1 infection; Peripheral neuropathy; Response to reverse transcriptase inhibitor,-	KCNMB4	MEA1
ENSG00000258317	NA	-6.32474153035318	1.44875713688139e-4	M2_vs_M1	HSALNG0091499	anti_sense	Q90	NA	Systemic scleroderma,-	SMARCC2	ENSG00000234622
ENSG00000258413	FBXO34-AS1	-2.87453377288042	0.00293971336940008	M2_vs_M1	HSALNG0101458	anti_sense	Q75	hsa-miR-4707-5p,hsa-miR-6763-3p,hsa-miR-6764-3p,hsa-miR-6791-3p,hsa-miR-6803-5p	Platelet count; Red blood cell distribution width,Eosinophil count,-	DLGAP5	ENSG00000230736
ENSG00000258441	LINC00641	-1.6653505750408	1.3101391105604698e-22	M2_vs_M1	HSALNG0099873	integenic	Not conserved	NA	Bipolar disorder,-	HNRNPC	P4HTM
ENSG00000258458	OXA1L-DT	2.83995983623619	1.07082049479245e-5	M2_vs_M1	HSALNG0099968	anti_sense	Q90	hsa-miR-4296	Susceptibility to infectious disease measurement,-	SLC7A7	FLNB
ENSG00000258515	NA	-4.81239870663832	0.0368483552090362	M2_vs_M1	HSALNG0099798	anti_sense	Q50	NA	NA	APEX1	ATG9A
ENSG00000258521	NA	-6.57147150087303	5.04410806932681e-76	M2_vs_M1	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	C1S
ENSG00000258559	NA	-2.98948393599506	8.34621022062143e-4	M2_vs_M1	HSALNG0102422	sense	Not conserved	hsa-miR-604,hsa-miR-619-5p	-	ABCD4	GUSBP11
ENSG00000258572	NA	3.3532160819033	2.41132323628538e-4	M2_vs_M1	HSALNG0103439	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587,hsa-miR-6798-3p	Pr interval,-	GLRX5	POLR1E
ENSG00000258634	NA	-1.0394008880174	3.33216558229542e-5	M2_vs_M1	HSALNG0005948	anti_sense,sense	Q90	NA	Cortical surface area measurement,-	STRIP1	B4GALT6
ENSG00000258667	HIF1A-AS3	-1.67508976932537	3.34677829567012e-6	M2_vs_M1	HSALNG0101781	anti_sense	Q50	hsa-miR-619-5p	-	TMEM30B	RGS20
ENSG00000258682	NA	-2.04954733188351	0.00164155664432723	M2_vs_M1	HSALNG0101623	anti_sense,sense	Not conserved	NA	-	PSMA3	ATRIP
ENSG00000258733	LINC02328	-2.60868509306312	2.97136495178014e-28	M2_vs_M1	HSALNG0102968	integenic	Not conserved	NA	NA	FLRT2	C19orf47
ENSG00000258738	BAZ1A-AS1	-1.72598093960556	3.08056540010779e-4	M2_vs_M1	HSALNG0100538	anti_sense	Q90	NA	Heel bone mineral density,Monocyte count,Reticulocyte measurement,-	SRP54	ENSG00000271830
ENSG00000258744	NA	-1.62491610166296	3.71353319504177e-7	M2_vs_M1	HSALNG0100146	anti_sense	Not conserved	hsa-miR-619-5p	Smooth surface dental caries,-	KHNYN	RPL10P13
ENSG00000258777	HIF1A-AS1	-5.12455225941861	0.018364337419796	M2_vs_M1	HSALNG0101776	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-5088-5p	Cd40 ligand measurement,Creatinine measurement,-	TMEM30B	NME8
ENSG00000258807	NA	1.42512514287917	4.13242750785898e-5	M2_vs_M1	HSALNG0103005	sense	Q50	hsa-miR-129-1-3p,hsa-miR-129-2-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6838-5p	Suicide,Borderline personality disorder,Epstein-barr virus infection,Breast carcinoma,Body height; Body mass index,-	GALC	FAM3B
ENSG00000258824	NA	-4.62832132078425	0.0434128241042076	M2_vs_M1	HSALNG0101883	anti_sense	Q75	NA	Neuropsychological test,Heel bone mineral density,Testosterone measurement,-	ZBTB25	ENSG00000258824
ENSG00000258859	LINC02296	1.95744816181169	0.0251602327272093	M2_vs_M1	HSALNG0103005	sense	Q50	hsa-miR-129-1-3p,hsa-miR-129-2-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6838-5p	Suicide,Borderline personality disorder,Epstein-barr virus infection,Breast carcinoma,Body height; Body mass index,-	GALC	MINDY2-DT
ENSG00000258875	NA	-2.23555531856159	5.919660111317039e-19	M2_vs_M1	HSALNG0103182	anti_sense	Q50	hsa-miR-7155-5p	NA	DGLUCY	SEZ6
ENSG00000258976	NA	4.66994452319327	0.0277985003892882	M2_vs_M1	HSALNG0102446	integenic	Q50	NA	NA	LTBP2	ABLIM3
ENSG00000259248	USP3-AS1	-3.33883618158638	3.02018375760798e-5	M2_vs_M1	HSALNG0106502	anti_sense	Q90	hsa-miR-612,hsa-miR-1226-5p,hsa-miR-3176,hsa-miR-4472,hsa-miR-6769b-5p	Self reported educational attainment; Mathematical ability,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Forced expiratory volume; Fev/fec ratio; Peak expiratory flow,Electrocardiography,Thyroxine measurement,Qrs duration,Aortic root size,Reticulocyte count; Reticulocyte measurement,Inflammatory biomarker measurement; Ykl40 measurement,Heel bone mineral density,-	HERC1	CCDC115
ENSG00000259250	NA	2.43137514333958	2.29092791659457e-17	M2_vs_M1	HSALNG0106240	anti_sense	Q50	NA	-	LIPC	ZNF594
ENSG00000259319	JDP2-AS1	-1.63036351796598	8.4812625562031e-5	M2_vs_M1	HSALNG0102519	anti_sense	Q75	hsa-miR-663b	-	ERG28	DNM1L
ENSG00000259354	NA	-4.20830877556717	1.0517661826920099e-23	M2_vs_M1	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	DSE
ENSG00000259366	NA	-1.13927494924488	5.79668923021334e-4	M2_vs_M1	HSALNG0064258	sense	Q90	NA	-	HMBOX1	MYDGF
ENSG00000259517	LINC02169	1.99164384595161	6.53446953621372e-22	M2_vs_M1	HSALNG0111559	integenic	Q75	NA	NA	IRX3	C1orf159
ENSG00000259590	LINC02244	-2.31374376418383	6.555728319818759e-23	M2_vs_M1	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	TEX29
ENSG00000259642	ST20-AS1	1.31804978571052	6.85516810290692e-10	M2_vs_M1	HSALNG0107566	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-4508,hsa-miR-7150,hsa-miR-8072	-	ZFAND6	PET100
ENSG00000259712	NA	-2.70748945099603	3.87494009204644e-4	M2_vs_M1	HSALNG0105950	anti_sense	Not conserved	NA	Adolescent idiopathic scoliosis,C-reactive protein measurement,Rostral middle frontal gyrus volume measurement,Heel bone mineral density,Fat body mass,Uric acid measurement; Response to allopurinol,-	BCL2L10	LINC02785
ENSG00000259760	NA	-2.59142421484294	2.50451984880574e-34	M2_vs_M1	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	NR1H3
ENSG00000259802	NA	1.52121657492132	9.04751645386375e-5	M2_vs_M1	HSALNG0040136	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-891a-3p,hsa-miR-4274,hsa-miR-6807-3p	Serum gamma-glutamyl transferase measurement,-	CMBL	ENSG00000277952
ENSG00000259810	NA	-5.68976717865871	9.34441262205637e-4	M2_vs_M1	HSALNG0110903	sense	Not conserved	NA	NA	KRBOX5	LINC02041
ENSG00000259865	NA	-1.61903798491528	3.48333587467827e-9	M2_vs_M1	HSALNG0012240	integenic	Not conserved	NA	-	ZNF124	MUC20P1
ENSG00000259869	NA	3.26286188975743	6.75908290090984e-4	M2_vs_M1	HSALNG0077502	integenic	Not conserved	NA	-	ZNF33B	TCAF2
ENSG00000259871	NA	6.12048956942707	1.9508296328146e-5	M2_vs_M1	HSALNG0109998	sense	Not conserved	hsa-miR-8485	NA	CLEC19A	ENSG00000259871
ENSG00000259953	LINC02977	1.44926182017684	1.69436567422356e-8	M2_vs_M1	HSALNG0073741	integenic	Not conserved	hsa-miR-619-5p	Physical activity	SUSD1	AFG3L2
ENSG00000259959	NA	1.4177116030254	0.0119160838596821	M2_vs_M1	HSALNG0034258	integenic	Not conserved	NA	NA	CORIN	ZNF70
ENSG00000260005	NA	-1.88289338603309	0.00329859341408234	M2_vs_M1	HSALNG0145178	anti_sense	Q50	hsa-miR-6862-5p	Blood protein measurement,-	NDUFAF8	ENSG00000289912
ENSG00000260018	MBTPS1-DT	2.43311371200168	5.97504599716122e-5	M2_vs_M1	HSALNG0113101	integenic	Not conserved	NA	-	DNAAF1	LINC01480
ENSG00000260035	NA	4.66931847517388	0.0439467383181498	M2_vs_M1	HSALNG0105619	sense	Q75	NA	-	SHF	LINC01611
ENSG00000260051	NA	-3.22245673047296	1.38932224007165e-6	M2_vs_M1	HSALNG0108901	anti_sense	Not conserved	hsa-miR-6798-5p	NA	PERCC1	TMEM141
ENSG00000260063	NA	2.94753768143198	0.014144488023821	M2_vs_M1	HSALNG0001922	anti_sense	Q90	NA	Heel bone mineral density,Body height; Serum alanine aminotransferase measurement; Platelet crit; Bilirubin measurement; Testosterone measurement; Total cholesterol measurement; Apolipoprotein b measurement; High density lipoprotein cholesterol measurement; Platelet count; Uric acid measurement; Triglyceride measurement; Alcohol consumption measurement; Sex hormone-binding globulin measurement; Metabolic syndrome; Alcohol drinking; Neutrophil count; Osteoprotegerin measurement; Protein measurement; Low density lipoprotein cholesterol measurement,Urate measurement,Hair colour measurement,Neutrophil percentage of leukocytes,-	GPN2	LINC02985
ENSG00000260086	NA	2.06548756642968	0.00589570463340813	M2_vs_M1	HSALNG0111257	integenic	Not conserved	NA	NA	LONP2	TMEM44-AS2
ENSG00000260101	AFTPH-DT	1.2405381037435	0.00224036515425119	M2_vs_M1	HSALNG0015480	anti_sense	Q90	NA	Epithelial cell adhesion molecule measurement,Gut microbiome measurement,-	SERTAD2	TMEM192
ENSG00000260135	MMP2-AS1	-6.17350258391808	7.898498312341279e-23	M2_vs_M1	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	LRRC38
ENSG00000260188	NA	1.65755977709863	2.0723246648826402e-14	M2_vs_M1	HSALNG0052706	anti_sense	Q50	hsa-miR-2113,hsa-miR-874-3p,hsa-miR-1268b,hsa-miR-4456,hsa-miR-4778-3p,hsa-miR-6089	Hba1c measurement,Heel bone mineral density,Arachidonic acid measurement,Alpha peak frequency measurement; Electroencephalogram measurement; Alpha wave measurement,-	CDC40	TGFB1I1
ENSG00000260196	NA	4.04084755357576	3.66672790952273e-47	M2_vs_M1	HSALNG0082946	integenic	Not conserved	NA	Pulse pressure measurement; Body mass index; Systolic blood pressure; Bmi-adjusted waist-hip ratio; Social communication impairment,Systolic blood pressure; Alcohol drinking	NCR3LG1	ENSG00000224413
ENSG00000260256	NA	-3.50789419730633	4.70049165270845e-6	M2_vs_M1	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	ZBTB38
ENSG00000260257	NA	2.8814248733899	1.78482265431394e-20	M2_vs_M1	HSALNG0129600	integenic	Not conserved	NA	Attention deficit hyperactivity disorder,-	EFCAB8	LRRK1
ENSG00000260260	SNHG19	3.00131237930892	2.18678770098822e-38	M2_vs_M1	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	PPP1R35
ENSG00000260265	LINC02562	-6.36298338607395	3.05321715641751e-5	M2_vs_M1	HSALNG0035237	anti_sense	Q75	NA	Nephrotic syndrome,Calcium measurement,C-x-c motif chemokine 10 measurement,Qt interval,-	BTC	NME8
ENSG00000260274	NA	1.63847701924275	4.28338636467215e-4	M2_vs_M1	HSALNG0107284	anti_sense	Q75	hsa-miR-1301-3p,hsa-miR-1207-3p,hsa-miR-6813-5p,hsa-miR-7156-3p	-	NEIL1	ENSG00000274270
ENSG00000260285	TRMT61A-DT	-1.05129392498267	6.65360307020554e-4	M2_vs_M1	HSALNG0104006	integenic	Q50	hsa-miR-6763-5p,hsa-miR-6810-3p	Reticulocyte count; Hemoglobin measurement; Reticulocyte measurement,Reticulocyte count; Hematocrit,Body height	CKB	JAZF1
ENSG00000260317	LINC02986	2.24725872246169	1.75262691238305e-4	M2_vs_M1	HSALNG0066510	integenic	Not conserved	NA	NA	ZBTB10	DPY30
ENSG00000260329	TMEM263-DT	2.73768458771816	0.00230239172345056	M2_vs_M1	HSALNG0093754	anti_sense	Q50	NA	Aging,Alkaline phosphatase measurement	MTERF2	ACSS2
ENSG00000260339	HEXA-AS1	-1.23205177731552	0.00321861147058369	M2_vs_M1	HSALNG0107054	anti_sense	Not conserved	NA	-	TMEM202	SMIM29
ENSG00000260479	NA	2.64391170553905	0.0058358996846092	M2_vs_M1	HSALNG0112882	sense	Q75	NA	NA	WWOX	VPS45
ENSG00000260528	FAM157C	-2.38895343983188	0.0046138905377538	M2_vs_M1	HSALNG0113696	integenic	Not conserved	hsa-let-7g-3p	-	GAS8	ZNF271P
ENSG00000260572	PPM1L-DT	1.33416927890082	0.0406807410055516	M2_vs_M1	HSALNG0030244	anti_sense	Q50	hsa-miR-4252	Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,-	KPNA4	GABPA
ENSG00000260583	NA	-4.39203867013804	2.81024020441882e-6	M2_vs_M1	HSALNG0147166	integenic	Not conserved	NA	NA	MRPL39	RHOQ-AS1
ENSG00000260588	NA	-1.01414014116432	0.0479684761614583	M2_vs_M1	HSALNG0064845	sense	Not conserved	hsa-miR-1268b	Mean reticulocyte volume	ANK1	PAXBP1
ENSG00000260630	SNAI3-AS1	1.69090555269406	1.5556412219210998e-24	M2_vs_M1	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	TTC14
ENSG00000260708	TBC1D22A-DT	2.48482618066497	3.6446861153222197e-23	M2_vs_M1	HSALNG0136034	integenic	Not conserved	NA	NA	CERK	BABAM1
ENSG00000260778	MIR3677HG	1.82874836798975	0.0189907270657846	M2_vs_M1	HSALNG0108999	anti_sense	Not conserved	hsa-miR-1343-3p,hsa-miR-6089,hsa-miR-6791-5p	Bmi-adjusted hip circumference,-	DNASE1L2	ENSG00000287593
ENSG00000260793	NA	1.84864330678037	0.0171067691536497	M2_vs_M1	HSALNG0116712	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4695-5p,hsa-miR-6085,hsa-miR-6090	Heel bone mineral density,Body weight; Body mass index,Visceral adipose tissue measurement,Reticulocyte count,Appendicular lean mass; Bone density,Cortical thickness,Uric acid measurement; Calcium measurement,Mean corpuscular hemoglobin concentration,Cortical surface area measurement,Self reported educational attainment,Body fat distribution,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	TMUB2	SGPP1
ENSG00000260804	LINC01963	1.55168229451139	1.31280098878048e-11	M2_vs_M1	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	PPP1R3C
ENSG00000260805	NA	1.78644958557125	4.669901932805e-5	M2_vs_M1	HSALNG0010371	integenic	Q50	hsa-miR-6090,hsa-miR-10392-3p	-	BATF3	TCEAL4
ENSG00000260806	PAPOLA-DT	1.65755523035285	0.00175074855199029	M2_vs_M1	HSALNG0103511	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-8072	NA	ATG2B	RPL36P14
ENSG00000260807	CEROX1	-5.3920214467374	0.00571474741978362	M2_vs_M1	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1	ENSG00000289110
ENSG00000260852	FBXL19-AS1	-2.28197203949274	7.94292276780647e-17	M2_vs_M1	HSALNG0110794	anti_sense	Q90	NA	Graves disease,-	BCL7C	EHBP1-AS1
ENSG00000260853	NFATC2IP-AS1	-2.56143904968011	2.34501486738859e-10	M2_vs_M1	HSALNG0110548	anti_sense	Q75	NA	Intelligence,Total blood protein measurement; Intelligence,Hemoglobin measurement; Serum non-albumin protein measurement,Hemoglobin measurement,-	RABEP2	ENSG00000290394
ENSG00000260868	LINC01960	-1.88757404876391	2.46929066677816e-4	M2_vs_M1	HSALNG0146267	integenic	Q75	NA	NA	SP9	HMSD
ENSG00000260876	LINC01229	1.24370412203992	1.3038073326447402e-9	M2_vs_M1	HSALNG0112914	integenic	Q90	NA	NA	WWOX	LMLN
ENSG00000260911	NA	-1.80743546904074	0.0452335182581322	M2_vs_M1	HSALNG0110810	integenic	Not conserved	NA	NA	STX4	MIER2
ENSG00000260912	NA	3.48242047795864	3.3654028194362003e-22	M2_vs_M1	NA	NA	NA	NA	NA	ACER2	PXMP2
ENSG00000260953	NA	-4.83332425950841	0.0415794489730102	M2_vs_M1	HSALNG0110584	integenic	Not conserved	hsa-miR-6783-3p	NA	NPIPB11	ASB16-AS1
ENSG00000260997	NA	-4.41986469828601	1.26064845383643e-12	M2_vs_M1	NA	NA	NA	NA	NA	MYO1G	WARS1
ENSG00000261000	NA	3.19767157978746	0.0186502948053514	M2_vs_M1	HSALNG0010032	integenic	Q75	NA	NA	RASSF5	FSTL1
ENSG00000261118	NA	1.95580698404302	0.0270376620575426	M2_vs_M1	HSALNG0113611	anti_sense	Not conserved	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-939-3p,hsa-miR-4292	Body height,Heel bone mineral density,Pulse pressure measurement	ANKRD11	LINC01133
ENSG00000261170	NA	2.42358951188937	0.0152433239147	M2_vs_M1	HSALNG0112689	integenic	Not conserved	NA	NA	NPIPB15	ENSG00000272338
ENSG00000261211	NA	-1.75129868928271	3.77236959193218e-4	M2_vs_M1	HSALNG0047833	integenic	Q75	hsa-miR-6833-3p	Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,-	F13A1	BCAS4
ENSG00000261220	ST3GAL1-DT	1.45508344356444	3.35211130855749e-10	M2_vs_M1	HSALNG0068753	integenic	Q75	hsa-miR-6746-3p	-	CCN4	DBT
ENSG00000261253	NA	4.04681697709114	1.35480513940439e-7	M2_vs_M1	HSALNG0113602	anti_sense	Not conserved	hsa-miR-505-5p,hsa-miR-1587,hsa-miR-3972,hsa-miR-6812-5p	Carotid plaque build	ZNF778	PGM2
ENSG00000261270	NA	-2.35622269199846	0.0378493894638903	M2_vs_M1	HSALNG0111737	sense	Q50	NA	NA	HERPUD1	PLEKHN1
ENSG00000261296	NA	-3.91552956608279	6.18040729204039e-5	M2_vs_M1	HSALNG0106417	integenic	Q50	NA	-	TLN2	DUSP8P5
ENSG00000261326	LINC01355	-1.13111532256438	0.00159219315316486	M2_vs_M1	HSALNG0001619	sense	Q90	NA	Monocyte count,Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,-	HNRNPR	EXOC8
ENSG00000261329	NA	-4.62990139092675	0.0488428199622389	M2_vs_M1	HSALNG0110456	anti_sense	Q50	hsa-miR-423-5p,hsa-miR-619-5p,hsa-miR-3944-3p	Myopia,Adolescent idiopathic scoliosis,Grey matter density measurement,Response to placebo; Fvc change measurement,-	GSG1L	TMEM116
ENSG00000261338	NA	2.08351158655295	2.47764752139918e-8	M2_vs_M1	NA	NA	NA	NA	NA	ARPC2	MIR223HG
ENSG00000261342	NA	1.44142351254864	0.00277288335210887	M2_vs_M1	HSALNG0123190	intronic_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6845-3p	Sex hormone-binding globulin measurement,-	NA	ZNF771
ENSG00000261346	NA	4.67313762681428	0.0469138189446824	M2_vs_M1	HSALNG0110741	anti_sense	Q50	NA	NA	SEPHS2	LINC02986
ENSG00000261366	MANEA-DT	-5.35706159930611	0.0100078762339619	M2_vs_M1	HSALNG0052066	anti_sense	Not conserved	NA	Blood protein measurement,Aspartate aminotransferase measurement,Bone mineral content measurement,Sex hormone-binding globulin measurement,Intelligence,Susceptibility to mononucleosis measurement,-	GPR63	DAB2IP
ENSG00000261416	CORO1A-AS1	1.65295998796922	0.00145728288481129	M2_vs_M1	HSALNG0110699	anti_sense	Q75	hsa-miR-92a-2-5p,hsa-miR-3178,hsa-miR-4308,hsa-miR-3689a-3p,hsa-miR-3689b-3p,hsa-miR-4447,hsa-miR-3689c,hsa-miR-4505,hsa-miR-4690-5p,hsa-miR-4734,hsa-miR-5787,hsa-miR-6085,hsa-miR-6737-5p,hsa-miR-7152-5p	-	BOLA2B	BEST4
ENSG00000261485	PAN3-AS1	1.44095044633623	5.02574415212603e-10	M2_vs_M1	HSALNG0095998	anti_sense	Q90	NA	-	FLT3	TSPYL5
ENSG00000261512	NA	-2.29110642312319	1.43216175507729e-6	M2_vs_M1	NA	NA	NA	NA	NA	SHCBP1	ENSG00000286366
ENSG00000261526	NA	1.30226624214613	1.29028339790539e-4	M2_vs_M1	HSALNG0123094	integenic	Not conserved	NA	NA	ABHD17A	MMP21
ENSG00000261616	NA	-4.98937583542205	0.0245020079041117	M2_vs_M1	HSALNG0108524	anti_sense	Not conserved	NA	Fev/fec ratio,-	SYNM	SPX
ENSG00000261618	LINC02605	-8.70547660729657	2.71011858592097e-26	M2_vs_M1	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	C1QTNF1
ENSG00000261644	CYLD-AS1	-2.85559186319179	1.43088103683705e-20	M2_vs_M1	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	DGKZ
ENSG00000261656	BEAN1-AS1	4.66672015304919	0.033575235658775	M2_vs_M1	HSALNG0112094	anti_sense,sense	Q50	hsa-miR-6852-5p,hsa-miR-7155-5p	Agouti-related protein measurement,-	NA	ENSG00000287507
ENSG00000261671	NA	3.59549867446507	9.64573927783418e-5	M2_vs_M1	HSALNG0076631	integenic	Q75	NA	-	COMMD3	ENSG00000267251
ENSG00000261770	NA	-2.60825100730175	9.40519899377856e-4	M2_vs_M1	HSALNG0125113	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-920	Testicular germ cell tumor,-	UQCRFS1	IL17RD
ENSG00000261795	NA	2.8277087776164	5.08148220841084e-27	M2_vs_M1	HSALNG0055499	integenic	Not conserved	NA	NA	PDGFA	RNPEP
ENSG00000261798	NA	1.77180041954104	1.57050775453658e-8	M2_vs_M1	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE	RAD54L
ENSG00000261799	NA	-1.15012022566884	0.0151364588201858	M2_vs_M1	HSALNG0088467	integenic	Not conserved	NA	Bmi-adjusted waist-hip ratio	KDM5A	LINC01133
ENSG00000261801	LOXL1-AS1	-3.46971435297122	0.00180926702664587	M2_vs_M1	HSALNG0107133	anti_sense	Q50	hsa-miR-3194-5p,hsa-miR-500b-3p,hsa-miR-4667-3p,hsa-miR-6089	Feeling """"fed-up"""" measurement,Body height,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Body height,Exfoliation syndrome,-	STOML1	TFAP2A
ENSG00000261824	LINC00662	-1.4737382669337	1.43161780347644e-50	M2_vs_M1	HSALNG0125113	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-920	Testicular germ cell tumor,-	UQCRFS1	PDE4D
ENSG00000261840	NA	2.15620827625777	0.0418929246381769	M2_vs_M1	HSALNG0110773	anti_sense	Q90	NA	-	CFAP119	ENSG00000289428
ENSG00000261879	ZNF594-DT	3.16057352020429	0.00137906647088085	M2_vs_M1	HSALNG0114109	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089	Head and neck squamous cell carcinoma,Family history of alzheimers disease,-	USP6	ENSG00000231181
ENSG00000261888	NA	2.06946911283357	2.07730111247519e-34	M2_vs_M1	HSALNG0145190	integenic	Not conserved	NA	Hematocrit	METRNL	APBB1
ENSG00000261971	MMP25-AS1	-2.69571202466242	2.4818662241668898e-62	M2_vs_M1	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2	OSBPL8
ENSG00000261997	NA	-2.93276322080113	0.0283213566964142	M2_vs_M1	NA	NA	NA	NA	NA	LPCAT2	ENSG00000290818
ENSG00000262061	RPH3AL-AS1	-5.25513997307721	0.0051366538053108	M2_vs_M1	HSALNG0113717	anti_sense	Q75	hsa-miR-631,hsa-miR-632,hsa-miR-1226-3p,hsa-miR-4516	NA	C17orf97	ANO3
ENSG00000262097	LINC02185	3.66155975198647	2.86233376143791e-55	M2_vs_M1	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	STMN1
ENSG00000262223	LINC03048	-3.09712365651456	2.93863965003454e-4	M2_vs_M1	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10	TAPBPL
ENSG00000262580	NA	-1.43095856491301	2.9923911052999904e-9	M2_vs_M1	HSALNG0119173	anti_sense	Q50	NA	Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH	MN1
ENSG00000262686	GLIS2-AS1	3.80719486531961	2.39039641523449e-6	M2_vs_M1	HSALNG0109231	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-7703	NA	PAM16	HM13
ENSG00000262691	NA	2.29957387010999	0.027588966670584	M2_vs_M1	NA	NA	NA	NA	NA	SLC9A5	SLC45A4
ENSG00000262766	NA	-3.03459531320365	0.0177894308988874	M2_vs_M1	HSALNG0110822	sense	Q90	hsa-miR-4640-3p,hsa-miR-6089,hsa-miR-7704	Smoking behavior; Body mass index,Anxiety; Family history of alzheimers disease,-	KAT8	ENSG00000226149
ENSG00000262879	NA	-1.48448821010239	7.71119330884571e-16	M2_vs_M1	HSALNG0116971	integenic	Not conserved	NA	NA	RPRML	LINC01948
ENSG00000262898	NA	5.0678759745865	3.1446543665101604e-17	M2_vs_M1	HSALNG0145192	integenic	Not conserved	NA	NA	METRNL	NPBWR1
ENSG00000262979	NA	-5.36126695019144	0.00686142194494909	M2_vs_M1	HSALNG0119186	sense	Not conserved	NA	-	RNF213	NNMT
ENSG00000263004	AKAP1-DT	1.89738067127731	0.0174702929421536	M2_vs_M1	HSALNG0117618	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6132	-	COIL	TCP1
ENSG00000263069	RNF213-AS1	-4.03049165381634	2.7893100370239297e-29	M2_vs_M1	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	FBXO39
ENSG00000263293	EFCAB13-DT	2.30000929259751	0.0280604300695886	M2_vs_M1	HSALNG0116989	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-4508	Bmi-adjusted hip circumference,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Brain volume measurement,Body height,Protein measurement; Bmi-adjusted hip circumference,Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Sex hormone-binding globulin measurement,Neuroimaging measurement; Brain measurement,-,Open-angle glaucoma	CDC27	MYO1B
ENSG00000263731	NA	1.5703673648198	0.0135223038180719	M2_vs_M1	HSALNG0119325	integenic	Not conserved	NA	NA	ALYREF	BROX
ENSG00000263826	NA	-2.58928858175434	0.0144683039575293	M2_vs_M1	HSALNG0031387	anti_sense	Q75	hsa-miR-1229-5p,hsa-miR-4638-5p,hsa-miR-4665-3p	Adiponectin measurement,-	RFC4	EIF1P5
ENSG00000263847	NA	-5.12315049956372	0.0104941874414291	M2_vs_M1	HSALNG0145536	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-891a-3p	Bmi-adjusted waist circumference,-	PPP4R1	ENSG00000267293
ENSG00000264107	MIR4733HG	2.53246499056067	1.4064123722306802e-9	M2_vs_M1	HSALNG0115678	anti_sense	Q90	hsa-miR-4430,hsa-miR-6829-3p	-	OMG	NDST3
ENSG00000264345	LINC01894	-5.69279024771057	7.08681628259645e-4	M2_vs_M1	HSALNG0120527	integenic	Q90	NA	-	ZNF521	MOV10L1
ENSG00000264456	NA	-2.05832813369122	5.32596569729556e-6	M2_vs_M1	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089	NA	RNF135	FAM234B
ENSG00000264666	NA	4.66963524951636	0.0343676815317746	M2_vs_M1	HSALNG0114965	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6726-5p	Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio	RAI1	ENSG00000264666
ENSG00000264769	NA	-3.74766589062158	4.77084517455193e-4	M2_vs_M1	HSALNG0145182	anti_sense	Q90	hsa-miR-4300,hsa-miR-4313,hsa-miR-4441,hsa-miR-6826-3p,hsa-miR-6878-3p	-	NPB	ENSG00000289912
ENSG00000265205	NA	-5.77596725789778	0.00152320826062253	M2_vs_M1	HSALNG0115495	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-6089	-	SDF2	TSNAXIP1
ENSG00000265206	MIR142HG	1.01228695840042	5.54757850734628e-15	M2_vs_M1	HSALNG0117712	integenic	Q75	hsa-miR-4313,hsa-miR-4722-5p,hsa-miR-6780a-3p	Platelet crit; Late-onset alzheimers disease; Platelet count; Monocyte count; Family history of alzheimers disease,Leukocyte count,-	TSPOAP1	RPL32P18
ENSG00000265485	LINC01915	-3.04921737042226	5.12723955664404e-7	M2_vs_M1	HSALNG0120520	integenic	Not conserved	NA	NA	HRH4	AP2B1
ENSG00000265494	NA	-4.63438564758904	1.65791367146582e-8	M2_vs_M1	NA	NA	NA	NA	NA	COX10	TP53INP2
ENSG00000265519	NA	-2.18698974956738	1.31181067024794e-6	M2_vs_M1	HSALNG0114816	integenic	Not conserved	hsa-miR-1224-3p	-	TRIM16	BNIP3L
ENSG00000265678	NA	-3.61232190267592	7.32182862249599e-4	M2_vs_M1	HSALNG0119378	anti_sense	Q50	NA	NA	SLC16A3	CATSPERE
ENSG00000265688	MILIP	1.6430864890474	9.001607685031479e-11	M2_vs_M1	HSALNG0119342	integenic	Not conserved	hsa-miR-5585-3p	-	NPB	MFSD9
ENSG00000265743	LINC02978	1.36725686242556	4.21127305878583e-7	M2_vs_M1	HSALNG0145260	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4492	NA	TEFM	SKIC2
ENSG00000265975	NA	-2.40621391414785	1.60855202287098e-8	M2_vs_M1	HSALNG0114480	integenic	Not conserved	NA	NA	NTN1	HSD11B1L
ENSG00000266088	NA	5.7644756955252	1.69092748989755e-28	M2_vs_M1	HSALNG0116373	integenic	Q50	hsa-miR-4463,hsa-miR-6803-5p,hsa-miR-7108-3p,hsa-miR-8485	-	IGFBP4	FAM20C
ENSG00000266258	LINC01909	2.73875642160662	0.00248193405126521	M2_vs_M1	HSALNG0122285	integenic	Q50	hsa-miR-1224-3p,hsa-miR-6877-3p	Deoxycholate measurement,Parental genotype effect measurement; Milk allergy measurement	SOCS6	TYW1B
ENSG00000266289	LINC02933	4.67047819950404	0.0201518006369064	M2_vs_M1	HSALNG0067518	integenic	Not conserved	NA	-	SLC25A32	LINC01611
ENSG00000266378	NA	2.30149281296347	0.0346703782346772	M2_vs_M1	HSALNG0114722	intronic_sense	Q50	NA	NA	HS3ST3B1	SRSF3
ENSG00000266389	PIK3R5-DT	-4.31252437296018	2.99324939583199e-11	M2_vs_M1	HSALNG0114479	integenic	Q75	hsa-miR-4492,hsa-miR-6810-3p,hsa-miR-6845-5p	NA	NTN1	HOXA5
ENSG00000266402	SNHG25	4.30467834758374	2.18061122482466e-39	M2_vs_M1	HSALNG0118080	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6716-5p	-	PRR29	SSNA1
ENSG00000266709	NA	1.07600761662667	4.96841071160653e-4	M2_vs_M1	HSALNG0114719	intronic_sense	Q50	NA	NA	HS3ST3B1	ENSG00000287884
ENSG00000266913	LINC01841	-2.92902818631693	0.0292318855601109	M2_vs_M1	HSALNG0124294	integenic	Not conserved	hsa-miR-766-3p,hsa-miR-4323	NA	DDX39A	SLC25A47
ENSG00000266947	NA	-1.10998051491271	5.05523073690786e-5	M2_vs_M1	HSALNG0115929	integenic	Not conserved	hsa-miR-619-5p	-	SLC35G3	FAM184A
ENSG00000266976	NA	-2.34508474247913	3.17109880176511e-13	M2_vs_M1	HSALNG0145715	integenic	Not conserved	NA	NA	VSTM2B	TSGA10
ENSG00000267040	ATP8B1-AS1	-1.59293301103208	9.72610784439923e-4	M2_vs_M1	HSALNG0121780	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4273,hsa-miR-4768-5p,hsa-miR-6089	Serum alanine aminotransferase measurement; Hemoglobin measurement; Gallstones; Serum gamma-glutamyl transferase measurement; Hematocrit; Red blood cell density measurement; Aspartate aminotransferase measurement,Low density lipoprotein cholesterol measurement; Cholelithiasis,Hemoglobin measurement,Erythrocyte count,Aspartate aminotransferase to alanine aminotransferase ratio; Serum gamma-glutamyl transferase measurement; Serum alanine aminotransferase measurement,Red blood cell density measurement,Hemoglobin measurement; Erythrocyte count,Serum alanine aminotransferase measurement; Hemoglobin measurement; Serum gamma-glutamyl transferase measurement; Hematocrit; Erythrocyte count,-	ONECUT2	FAT2
ENSG00000267074	NA	-8.18891726590341	1.19659208025447e-19	M2_vs_M1	HSALNG0115953	sense	Not conserved	NA	Macrophage inflammatory protein 1b measurement	SLFN12L	GBP1
ENSG00000267100	ILF3-DT	1.27125919623393	2.0997716048345102e-17	M2_vs_M1	HSALNG0123950	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4784	NA	AP1M2	KLHL11
ENSG00000267101	NA	4.6702994920047	0.0223059960033078	M2_vs_M1	HSALNG0121248	anti_sense	Q50	hsa-miR-1229-5p,hsa-miR-4281,hsa-miR-6089,hsa-miR-6728-3p	Smoking status measurement,Smoking behavior,Alopecia,Self reported educational attainment,Balding measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Intelligence,Bmi-adjusted hip circumference,Smoking initiation,Urate measurement,Biological sex,Uric acid measurement,Cognitive function measurement; Parental longevity,Creatinine measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	EPG5	LGI4
ENSG00000267106	ZNF561-AS1	1.38133772420317	3.63837562754018e-5	M2_vs_M1	HSALNG0123842	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-1199-5p	Myopathy; Response to simvastatin,-	UBL5	SLC10A4
ENSG00000267141	NA	-5.1331835209076	0.0183772178437743	M2_vs_M1	HSALNG0145643	intronic_antisense	Not conserved	hsa-miR-4281	NA	SCAMP4	RGS17P1
ENSG00000267244	NA	-2.58652098925227	4.34383260367809e-4	M2_vs_M1	HSALNG0123085	anti_sense	Not conserved	hsa-miR-4436a,hsa-miR-6878-3p,hsa-miR-7704	-	ONECUT3	KBTBD4
ENSG00000267260	NA	4.92772489444262	0.019960720201051	M2_vs_M1	HSALNG0125788	integenic	Not conserved	hsa-miR-378g,hsa-miR-3960	NA	ZNF567	C12orf29
ENSG00000267262	NA	3.15499881292896	8.908459129924459e-11	M2_vs_M1	HSALNG0123520	anti_sense	Q75	hsa-miR-619-5p	-	ACSBG2	LINC01588
ENSG00000267265	GP6-AS1	-1.58444278983838	0.00364700815419257	M2_vs_M1	HSALNG0127589	anti_sense	Q75	hsa-miR-619-5p	Platelet glycoprotein vi measurement,Colorectal cancer; Breast carcinoma,Mean platelet volume; Blood protein measurement,Mean platelet volume; Platelet component distribution width; Mitochondrial dna measurement; Dickkopfrelated protein 1 measurement,-,Mean corpuscular volume; Mean corpuscular hemoglobin,Reticulocyte count; Platelet aggregation; Platelet count,Inflammatory biomarker measurement,Reticulocyte count; Reticulocyte measurement	NLRP2	SLC35A3
ENSG00000267279	NA	5.49623481807217	0.00156177191546423	M2_vs_M1	HSALNG0121939	anti_sense	Q75	hsa-miR-4307,hsa-miR-6071,hsa-miR-6124	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Energy intake,Glomerular filtration rate,Sex hormone-binding globulin measurement,Reticulocyte count,Reticulocyte measurement,Creatinine measurement,Creatinine measurement; Glomerular filtration rate,-	RNF152	ENSG00000289091
ENSG00000267280	TBX2-AS1	4.09112317377456	2.46650962258904e-4	M2_vs_M1	HSALNG0117877	anti_sense	Q90	hsa-miR-615-5p,hsa-miR-615-3p,hsa-miR-4447,hsa-miR-4505,hsa-miR-4747-3p,hsa-miR-6754-5p,hsa-miR-8485	Gout,Nephrolithiasis; Hemoglobin measurement; Gout,Glomerular filtration rate; Urate measurement; Creatinine measurement; Hematocrit; Erythrocyte count,Gout; Erythrocyte count,Creatinine measurement; Glomerular filtration rate,Red blood cell density measurement,Chronic kidney disease; Urolithiasis; Glomerular filtration rate; Vitamin c measurement; Cystatin c measurement; Renal system measurement; Beta blocking agent use measurement; Creatinine measurement; Calcium measurement; Hematocrit; Uric acid measurement; Hemoglobin measurement; Erythrocyte count; Red blood cell density measurement; Urate measurement,Urolithiasis; Glomerular filtration rate; Protein measurement; Blood metabolite measurement; Amino acid measurement; Urate measurement,Bmi-adjusted waist circumference; Myopia,Bmi-adjusted waist circumference,Body height,Reticulocyte count; Agents acting on the renin-angiotensin system use measurement,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Systolic blood pressure; Mean arterial pressure; Creatinine measurement,Abnormality of refraction; Cardiovascular disease; Diuretic use measurement; Refractive error,Age-related hearing impairment,Calcium measurement,Diastolic blood pressure; Pulse pressure measurement; Mean arterial pressure; Systolic blood pressure; Calcium channel blocker use measurement,Fibroblast growth factor 23 measurement; Glomerular filtration rate; Calcium channel blocker use measurement,Spontaneous preterm birth,Urolithiasis; Coronary artery disease; Systolic blood pressure,Corneal hysteresis; Agents acting on the renin-angiotensin system use measurement; Corneal resistance factor,Creatinine measurement,Diastolic blood pressure; Mean arterial pressure,Bmi-adjusted waist circumference; Chloride measurement; Potassium measurement,-,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Mean arterial pressure; Systolic blood pressure	NACA2	HNRNPA1L3
ENSG00000267296	CEBPA-DT	1.31085073930124	6.89421822529957e-13	M2_vs_M1	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	ARHGAP12
ENSG00000267321	SNHG30	1.42909102958577	1.0401836410083e-4	M2_vs_M1	HSALNG0115960	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-7107-5p	Mean platelet volume; Platelet component distribution width; Platelet count,-	AP2B1	TSLP
ENSG00000267348	GEMIN7-AS1	-1.31487610845911	0.0196686986256133	M2_vs_M1	HSALNG0126529	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-4455	C-reactive protein measurement; Family history of alzheimers disease,Family history of alzheimers disease; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,Family history of alzheimers disease,-	ZNF296	ENSG00000267149
ENSG00000267365	KCNJ2-AS1	1.04284138146861	0.0488160629257138	M2_vs_M1	HSALNG0118455	anti_sense	Q50	NA	Body weight,-	ABCA5	ZNF500
ENSG00000267366	NA	1.51983111650899	4.73011803301903e-4	M2_vs_M1	HSALNG0120177	anti_sense	Q75	NA	NA	FAM210A	TBC1D15
ENSG00000267387	NA	-2.46323270600715	0.00839339318584376	M2_vs_M1	HSALNG0123890	anti_sense	Q75	NA	-	ANGPTL6	HSD3BP5
ENSG00000267394	ATXN7L3-AS1	-2.51278794634233	0.0209647866001204	M2_vs_M1	HSALNG0116712	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4695-5p,hsa-miR-6085,hsa-miR-6090	Heel bone mineral density,Body weight; Body mass index,Visceral adipose tissue measurement,Reticulocyte count,Appendicular lean mass; Bone density,Cortical thickness,Uric acid measurement; Calcium measurement,Mean corpuscular hemoglobin concentration,Cortical surface area measurement,Self reported educational attainment,Body fat distribution,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	TMUB2	CARMIL1
ENSG00000267397	NA	2.41762824688835	2.98798492574369e-4	M2_vs_M1	HSALNG0120911	integenic	Not conserved	NA	NA	GALNT1	PKD1P2
ENSG00000267414	SETBP1-DT	1.09223231020914	0.0127657512356945	M2_vs_M1	HSALNG0121238	integenic	Q75	hsa-miR-92b-5p,hsa-miR-3960,hsa-miR-6838-5p,hsa-miR-8485	Reaction time measurement,Platelet crit,-	EPG5	EIF3FP3
ENSG00000267432	DNAH17-AS1	-2.99979313083697	1.31007744198845e-14	M2_vs_M1	HSALNG0119037	anti_sense	Q90	hsa-miR-515-3p,hsa-miR-3197,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6165,hsa-miR-6879-3p,hsa-miR-7843-5p	-	PGS1	MRPL46
ENSG00000267475	NUDT19-DT	3.51387315401693	1.00823862723167e-20	M2_vs_M1	HSALNG0125387	anti_sense	Q50	NA	Mean corpuscular volume,-	ANKRD27	ZNF32
ENSG00000267501	NA	-4.6229068381561	0.0498173642704124	M2_vs_M1	HSALNG0121829	anti_sense	Q50	NA	NA	ALPK2	ENSG00000267501
ENSG00000267543	NA	-5.12250599914985	0.00855358846159983	M2_vs_M1	HSALNG0118851	anti_sense,sense	Q75	hsa-miR-363-5p,hsa-miR-1205,hsa-miR-378g,hsa-miR-4505,hsa-miR-6089	Colorectal cancer,Adolescent idiopathic scoliosis,Macular telangiectasia type 2,Pulse pressure measurement,Reaction time measurement,Leukocyte count; Neutrophil count,Mathematical ability,Eye measurement,Diabetic nephropathy; Moderate albuminuria,-,Blood protein measurement	PRCD	RNF24
ENSG00000267571	NA	-2.20545582817432	3.9271569858991e-4	M2_vs_M1	HSALNG0123509	anti_sense,intronic_antisense	Not conserved	hsa-miR-619-5p	NA	RANBP3	LRRFIP1P1
ENSG00000267632	NA	-2.80749873584498	0.00313847709694524	M2_vs_M1	NA	NA	NA	NA	NA	ATP6V0A1	TUT1
ENSG00000267712	LINC01539	-6.77909757138564	4.42541491815542e-7	M2_vs_M1	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	NAT8
ENSG00000267751	BSG-AS1	1.76527389836354	1.73944231067508e-4	M2_vs_M1	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	DYNLRB2
ENSG00000267904	NA	-3.13860322628244	0.0141503293981865	M2_vs_M1	HSALNG0124459	sense	Not conserved	hsa-miR-7113-3p	NA	SMIM7	ENSG00000246575
ENSG00000267939	NA	3.00676503941325	0.0393225523114676	M2_vs_M1	HSALNG0123702	anti_sense	Q75	hsa-miR-4463,hsa-miR-6829-3p,hsa-miR-6865-5p	NA	CCL25	EEA1
ENSG00000267940	NA	2.60249244910028	2.10358471574787e-4	M2_vs_M1	HSALNG0082398	anti_sense	Q75	NA	-	FHIP1B	ITPR1-DT
ENSG00000268027	NA	6.7595493972668	5.48462678057081e-7	M2_vs_M1	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	CD28
ENSG00000268030	NA	-2.51066578834533	1.53547669667033e-6	M2_vs_M1	HSALNG0124641	anti_sense	Q50	hsa-miR-5189-3p	-	CRLF1	NPIPB3
ENSG00000268218	NA	-1.29393846302904	4.04090210886158e-4	M2_vs_M1	HSALNG0144826	anti_sense	Not conserved	NA	-	ZNF778	CNNM4
ENSG00000268403	NA	1.372935291615	0.00370128094927335	M2_vs_M1	HSALNG0082607	anti_sense	Q50	NA	-	TMEM41B	SUSD2
ENSG00000268516	ZNF8-DT	1.60891162424162	0.00389379581887741	M2_vs_M1	HSALNG0127940	anti_sense	Not conserved	hsa-miR-6769a-3p	Attention deficit hyperactivity disorder,-	A1BG	AUH
ENSG00000268707	NA	2.31435280880492	0.00228416807314528	M2_vs_M1	HSALNG0074703	integenic	Not conserved	hsa-miR-6089	-	NA	RPS2P5
ENSG00000268941	LINC01711	3.36395843560392	0.00910315706355983	M2_vs_M1	HSALNG0131262	integenic	Not conserved	NA	NA	STX16	RTF1
ENSG00000268996	MAN1B1-DT	1.51675519205129	3.42753055559706e-6	M2_vs_M1	HSALNG0075350	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1285-5p	NA	SAPCD2	ENSG00000276533
ENSG00000269044	NA	1.33740369179692	1.79336478930256e-6	M2_vs_M1	HSALNG0124458	sense	Not conserved	hsa-miR-665	NA	SMIM7	DEFA4
ENSG00000269053	NA	-1.54964695901174	0.0451915161146531	M2_vs_M1	HSALNG0124523	anti_sense	Q50	hsa-miR-619-5p	Blood phosphate measurement	BST2	SCML1
ENSG00000269176	NA	2.29785268062783	0.0362638162604128	M2_vs_M1	HSALNG0084656	anti_sense,sense	Q75	hsa-miR-619-5p	-	TMEM223	ENSG00000278546
ENSG00000269220	LINC00528	1.40000166239652	0.00736797460034989	M2_vs_M1	HSALNG0133922	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-4257,hsa-miR-6089,hsa-miR-6877-3p	Response to diisocyanate,Adiponectin measurement	BCL2L13	ZDHHC11
ENSG00000269235	ZNF350-AS1	-2.06017774013304	0.014034407652808	M2_vs_M1	HSALNG0127274	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587	-	ZNF613	ST6GALNAC6
ENSG00000269243	NA	-1.80062547283905	0.00878593831026199	M2_vs_M1	HSALNG0124421	anti_sense	Not conserved	hsa-miR-4463,hsa-miR-4665-5p,hsa-miR-6089	Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Myeloperoxidase measurement,Mean corpuscular hemoglobin concentration,Mean corpuscular volume,Red blood cell distribution width,Mean corpuscular hemoglobin,Mean corpuscular hemoglobin concentration; Red blood cell distribution width,-	CIB3	ENSG00000287494
ENSG00000269246	NA	4.10016853558146	4.61044057196641e-8	M2_vs_M1	HSALNG0125993	overlap_antisense,overlap_sense,anti_sense	Not conserved	hsa-miR-6089	Eotaxin measurement,Lung adenocarcinoma,Serum alanine aminotransferase measurement,Physical activity,-	GMFG	PYCR3
ENSG00000269293	ZSCAN16-AS1	2.35664759795374	7.47437207164717e-24	M2_vs_M1	HSALNG0048933	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-7150	NA	OR2B8P	ENSG00000233028
ENSG00000269386	RAB11B-AS1	1.89953787752294	2.6713973566296497e-11	M2_vs_M1	HSALNG0123735	anti_sense	Q90	hsa-miR-564,hsa-miR-619-5p,hsa-miR-4286,hsa-miR-4483,hsa-miR-4505,hsa-miR-6089,hsa-miR-6873-3p,hsa-miR-6895-5p	High density lipoprotein cholesterol measurement,Alcohol consumption measurement; Phospholipid measurement; Reticulocyte measurement; Red blood cell distribution width; Metabolic syndrome; Apolipoprotein a 1 measurement; Myocardial infarction; Alcohol drinking; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Lipoprotein measurement; Blood metabolite measurement; Mean corpuscular volume; Coronary artery disease; Triglyceride measurement,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Triglyceride measurement,Mean corpuscular volume,Erythrocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin,Total cholesterol measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume,Triglyceride measurement; Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Mean corpuscular hemoglobin; Red blood cell density measurement,Triglyceride measurement; Physical activity,Sleep duration; High density lipoprotein cholesterol measurement,-	KANK3	NBEAL1
ENSG00000269420	PLA2G4C-AS1	-5.77722322108566	0.00108570387094559	M2_vs_M1	HSALNG0126825	anti_sense	Q50	hsa-miR-6803-5p	-	ELSPBP1	ENSG00000253667
ENSG00000269570	NA	-4.83628792209732	0.0475964925390712	M2_vs_M1	HSALNG0084353	anti_sense	Q75	NA	NA	GLYAT	ENSG00000225931
ENSG00000269688	NA	-6.63155040274043	2.73549558442208e-6	M2_vs_M1	HSALNG0125952	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4505	NA	HNRNPL	DHRS11
ENSG00000269867	NA	1.21704669811144	0.0148827768680525	M2_vs_M1	HSALNG0127893	anti_sense,intronic_sense	Q75	NA	-	ZNF814	ENSG00000267260
ENSG00000269893	SNHG8	1.13674558346377	1.25300598584738e-38	M2_vs_M1	HSALNG0036656	anti_sense	Q75	NA	-	NDST3	MAGOH
ENSG00000269918	NA	1.07830412034959	3.71864504491661e-7	M2_vs_M1	HSALNG0063411	sense	Not conserved	NA	Cortical surface area measurement,Alkaline phosphatase measurement; Bmi-adjusted waist-hip ratio	XKR6	MFSD14A
ENSG00000269952	NA	-3.13310437445229	0.0107345512029027	M2_vs_M1	HSALNG0077270	sense	Q50	NA	NA	CREM	MMP17
ENSG00000269956	MKNK1-AS1	-3.91478488378417	6.05108500317012e-5	M2_vs_M1	HSALNG0003339	anti_sense	Q90	NA	-	DMBX1	ABHD3
ENSG00000269958	NA	1.50221104068427	3.09622722370898e-35	M2_vs_M1	HSALNG0104025	sense	Not conserved	hsa-miR-6085,hsa-miR-10392-3p	NA	KLC1	CRKL
ENSG00000269970	NA	3.53671839220756	6.3811097557135206e-9	M2_vs_M1	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	H2AZ2-DT
ENSG00000269973	NA	1.38310262301831	2.51773551717397e-8	M2_vs_M1	HSALNG0012933	sense	Not conserved	NA	-	TAF1B	SH3BP1
ENSG00000270019	NA	-4.95539659503064	0.0271172223161236	M2_vs_M1	HSALNG0018095	anti_sense	Q50	hsa-miR-222-3p,hsa-miR-619-5p,hsa-miR-4492,hsa-miR-4731-5p,hsa-miR-6089,hsa-miR-6735-5p	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Fusiform gyrus volume measurement,Bmi-adjusted waist-hip ratio,Eye colour measurement,Sex hormone-binding globulin measurement,Bmi-adjusted waist circumference,-	SLC35F5	ZBTB8OSP2
ENSG00000270049	ATP6V0D1-DT	1.57328976710783	1.71717198864642e-5	M2_vs_M1	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1	BHLHE40-AS1
ENSG00000270055	NA	2.96835110027697	2.93232372930937e-5	M2_vs_M1	HSALNG0104765	integenic	Not conserved	NA	NA	GOLGA8Q	BCKDHB
ENSG00000270069	MIR222HG	2.1829826122413	1.80803423904164e-88	M2_vs_M1	HSALNG0137593	integenic	Q90	hsa-miR-574-5p,hsa-miR-1343-3p,hsa-miR-6803-5p,hsa-miR-6873-3p,hsa-miR-9899	Body height; Inguinal hernia; Body weight	DIPK2B	MTLN
ENSG00000270083	NA	-4.81301060786753	0.0457773685737412	M2_vs_M1	HSALNG0135689	sense	Not conserved	hsa-miR-6089	NA	NDUFA6	RAE1
ENSG00000270112	ST8SIA5-DT	3.15287585725166	3.06212103313526e-10	M2_vs_M1	HSALNG0121346	anti_sense	Q75	hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6803-5p	Adolescent idiopathic scoliosis,-	KATNAL2	ERVMER34-1
ENSG00000270120	NA	-4.95715741302427	2.81962416842382e-8	M2_vs_M1	HSALNG0111360	sense	Q50	NA	NA	NOD2	ENSG00000288954
ENSG00000270164	LINC01480	3.13302725705335	4.19012902147897e-10	M2_vs_M1	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	CXXC1
ENSG00000270175	NA	1.5622855589794	0.00976900110679195	M2_vs_M1	HSALNG0091285	anti_sense	Q75	NA	-	MAP3K12	KLF12
ENSG00000270184	NA	-4.98098246777949	0.0248476773175127	M2_vs_M1	HSALNG0113238	anti_sense	Not conserved	NA	Eosinophil count	COX4I1	UQCC3
ENSG00000270190	NA	4.92230743752158	0.0151011890467694	M2_vs_M1	HSALNG0017878	integenic	Q50	NA	NA	ANAPC1	ENSG00000270190
ENSG00000270194	GOLGA4-AS1	-1.60604969530901	1.00693775958852e-6	M2_vs_M1	HSALNG0025176	anti_sense	Q90	NA	-	LRRFIP2	POMGNT2
ENSG00000270332	SMC2-DT	3.0067650396284	0.0393225523114676	M2_vs_M1	HSALNG0073384	integenic	Q75	NA	-	OR13C4	LINC00513
ENSG00000270362	HMGN3-AS1	-1.71223550788385	4.737670832413839e-18	M2_vs_M1	HSALNG0051432	anti_sense	Q50	hsa-miR-762,hsa-miR-6873-3p	-	IRAK1BP1	CDKN2AIP
ENSG00000270372	NA	2.40818561504359	3.63314165030006e-12	M2_vs_M1	HSALNG0069960	integenic	Not conserved	NA	Lysophosphatidylcholine 22:6 measurement,Attention deficit hyperactivity disorder; Smoking behavior; Smoking status measurement; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,Gut microbiome measurement,Wellbeing measurement,Venous thromboembolism,C-x-c motif chemokine 10 measurement,Spontaneous preterm birth,Smoking status measurement,-	PTPRD	LINC00390
ENSG00000270419	CAHM	2.23905986562391	7.228327001571661e-9	M2_vs_M1	HSALNG0054937	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-3178,hsa-miR-4651,hsa-miR-5587-3p,hsa-miR-7108-3p,hsa-miR-10394-3p	-	PRKN	DNAJC3
ENSG00000270673	YTHDF3-DT	2.06374018353787	1.24589357440281e-11	M2_vs_M1	HSALNG0065750	integenic	Not conserved	hsa-miR-4539,hsa-miR-5001-3p,hsa-miR-6746-3p	NA	TTPA	NDST3
ENSG00000270871	NA	-1.95895216440105	0.0066218366170415	M2_vs_M1	HSALNG0115978	anti_sense	Not conserved	hsa-miR-3929	Reticulocyte count	MMP28	EFNA1
ENSG00000271009	NA	-4.81192406215895	0.0317432706048852	M2_vs_M1	HSALNG0112602	anti_sense	Q90	NA	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Body weight; Aspartate aminotransferase measurement,-	DHX38	ABI2
ENSG00000271032	NA	-2.43819804180126	0.0223893317572188	M2_vs_M1	HSALNG0125561	anti_sense	Not conserved	NA	Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792	HMCES
ENSG00000271119	NA	-5.70894175037045	0.00174975352678096	M2_vs_M1	HSALNG0039573	integenic	Not conserved	hsa-miR-7108-3p	-	NDUFS6	LRRC37A15P
ENSG00000271216	LINC01050	-5.68389793714119	1.1234776721279099e-54	M2_vs_M1	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1	EFCAB3
ENSG00000271474	UNC5C-AS1	-2.57530633833161	1.69635162688105e-4	M2_vs_M1	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	CDIN1
ENSG00000271590	NA	-4.62346725495425	0.0440816854293053	M2_vs_M1	HSALNG0017865	anti_sense,sense	Q90	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-887-5p,hsa-miR-4492,hsa-miR-1343-3p,hsa-miR-5047,hsa-miR-5787,hsa-miR-6728-3p,hsa-miR-6800-3p,hsa-miR-6813-5p	Adolescent idiopathic scoliosis,Serum non-albumin protein measurement,Total blood protein measurement; Monocyte count,Neutrophil percentage of leukocytes; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Monocyte count,Monocyte percentage of leukocytes; Monocyte count,Chronic lymphocytic leukemia,Mean reticulocyte volume; Red blood cell distribution width; Protein measurement; Mean corpuscular hemoglobin; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell distribution width,High density lipoprotein cholesterol measurement,Urinary albumin to creatinine ratio; Moderate albuminuria,Blood protein measurement; Serum non-albumin protein measurement,Ovarian serous carcinoma; Ovarian carcinoma,Alopecia areata,Erythrocyte count,Mean corpuscular hemoglobin concentration,Mean corpuscular volume,Bmi-adjusted waist circumference,Blood protein measurement,Aspartate aminotransferase measurement,Platelet component distribution width,Churg-strauss syndrome,Prostate carcinoma,Igf-1 measurement,Triglyceride measurement; Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist-hip ratio,Neutrophil count; Bmi-adjusted waist-hip ratio,Body height,Sex hormone-binding globulin measurement; Eosinophil count; Granulocyte percentage of myeloid white cells; Eosinophil percentage of leukocytes; Monocyte count; Reticulocyte measurement; Monocyte percentage of leukocytes,Corneal endothelial cell measurement,Body mass index; Neutrophil count; Adult onset asthma,Systemic lupus erythematosus,Urinary albumin to creatinine ratio,Bmi-adjusted hip circumference,Mean corpuscular volume; Lymphocyte count,Neutrophil percentage of leukocytes,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Bmi-adjusted waist circumference; Basophil count; Eosinophil percentage of leukocytes; Eosinophil count,Waist-hip ratio; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Cancer,Sex hormone-binding globulin measurement,Waist-hip ratio,Ovarian carcinoma; Breast carcinoma; Prostate carcinoma; Mean reticulocyte volume,Body weight; Bmi-adjusted waist-hip ratio; Body mass index,Lymphocyte count,Granulocyte percentage of myeloid white cells; Heel bone mineral density; Monocyte percentage of leukocytes; Monocyte count,Body weight,Age at menopause,Leukocyte count; Platelet count,Mean corpuscular hemoglobin,Reticulocyte count,Breast carcinoma,Hba1c measurement; Urate measurement,Neutrophil count; Alkaline phosphatase measurement; Fev/fec ratio; Eosinophil count; Sclerosing cholangitis,Neutrophil count,Lymphoid leukemia; Reticulocyte count; Body height; Uric acid measurement; Reticulocyte measurement; Triglyceride measurement,Testosterone measurement,Reticulocyte count; Neutrophil percentage of leukocytes; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Reticulocyte measurement,Hemoglobin a1 measurement,Lymphocyte percentage of leukocytes,Platelet count,Hormone measurement,Platelet crit,Cleft lip; Bmi-adjusted waist-hip ratio,Atopic eczema,Testosterone measurement; Sclerosing cholangitis,Cognitive function measurement,Systolic blood pressure,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vitiligo,Heel bone mineral density,Triacylglycerol 50:4 measurement; Diacylglycerol 36:2 measurement,Mean corpuscular hemoglobin; Erythrocyte count,Reticulocyte measurement; Visual perception measurement,Reticulocyte measurement; Erythrocyte count,Hematocrit,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Basophil count; Mean corpuscular hemoglobin; Platelet-to-lymphocyte ratio; Platelet count; Hematocrit; Mean corpuscular volume; Serum non-albumin protein measurement; Erythrocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin,Lymphocyte percentage of leukocytes; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume; Reticulocyte measurement,Mean corpuscular volume; Red blood cell density measurement; Platelet crit; Platelet count,Mean reticulocyte volume; Platelet crit; Mean corpuscular hemoglobin; Platelet count; Mean corpuscular volume; Erythrocyte count,Platelet-to-lymphocyte ratio,Eosinophil count; Total blood protein measurement; Immunoglobulin isotype switching measurement,Corneal endothelial cell measurement; Serum albumin measurement,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count,Hematocrit; Hemoglobin measurement,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Mean reticulocyte volume; Hemoglobin measurement; Mean corpuscular hemoglobin; Hematocrit; Mean corpuscular volume; Reticulocyte measurement; Erythrocyte count,Bmi-adjusted waist circumference; Lean body mass; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist circumference; Calcium measurement; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Atopic asthma,Eczema,Eczema; Interleukin-6 measurement,Cognitive decline measurement,Testosterone measurement; Mean corpuscular hemoglobin; Erythrocyte count,Tonsillectomy risk measurement,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count,Eosinophil percentage of granulocytes,Diastolic blood pressure; Smoking status measurement,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Bmi-adjusted waist-hip ratio; Adult onset asthma,Eczema; Allergic rhinitis,Drugs used in diabetes use measurement; Erythrocyte count,Basophil percentage of granulocytes; Mean corpuscular hemoglobin concentration; Basophil percentage of leukocytes,-	ANAPC1	SLFN13
ENSG00000271653	NA	4.67661490985096	0.0419355952343819	M2_vs_M1	HSALNG0025172	integenic	Not conserved	NA	NA	GOLGA4	CFAP144
ENSG00000271737	NA	3.05597748162407	5.75059626675812e-8	M2_vs_M1	HSALNG0044939	anti_sense	Q50	NA	-	TCF7	PIGT
ENSG00000271780	NA	1.83785122600735	3.58610625852867e-5	M2_vs_M1	HSALNG0103867	sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089,hsa-miR-7160-3p	Body mass index,-,Age at menopause	DYNC1H1	SLC39A5
ENSG00000271781	NA	2.77580972941121	8.07520188289631e-8	M2_vs_M1	HSALNG0039474	anti_sense	Not conserved	hsa-miR-6813-5p,hsa-miR-6837-5p	Glomerular filtration rate,Nystagmus	CEP72	TM2D2
ENSG00000271789	NA	2.52637136225016	0.0245286602859866	M2_vs_M1	HSALNG0052772	sense	Not conserved	NA	NA	MFSD4B	ZSWIM9
ENSG00000271830	NA	-2.48691751937023	0.00726328356626475	M2_vs_M1	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	TMEM220
ENSG00000271848	SYNPO2L-AS1	4.92464727969104	0.00813370496566513	M2_vs_M1	HSALNG0078853	anti_sense	Q90	hsa-miR-4436a	Atrial fibrillation,Pr interval,Heart failure,Atrial fibrillation; Systolic blood pressure,Electrocardiography,Serum gamma-glutamyl transferase measurement,Systolic blood pressure,-	SEC24C	ZBTB46-AS1
ENSG00000271856	LINC01215	-1.38439509971936	0.0138944697406118	M2_vs_M1	HSALNG0027888	integenic	Q50	NA	NA	HHLA2	FOXD3
ENSG00000271862	NA	1.34593248518332	0.00357346197132831	M2_vs_M1	HSALNG0043133	integenic	Q90	NA	-	TMEM167A	WNT1
ENSG00000271869	DCTN6-DT	2.34818093659998	3.56108901404632e-6	M2_vs_M1	HSALNG0064342	anti_sense	Not conserved	NA	NA	MBOAT4	LINC02356
ENSG00000271882	NA	1.13747242759034	9.95113931938719e-5	M2_vs_M1	HSALNG0067354	anti_sense	Q75	hsa-miR-6722-3p	-	GRHL2	GGCT
ENSG00000271913	TAGAP-AS1	-2.2592531728661	5.08807976428087e-13	M2_vs_M1	HSALNG0054719	anti_sense	Q50	hsa-miR-485-5p,hsa-miR-4467,hsa-miR-4516,hsa-miR-4530,hsa-miR-3960,hsa-miR-4707-3p,hsa-miR-6791-5p,hsa-miR-6858-3p,hsa-miR-7108-3p,hsa-miR-7112-5p	Leukocyte count,Lymphocyte count,Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Rheumatoid arthritis; Celiac disease,-,Systemic lupus erythematosus,Cognitive inhibition measurement,Eosinophil percentage of leukocytes	FNDC1	NR4A2
ENSG00000271936	NA	1.21883896817674	0.0422517630888419	M2_vs_M1	HSALNG0013623	anti_sense	Q50	NA	Appendicular lean mass,Body height,Age at menarche,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Susceptibility to pneumonia measurement,Body mass index,Reticulocyte count,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,C-reactive protein measurement,-	CENPO	KLHL25
ENSG00000271959	NA	3.51803234431885	0.00918848956595066	M2_vs_M1	HSALNG0069093	integenic	Q75	hsa-miR-4433a-3p,hsa-miR-6769b-5p	-	PTP4A3	RN7SL138P
ENSG00000271964	NA	3.76782284415714	0.00419571685982861	M2_vs_M1	HSALNG0024477	anti_sense,sense	Not conserved	hsa-miR-6763-5p	NA	OXNAD1	PSMA6P2
ENSG00000272054	NA	-3.79423211474149	3.10676231231379e-4	M2_vs_M1	HSALNG0014233	anti_sense,sense	Q75	NA	-	CEBPZOS	ENSG00000251161
ENSG00000272068	BCAN-AS1	3.72024300483486	2.14188575038249e-38	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	WDR5
ENSG00000272072	NA	-3.03903290038472	0.0198138035247988	M2_vs_M1	HSALNG0060408	anti_sense	Q50	NA	Calcium measurement,-	COG5	ENSG00000286242
ENSG00000272079	NA	1.50694132354415	0.029717631641631	M2_vs_M1	HSALNG0109099	integenic	Q50	hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6784-5p,hsa-miR-6813-5p,hsa-miR-8072	-	NA	SOCS7
ENSG00000272145	NFYC-AS1	-2.26776092197944	3.1223615407871097e-31	M2_vs_M1	HSALNG0002891	anti_sense	Q90	hsa-miR-661,hsa-miR-4447,hsa-miR-4761-3p,hsa-miR-8072	Body height,-	RIMS3	ZMYM1
ENSG00000272168	CASC15	2.53785310174207	0.00926418809206141	M2_vs_M1	HSALNG0048556	integenic	Not conserved	NA	NA	HDGFL1	ENSG00000232995
ENSG00000272172	NA	2.03792395993168	2.92815018540708e-4	M2_vs_M1	HSALNG0069270	anti_sense	Not conserved	hsa-miR-3960	Body height,-	TOP1MT	NDUFB2-AS1
ENSG00000272255	NA	1.00185578001785	0.00164945363942668	M2_vs_M1	HSALNG0045260	anti_sense	Q50	hsa-miR-3178	-	STING1	PCGF1
ENSG00000272282	LINC02084	3.10643322794009	5.1827598979683703e-14	M2_vs_M1	HSALNG0024810	integenic	Q50	hsa-miR-920,hsa-miR-4707-5p	Macula measurement,Leukocyte count; Total blood protein measurement; Lymphocyte count; Myeloid white cell count,-	CMC1	ENSG00000259871
ENSG00000272288	ILRUN-AS1	1.91965820268599	3.40311443270534e-10	M2_vs_M1	HSALNG0049635	anti_sense	Q90	hsa-miR-3960	-	SNRPC	S100A9
ENSG00000272338	NA	3.99329527366404	6.9684089637259e-10	M2_vs_M1	HSALNG0064463	integenic	Not conserved	NA	NA	FUT10	ENSG00000261170
ENSG00000272341	NA	3.24009312719408	6.66185509789981e-17	M2_vs_M1	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	MPL
ENSG00000272356	NA	1.0912024594234	0.0201125398795097	M2_vs_M1	HSALNG0149229	anti_sense,sense	Q90	NA	NA	MFSD4B	RPL29P26
ENSG00000272405	NA	3.55003931670565	1.1619269027477898e-147	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	PCYOX1L
ENSG00000272425	NA	1.94648116756766	3.88045932218888e-6	M2_vs_M1	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	DISP1
ENSG00000272449	NA	-1.41235208904805	9.0443295230869e-7	M2_vs_M1	HSALNG0000274	integenic	Not conserved	hsa-miR-8485	NA	TNFRSF14	BET1L
ENSG00000272476	NA	1.17377398552102	0.00732288045981254	M2_vs_M1	HSALNG0052540	anti_sense	Q90	hsa-miR-504-3p,hsa-miR-4467,hsa-miR-3960	-	NR2E1	ENSG00000287784
ENSG00000272501	NA	-1.3962872871582	0.0461152228422221	M2_vs_M1	HSALNG0049245	anti_sense,sense	Q75	hsa-miR-556-3p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-1199-5p,hsa-miR-6803-5p	Membranous glomerulonephritis,Crohn's disease; Toxic epidermal necrolysis; Stevens-johnson syndrome,Hiv-1 infection; Neutrophil count; Basophil count,Body height; Multiple myeloma,Age at diagnosis,Neutrophil count; Bmi-adjusted waist-hip ratio,Cleft lip; Bmi-adjusted waist-hip ratio; Cleft palate,Aging,Psoriatic arthritis,Susceptibility to cold sores measurement,Bmi-adjusted hip circumference,Hemoglobin measurement,Psoriasis,Bmi-adjusted waist-hip ratio,Parental longevity,Von willebrand factor measurement,Lung carcinoma,Tonsillectomy risk measurement,Monocyte count,Monocyte percentage of leukocytes,Mean platelet volume,Reticulocyte measurement,Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Platelet crit; Monocyte count,Lymphocyte count,Bmi-adjusted waist circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,Takayasu arteritis,Serum ige measurement,High density lipoprotein cholesterol measurement,Cancer,Response to vaccine,Susceptibility to plantar warts measurement,Eosinophil count,Sarcoidosis,Basophil count,Reticulocyte count,C-reactive protein measurement,Cervical carcinoma,Platelet-to-lymphocyte ratio; Lymphocyte count; Neutrophil count; Monocyte count,Drugs used in diabetes use measurement,Ulcerative colitis,Bmi-adjusted hip circumference; Basal cell carcinoma,Susceptibility to childhood ear infection measurement,Leukocyte count,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Platelet count,Eosinophil percentage of leukocytes,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Basophil count; Bmi-adjusted hip circumference; Leukocyte count; Bmi-adjusted waist-hip ratio; Eosinophil count; Granulocyte count,Chronic hepatitis b virus infection; Hepatitis b virus infection,Chronic hepatitis b virus infection,Serum metabolite measurement,Neutrophil-to-lymphocyte ratio; Lymphocyte percentage of leukocytes,Prostate carcinoma,Viral subtype carrier status,Mean corpuscular volume,Leukocyte count; Myeloid white cell count; Anti-anoctamin 2 antibody measurement; Monocyte count,Mean corpuscular hemoglobin,Waist-hip ratio,Triglyceride measurement; Bmi-adjusted hip circumference,Leukocyte count; Neutrophil count; Lymphocyte count; Myeloid white cell count,Bmi-adjusted waist-hip ratio; Cytokine measurement,Irritable bowel syndrome; Bmi-adjusted waist-hip ratio,Dna methylation,Protein measurement,Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Skin pigmentation measurement,Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Varicose veins,Granulocyte percentage of myeloid white cells,Erythrocyte count,Mean reticulocyte volume,Vitiligo,Monoclonal gammopathy; Multiple myeloma,Mean corpuscular hemoglobin concentration; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Leukocyte count; Body height,Cd4:cd8 lymphocyte ratio; Cd8-positive t-lymphocyte count,Leprosy,Eczema,Bmi-adjusted waist-hip ratio; Gastric carcinoma,Systemic lupus erythematosus,Granzyme a measurement,Leukocyte count; Reticulocyte count,Neutrophil count,Interleukin 18 measurement,Aids; Psoriasis; Cutaneous psoriasis measurement,Triglyceride measurement; Body height; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Nasopharyngeal neoplasm,Atopic eczema,Psoriasis; Psoriasis vulgaris,Crohn's disease,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Body height; Blood protein measurement; Triglyceride measurement,Hypertension,Autoimmune disease,Mean corpuscular volume; Bmi-adjusted waist-hip ratio,Stomach polyp,Sex hormone-binding globulin measurement,Oral ulcer,Major depressive disorder; Major depressive episode,Unipolar depression,Mhc class i polypeptide-related sequence a measurement,Myeloid white cell count,Body weight; Bmi-adjusted hip circumference; Perceived unattractiveness to mosquitos measurement,Body height,Maximum cigarettes per day measurement,Lymphocyte percentage of leukocytes,Myelodysplastic syndrome,Appendicular lean mass,Angiopoietin-1 receptor measurement,Vasodilators used in cardiac diseases use measurement,Intelligence; Unipolar depression,Severe aplastic anemia,Non-melanoma skin carcinoma,Systemic lupus erythematosus; Bmi-adjusted waist-hip ratio,Post-traumatic stress disorder,Triglyceride measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Alpha-2-macroglobulin receptor-associated protein measurement,Psoriasis vulgaris,Facial morphology measurement,Feeling miserable measurement,Psoriasis; Membranous glomerulonephritis,Response to interferon beta; Mean corpuscular hemoglobin concentration; Human papilloma virus infection; Anti-drug antibody measurement; Hiv-1 infection; Oral cavity cancer; Beta-2 microglobulin measurement,Hiv viral set point measurement,Diffuse large b-cell lymphoma; Visual perception measurement,Immunoglobulin isotype switching measurement; Bmi-adjusted hip circumference; Rheumatic heart disease,Atopic asthma,Apolipoprotein a 1 measurement; Autism spectrum disorder; Feeling nervous measurement,Allergic rhinitis; Nasal cavity polyp; Adult onset asthma,Serum albumin measurement,Angina pectoris; Liver neoplasm,Seasonal allergic rhinitis; Platelet count,Neutrophil count; Basophil count,Bmi-adjusted waist circumference; Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Hypothyroidism; Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Self reported educational attainment; Metabolic syndrome; Bmi-adjusted hip circumference; Mathematical ability; Triglyceride measurement,Mean reticulocyte volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Cannabis use; Bmi-adjusted waist-hip ratio; Age at onset,Cirrhosis of liver,Chronic hepatitis c virus infection,Pneumonia,Cognitive function measurement; Mathematical ability,Iga glomerulonephritis; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Myocardial infarction,17-hydroxyprogesterone measurement,Gastroesophageal reflux disease,Glomerular filtration rate,Keratinocyte carcinoma,Body fat percentage,Proliferative diabetic retinopathy; Skin neoplasm,Frontal fibrosing alopecia,Ankylosing spondylitis,Cx3cl1 measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Monocyte count,Susceptibility to mumps measurement,Susceptibility to chickenpox measurement,Autism spectrum disorder; Small cell lung carcinoma,Mean corpuscular volume; Bmi-adjusted hip circumference; Erythrocyte count,Triglyceride measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Eosinophil percentage of granulocytes,Susceptibility to strep throat measurement,Mosquito bite reaction itch intensity measurement,Colorectal cancer; Colorectal adenoma; Mean platelet volume,Neutrophil percentage of leukocytes,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Red blood cell density measurement,Platelet component distribution width,Behcet's syndrome,Mean platelet volume; Bipolar disorder; Eosinophil percentage of leukocytes,Hiv-1 infection; Anxiety measurement,Trichloroethylene-induced hypersensitivity,Marginal zone b-cell lymphoma,Diastolic blood pressure; Systolic blood pressure,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Atopic asthma,Squamous cell lung carcinoma,Bmi-adjusted hip circumference; White matter integrity; Bmi-adjusted waist-hip ratio,Anterior uveitis,Neutrophil count; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Basophil count; Bmi-adjusted waist-hip ratio,Tropical spastic paraparesis,Neutrophil-to-lymphocyte ratio; Monocyte count,Eosinophil count; Lymphocyte count; Bmi-adjusted hip circumference,Neutrophil percentage of leukocytes; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Gastroesophageal reflux disease; Bmi-adjusted waist circumference; Oral ulcer; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Aspirin use measurement,Oral ulcer; Bmi-adjusted hip circumference; Aspirin use measurement; Calcium channel blocker use measurement; Antithrombotic agent use measurement,Systolic blood pressure,Iritis,Pulse pressure measurement; Systolic blood pressure,Blood protein measurement; Heel bone mineral density,Viral load,Self reported educational attainment; Cognitive function measurement,Mathematical ability,Antithrombotic agent use measurement,Bmi-adjusted waist circumference; Mhc class i polypeptide-related sequence a measurement,Platelet crit,Hematocrit,Sjogren syndrome,Neutrophil percentage of granulocytes,Eosinophil count; Basophil count,Basophil percentage of granulocytes,Body height; Cerebrospinal fluid biomarker measurement,Graves disease; Thyrotoxic periodic paralysis,Body height; Bmi-adjusted hip circumference; Low density lipoprotein cholesterol measurement,Allergic sensitization measurement,Rheumatoid arthritis,Chronic obstructive pulmonary disease; Rosacea severity measurement,Surfactant protein d measurement; Blood protein measurement; Chronic obstructive pulmonary disease; Adult onset asthma,Gastric carcinoma,Autoimmune disease; Bmi-adjusted hip circumference,Anterior uveitis; Ankylosing spondylitis,Hemoglobin a1 measurement,Eosinophil count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Response to sulfasalazine; Bmi-adjusted waist-hip ratio; Drug-induced agranulocytosis,Anti-anoctamin 2 antibody measurement,Autism spectrum disorder; Bmi-adjusted hip circumference,Sclerosing cholangitis,Hepatocellular carcinoma,Hiv-1 infection,Beta-2 microglobulin measurement,Autoimmune thyroid disease,Female reproductive system disease,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Conotruncal heart malformations; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum iga measurement,Uveitis,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Body weight,Response to antineoplastic agent,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Susceptibility to mononucleosis measurement,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Glucose measurement,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Mhc class i polypeptide-related sequence b measurement,Alcohol use disorder measurement,Testosterone measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Mathematical ability,Lobe attachment; Lymphocyte count,Atopic eczema; Susceptibility to strep throat measurement,Comparative body size at age 10, self-reported,Response to thioamide; Drug-induced agranulocytosis,Surfactant protein d measurement; Chronic obstructive pulmonary disease,Mean platelet volume; Neutrophil count; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Basophil count; Leukocyte count; Platelet count; Monocyte count; Eosinophil count; Mean corpuscular volume; Erythrocyte count,Toxic epidermal necrolysis; Response to reverse transcriptase inhibitor; Stevens-johnson syndrome,Triglyceride measurement; C-reactive protein measurement,Response to rhododendrol; Vitiligo,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Eczema; Allergic rhinitis,Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Estrogen-receptor negative breast cancer,Cervical intraepithelial neoplasia grade 2/3; Cervical carcinoma,Response to anti-thyroid drug; Drug-induced agranulocytosis,Hypersensitivity reaction disease; Response to reverse transcriptase inhibitor,Response to drug; Drug-induced agranulocytosis,Human papilloma virus infection; Oropharynx cancer,Puberty; Height growth measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Hiv-1 infection; Crohn's disease; Inflammatory bowel disease,Handedness,Lupus nephritis; Blood protein measurement,Leukocyte count; Lymphocyte count,Glucose metabolism decline measurement; Cingulate cortex measurement,Igg galactosylation measurement,Mean platelet volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Reticulocyte count; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Human herpesvirus 6 seropositivity; Neutrophil count; Bmi-adjusted waist-hip ratio,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Platelet-to-lymphocyte ratio,Autism spectrum disorder; Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Angiopoietin-1 receptor measurement; Platelet count; Platelet crit,Bmi-adjusted hip circumference; Basophil count,Drug-induced agranulocytosis; Response to clozapine,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Basal cell carcinoma,Low density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement,Age at onset,Susceptibility to pneumonia measurement,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio,-	POU5F1	ZRANB2-DT
ENSG00000272512	NA	-7.55434672605305	2.93692348025945e-11	M2_vs_M1	HSALNG0000065	integenic	Not conserved	NA	Apolipoprotein a 1 measurement,Parental longevity,-	HES4	CETP
ENSG00000272619	FAM131B-AS1	4.69646932379713	1.43441177924075e-7	M2_vs_M1	HSALNG0061958	anti_sense	Q90	NA	-	CLCN1	SNRPF
ENSG00000272625	NA	-2.00637937864969	0.00510315135017344	M2_vs_M1	HSALNG0119665	anti_sense,sense	Q75	hsa-miR-4520-5p	-	EMILIN2	TUBB1
ENSG00000272666	KLHDC7B-DT	-5.69488072116308	7.24740801434255e-4	M2_vs_M1	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3	KLHDC7B-DT
ENSG00000272669	NA	-1.84833485665565	4.32433365983737e-9	M2_vs_M1	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	FAM151B
ENSG00000272690	LINC02018	2.00004684748552	1.9750436596713e-4	M2_vs_M1	HSALNG0026918	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-1207-3p,hsa-miR-3972,hsa-miR-1343-3p,hsa-miR-5787,hsa-miR-6728-3p,hsa-miR-7150,hsa-miR-7703,hsa-miR-8077	-	FRG2C	TAF10
ENSG00000272695	GAS6-DT	1.51865730424035	0.00190534722723504	M2_vs_M1	HSALNG0099631	integenic	Q50	hsa-miR-1268b	NA	TMEM255B	GPR146
ENSG00000272720	NA	1.70535108652271	1.9755549814458e-4	M2_vs_M1	HSALNG0135382	anti_sense	Q75	hsa-miR-363-5p,hsa-miR-1238-5p,hsa-miR-3196,hsa-miR-3620-5p,hsa-miR-4446-3p,hsa-miR-4463,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-3960,hsa-miR-4722-5p,hsa-miR-4758-5p	White matter microstructure measurement,Age-related hearing impairment,Tinnitus,Glioma; Central nervous system cancer; Glioblastoma multiforme,-	PICK1	KLHL32
ENSG00000272767	JMJD1C-AS1	2.78234385061862	6.04852118357738e-16	M2_vs_M1	HSALNG0078365	anti_sense	Q50	hsa-miR-211-3p,hsa-miR-874-3p	Sex hormone-binding globulin measurement,-	REEP3	ZNF629
ENSG00000272777	NA	3.64459368429472	0.00211758886340021	M2_vs_M1	HSALNG0035980	integenic	Not conserved	NA	NA	ADH5	TUBB1
ENSG00000272787	NA	2.53480888020204	0.00177587367256968	M2_vs_M1	HSALNG0134457	sense	Not conserved	NA	NA	DDTL	ENSG00000218565
ENSG00000272812	NA	-4.9524072556791	0.0323336417538544	M2_vs_M1	HSALNG0062860	intronic_sense	Not conserved	NA	NA	ZNF596	AGAP5
ENSG00000272824	NA	3.0098989654518	0.0389254381192777	M2_vs_M1	HSALNG0142333	integenic	Not conserved	NA	NA	PPIAL4G	UBE2D4
ENSG00000272825	NA	1.70552476239794	3.01578275834589e-74	M2_vs_M1	HSALNG0133587	anti_sense	Not conserved	hsa-miR-933,hsa-miR-6089	Heel bone mineral density	SLX9	THAP7
ENSG00000272839	NA	4.30266494832871	6.91208961987684e-21	M2_vs_M1	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463	NA	DNAJB6	RRP9
ENSG00000272841	MAP3K4-AS1	-1.8271814989928301	6.8224686208477e-16	M2_vs_M1	NA	NA	NA	NA	NA	AGPAT4	ENSG00000288162
ENSG00000272871	NA	1.01266284156883	0.020553135476449	M2_vs_M1	HSALNG0070100	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-1587	Response to ketamine,-	ZDHHC21	EXOC3-AS1
ENSG00000272909	NA	-4.62376984256152	0.0415437281257364	M2_vs_M1	HSALNG0101884	anti_sense	Q50	hsa-miR-6089	-	ZBTB25	ENSG00000272909
ENSG00000272914	NA	-2.09992789983476	0.0021972169876287	M2_vs_M1	HSALNG0077069	sense	Q90	NA	Body height,Neuroimaging measurement; Brain measurement,Neuroimaging measurement; Cortical thickness,-	ZNF438	GADD45A
ENSG00000272931	LRRC8D-DT	4.26347935079933	2.1138883522154902e-58	M2_vs_M1	HSALNG0005094	anti_sense	Q75	hsa-miR-6746-3p,hsa-miR-6800-3p	-	GBP5	TBRG4
ENSG00000272941	NA	-4.88454930620176	3.19843012241234e-51	M2_vs_M1	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	ENSG00000275993
ENSG00000272954	NA	4.66571736969249	0.0428453986693391	M2_vs_M1	HSALNG0134244	integenic	Q50	NA	Autoantibody measurement; Disease free survival; Event free survival time,-	PPIL2	ENSG00000272954
ENSG00000272990	NA	6.39748934650453	3.94586564104634e-6	M2_vs_M1	HSALNG0030055	anti_sense	Q75	NA	-	SSR3	ENSG00000289597
ENSG00000273001	PFKP-DT	3.6475394760881	0.00208118056656638	M2_vs_M1	HSALNG0075643	anti_sense	Not conserved	hsa-miR-215-3p,hsa-miR-4508,hsa-miR-6803-5p,hsa-miR-7111-5p,hsa-miR-10392-3p	Mean platelet volume,-	PITRM1	PITX1-AS1
ENSG00000273018	FAM106A	-6.72868287913049	6.73150625615602e-7	M2_vs_M1	HSALNG0115056	integenic	Not conserved	NA	-	TBC1D28	MTOR
ENSG00000273026	NA	1.70358992206885	1.62485550644858e-5	M2_vs_M1	HSALNG0007361	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4258,hsa-miR-5787	Lentiform nucleus measurement,-	CREB3L4	NAB1
ENSG00000273033	LINC02035	-1.06112538770122	0.00407674614567234	M2_vs_M1	HSALNG0028514	integenic	Q75	NA	Protein measurement,-	SLC49A4	ENSG00000283208
ENSG00000273058	NA	1.21125717933339	2.33303074108789e-4	M2_vs_M1	HSALNG0011778	anti_sense	Not conserved	hsa-miR-4281	-	HEATR1	ESRRA
ENSG00000273061	CDC37L1-DT	1.69223326968852	0.00431257874074529	M2_vs_M1	HSALNG0069737	integenic	Q50	hsa-miR-6862-5p,hsa-miR-8485	NA	SPATA6L	HNRNPA1P49
ENSG00000273076	NA	-5.76430997093946	0.00167175846028467	M2_vs_M1	HSALNG0135443	anti_sense	Not conserved	hsa-miR-6779-5p	NA	GTPBP1	ENSG00000273076
ENSG00000273080	NA	2.43757939739683	0.0118128328858373	M2_vs_M1	HSALNG0016568	anti_sense	Q75	hsa-miR-619-5p	-	MRPL35	LMBR1L
ENSG00000273084	NA	1.76242189561455	1.87957340058949e-4	M2_vs_M1	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4	RXRB
ENSG00000273141	NA	2.53814898003658	0.0470565582471752	M2_vs_M1	HSALNG0120067	integenic	Not conserved	hsa-miR-4281	NA	GNAL	ENSG00000279483
ENSG00000273143	DUSP5-DT	-1.10092216971776	0.0323698315124351	M2_vs_M1	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	ACOT1
ENSG00000273151	NA	-1.13487070263353	3.0170112665491e-4	M2_vs_M1	NA	NA	NA	NA	NA	ADAP1	PAFAH1B2
ENSG00000273176	NA	3.00676650202517	0.0393225523114676	M2_vs_M1	HSALNG0135134	anti_sense	Q75	NA	-	MB	PDF
ENSG00000273183	NA	2.00277339691285	0.00467820801393756	M2_vs_M1	HSALNG0149847	anti_sense	Not conserved	NA	NA	DPP6	LINC01909
ENSG00000273186	NA	2.53379678387167	0.00905681727539389	M2_vs_M1	HSALNG0074624	sense	Not conserved	hsa-miR-331-3p,hsa-miR-4292	NA	CERCAM	SIGLEC10
ENSG00000273209	NA	4.92729066762451	0.0161760677521501	M2_vs_M1	HSALNG0021587	integenic	Q90	hsa-miR-1199-5p	-	SUMO1	CNTD1
ENSG00000273216	NA	5.31859190968411	0.0120548605230331	M2_vs_M1	HSALNG0134823	sense	Not conserved	hsa-miR-4447	NA	RASL10A	ENSG00000239203
ENSG00000273226	NA	1.91243073859717	0.00305509021790554	M2_vs_M1	HSALNG0070293	anti_sense	Not conserved	NA	NA	DENND4C	ZSWIM9
ENSG00000273243	NA	-3.1317602476635	0.0115814506505319	M2_vs_M1	HSALNG0135916	integenic	Q50	hsa-miR-4492,hsa-miR-6763-5p	Mean corpuscular hemoglobin concentration,-	KIAA0930	FAM174B
ENSG00000273314	NA	-1.4618861596002	1.98996458011854e-9	M2_vs_M1	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	CLDN23
ENSG00000273341	NA	-2.86903984276828	4.60940791027163e-12	M2_vs_M1	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146	ALG1
ENSG00000273356	LINC02019	1.59299413588411	1.449920115771e-8	M2_vs_M1	HSALNG0026057	integenic	Q90	NA	-	DOCK3	CCT8
ENSG00000273382	TMEM167B-DT	1.71760077984675	4.7210620658712395e-11	M2_vs_M1	HSALNG0005853	anti_sense	Q75	hsa-miR-619-5p	Apolipoprotein b measurement,Leukocyte count,-	TAF13	GRAP2
ENSG00000273416	NA	2.3922224803859	0.00133744677921645	M2_vs_M1	HSALNG0011679	integenic	Not conserved	hsa-miR-486-3p,hsa-miR-4455,hsa-miR-1587,hsa-miR-4690-3p,hsa-miR-4776-5p,hsa-miR-6089,hsa-miR-8485	Respiratory quotient	TOMM20	GTF2F1
ENSG00000273443	NA	-1.7066262522347	2.42319343099753e-5	M2_vs_M1	HSALNG0000079	integenic	Not conserved	hsa-miR-3615	-	RNF223	AP1G2
ENSG00000273456	NA	1.75952310435965	0.00194707620535816	M2_vs_M1	HSALNG0021618	anti_sense	Q90	hsa-miR-6786-5p,hsa-miR-7113-3p	-	SUMO1	ENSG00000270277
ENSG00000273472	NA	-2.20184618611546	1.71438986660387e-6	M2_vs_M1	HSALNG0148201	integenic	Q50	NA	NA	ELMOD2	SMARCA1
ENSG00000273486	NA	1.76821943683912	4.75377289290308e-4	M2_vs_M1	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	SOBP
ENSG00000273487	NA	3.19859692766338	5.3255094759102704e-14	M2_vs_M1	HSALNG0005192	sense	Q50	NA	Serum alanine aminotransferase measurement,Aspartate aminotransferase measurement,-	BTBD8	ADGRL1-AS1
ENSG00000273619	NA	1.5486091429254	0.00187509127775154	M2_vs_M1	HSALNG0131521	anti_sense	Not conserved	hsa-miR-619-5p	-	CABLES2	ATG9B
ENSG00000273669	NA	5.52428101939599	1.71099628260492e-13	M2_vs_M1	HSALNG0122476	integenic	Q50	hsa-miR-4650-5p,hsa-miR-4695-5p,hsa-miR-6763-5p	Total blood protein measurement; Insomnia,-	ZNF407	ARHGDIA
ENSG00000273702	NA	1.56803811848948	0.00850861612799817	M2_vs_M1	HSALNG0117777	anti_sense	Q75	hsa-miR-505-5p	Creatinine measurement; Glomerular filtration rate,-	PTRH2	PLPBP
ENSG00000273759	NA	1.3080049132828	0.0295542941976824	M2_vs_M1	HSALNG0131576	sense	Not conserved	hsa-miR-940	NA	DIDO1	THAP5
ENSG00000273824	NA	-5.37998234157237	0.00531875547623252	M2_vs_M1	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	CCDC198
ENSG00000273828	NA	-7.36090259829252	7.70404772754727e-10	M2_vs_M1	HSALNG0130476	anti_sense	Q50	NA	-	CD40	ORC5
ENSG00000273855	NA	4.11448348956627	1.3129086426786801e-46	M2_vs_M1	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p	NA	PLCB2	MIR210HG
ENSG00000274021	NA	-1.19641208455567	0.00415508745801013	M2_vs_M1	HSALNG0092941	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4312,hsa-miR-4447,hsa-miR-548an,hsa-miR-8485	Attention deficit hyperactivity disorder,Self reported educational attainment; Attention deficit hyperactivity disorder,Body mass index,Brain volume measurement,Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Attention deficit hyperactivity disorder; Body fat percentage; Waist-hip ratio; Unipolar depression; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Platelet count; Aspartate aminotransferase measurement,Body weight; Body mass index,Sleep quality,Eosinophil count,Monocyte count,Hair colour measurement,Blood protein measurement; Lymphocyte count,Lymphocyte count,Attention deficit hyperactivity disorder; Cannabis use,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Diastolic blood pressure; Mean arterial pressure; Alcohol drinking,-	TMTC3	ENSG00000271580
ENSG00000274213	NA	-1.39964776117367	6.46320446815513e-4	M2_vs_M1	HSALNG0117605	integenic	Not conserved	hsa-miR-500b-3p	-	DGKE	ENSG00000279144
ENSG00000274270	NA	1.65915044903097	0.00163985329730819	M2_vs_M1	HSALNG0097105	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4286,hsa-miR-4710,hsa-miR-7152-5p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Appendicular lean mass; Monocyte count,Sex hormone-binding globulin measurement,Body height,Serum alanine aminotransferase measurement; Forced expiratory volume; Lean body mass; Body height; Vital capacity; Triglyceride measurement,Intelligence,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Glomerular filtration rate; Creatinine measurement; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Monocyte percentage of leukocytes; Monocyte count,Diabetic maculopathy,Body height; Bmi-adjusted hip circumference,Basophil count,Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Electrocardiography,Psoriasis,Psoriasis; Bmi-adjusted hip circumference; Primary biliary cirrhosis; Bmi-adjusted waist-hip ratio; Autoimmune disease,Appendicular lean mass,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hypothyroidism,Snoring measurement; Aortic root size,Eczema; Allergic rhinitis,High density lipoprotein cholesterol measurement,Celiac disease,Leukocyte count; Lymphocyte count,Tnf-related apoptosis-inducing ligand measurement,Fatty acid measurement,Diffuse large b-cell lymphoma; Bmi-adjusted hip circumference; Chronic lymphocytic leukemia; Triglyceride measurement,Hematocrit; Hemoglobin measurement,Thyroid peroxidase antibody measurement,Lipoprotein a measurement,Creatinine measurement; Glomerular filtration rate,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Adiponectin measurement,Bmi-adjusted adiponectin measurement,Body mass index,Low density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Left ventricular structural measurement,Fear of severe pain measurement,Hemoglobin measurement,Gamma-aminoisobutyric acid measurement,Eosinophil count,Heel bone mineral density,Prostate carcinoma,Grip strength measurement,Prostate specific antigen measurement,Blood urea nitrogen measurement; Forced expiratory volume,Grip strength measurement; Appendicular lean mass,Magnesium measurement,Caudal anterior cingulate cortex volume measurement,Blood urea nitrogen measurement,Breast carcinoma,Puberty; Heel bone mineral density; Bmi-adjusted hip circumference; Body height; Height growth measurement,Body height; Diastolic blood pressure; Systolic blood pressure,Hip circumference,Body height; Cardiovascular disease; Bmi-adjusted hip circumference; Systolic blood pressure,Transforming growth factor beta measurement,Primary biliary cirrhosis,Appendicular lean mass; Bmi-adjusted hip circumference,Body weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Protein measurement,Tumor necrosis factor-alpha measurement,Urinary albumin to creatinine ratio,Body height; Attention deficit hyperactivity disorder,Hematocrit,Bmi-adjusted waist circumference,Osteosarcoma; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Inguinal hernia,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Waist-hip ratio; Bmi-adjusted waist-hip ratio,Interleukin 9 measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Snoring measurement,Sphingomyelin 22:0 measurement,Platelet component distribution width,Lymphocyte count,Total blood protein measurement,Hematocrit; Odontogenesis,Blood phosphate measurement,Platelet count,Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement,Hemorrhoid,Anthropometric measurement; Brachial circumference,Bipolar disorder; Unipolar depression,Benign prostatic hyperplasia; Lower urinary tract symptom,Platelet-to-lymphocyte ratio,Eosinophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement,Adolescent idiopathic scoliosis,-	KCNRG	ENSG00000286431
ENSG00000274370	NA	1.71118547375589	1.8048690604625e-5	M2_vs_M1	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	ENSG00000271780
ENSG00000274372	LINC02804	1.8537863923728	2.9342576385613e-4	M2_vs_M1	HSALNG0006845	integenic	Not conserved	NA	-	GPR89B	GATAD2A
ENSG00000274414	NA	1.30797578859616	0.0290001203345051	M2_vs_M1	HSALNG0129378	integenic	Q50	NA	Response to diisocyanate,Cystatin c measurement,-	ABHD12	YAE1
ENSG00000274425	NA	2.14312574825035	0.00622012338913246	M2_vs_M1	NA	NA	NA	NA	NA	ICAM5	ZNF385C
ENSG00000274565	NA	2.45009425774671	8.883769882989621e-9	M2_vs_M1	HSALNG0117970	anti_sense	Q75	NA	-	MARCHF10	LNX1
ENSG00000274605	PCCA-DT	1.36311633044804	1.09247906590775e-12	M2_vs_M1	HSALNG0098967	integenic	Q50	NA	NA	ZIC5	DMTF1
ENSG00000274719	NA	8.46831983398913	1.2779335218749299e-20	M2_vs_M1	HSALNG0106206	sense	Not conserved	NA	NA	ALDH1A2	LINC00334
ENSG00000274828	NA	1.32771020781431	4.77951642268505e-8	M2_vs_M1	HSALNG0122776	integenic	Not conserved	hsa-miR-6867-3p	Monocyte count,Mean corpuscular hemoglobin	SLC66A2	ZNF837
ENSG00000274918	NA	2.04155040756973	0.0377855343725016	M2_vs_M1	HSALNG0120879	integenic	Not conserved	hsa-miR-6883-5p	NA	ZNF397	TMEM200A
ENSG00000274929	NA	2.35507257429961	0.00789827711365926	M2_vs_M1	HSALNG0096999	anti_sense,sense	Not conserved	NA	NA	RCBTB2	LINC01909
ENSG00000275202	NA	4.05474186492357	3.9798930599621204e-110	M2_vs_M1	HSALNG0097019	anti_sense	Q75	hsa-miR-4268,hsa-miR-4280,hsa-miR-3960,hsa-miR-4707-5p	-	CAB39L	ENSG00000227615
ENSG00000275278	NA	3.31310391337477	2.20535356526335e-10	M2_vs_M1	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	ENSG00000285793
ENSG00000275532	NA	-5.36823185814403	0.00623428417657487	M2_vs_M1	HSALNG0116178	anti_sense	Q75	hsa-miR-4281,hsa-miR-4508,hsa-miR-5088-3p,hsa-miR-7151-5p,hsa-miR-8072	Cognitive decline measurement,Cortical surface area measurement,Leukocyte count	PCGF2	ENSG00000282988
ENSG00000275582	NA	-5.61302922289733	0.00438222641464504	M2_vs_M1	HSALNG0128287	anti_sense	Not conserved	NA	-	RNF24	PITRM1-AS1
ENSG00000275765	NA	1.7001136486816	0.0101674525969745	M2_vs_M1	HSALNG0045934	anti_sense,sense	Q50	hsa-miR-6783-3p,hsa-miR-6789-3p	Red blood cell distribution width,-	ATOX1	ENSG00000235978
ENSG00000275830	NA	3.99123081895295	2.18696029717172e-7	M2_vs_M1	HSALNG0099354	integenic	Not conserved	hsa-miR-4472	Erosive tooth wear measurement,Cup-to-disc ratio measurement,Sleep duration,Igfbp-3 measurement,Diastolic blood pressure change measurement; Response to diuretic,-	COL4A1	CCL4
ENSG00000275880	NA	-2.67218726720095	0.00735056587419522	M2_vs_M1	HSALNG0099381	integenic	Not conserved	hsa-miR-619-5p	NA	CARS2	JAZF1
ENSG00000275964	NA	1.36288120286916	7.62987186223359e-7	M2_vs_M1	HSALNG0095490	integenic	Q50	hsa-miR-3178,hsa-miR-4281,hsa-miR-6729-5p,hsa-miR-6763-3p,hsa-miR-6803-5p	Arterial stiffness measurement,Calcium measurement,Alcohol use disorder measurement; Longitudinal alcohol consumption measurement,-	ZMYM2	FCAR
ENSG00000276148	NA	2.46175993916445	0.00177254817755609	M2_vs_M1	HSALNG0090284	anti_sense	Q75	NA	NA	YARS2	SPATA6
ENSG00000276170	NA	5.25604472437237	2.9176387013350797e-11	M2_vs_M1	HSALNG0116158	intronic_antisense	Q50	hsa-miR-939-3p,hsa-miR-4312,hsa-miR-6812-3p	Red blood cell distribution width	SRCIN1	SRSF2
ENSG00000276261	NA	3.50400179416816	0.00889532130137123	M2_vs_M1	HSALNG0143365	integenic	Not conserved	NA	NA	REP15	COQ3
ENSG00000276317	NA	-1.9089039292918	0.0100197573699169	M2_vs_M1	HSALNG0131550	anti_sense	Not conserved	hsa-miR-940,hsa-miR-4492,hsa-miR-6752-3p,hsa-miR-6810-5p,hsa-miR-6810-3p,hsa-miR-7160-3p	Hemoglobin a1 measurement	GATA5	TOMM5
ENSG00000276529	NA	2.83297497787309	6.83806780500811e-16	M2_vs_M1	NA	NA	NA	NA	NA	SLX9	TMEM147
ENSG00000276533	NA	1.51371412445275	0.00791796394389568	M2_vs_M1	HSALNG0106063	sense	Not conserved	hsa-miR-204-3p,hsa-miR-4296,hsa-miR-4448,hsa-miR-6769a-3p	NA	RAB27A	MAN1B1-DT
ENSG00000276728	NA	1.34575273124563	0.00340086256464863	M2_vs_M1	HSALNG0116821	integenic	Q75	hsa-miR-6887-3p,hsa-miR-7108-3p	Insomnia,-	PLCD3	MTND6P4
ENSG00000276850	NA	5.6441861840359	8.74979741481535e-4	M2_vs_M1	HSALNG0142768	integenic	Q50	NA	NA	FAM25C	LINC00334
ENSG00000276952	NA	-1.86711204255883	0.0423727360383366	M2_vs_M1	HSALNG0129380	anti_sense	Not conserved	NA	NA	ABHD12	BBS7
ENSG00000277228	NA	4.85837984226154	1.64229134518626e-48	M2_vs_M1	HSALNG0096883	integenic	Q50	hsa-miR-4492	-	LRCH1	THOC2
ENSG00000277232	GTSE1-DT	2.53643441203738	0.00731987965428153	M2_vs_M1	HSALNG0136018	integenic	Q50	hsa-miR-939-3p	-	PKDREJ	STIMATE-MUSTN1
ENSG00000277245	NA	3.76760713982837	0.00971591878040305	M2_vs_M1	HSALNG0106134	anti_sense	Not conserved	NA	-	TEX9	ENSG00000272750
ENSG00000277283	NA	2.57839590677785	6.57273268614935e-12	M2_vs_M1	HSALNG0094493	anti_sense	Not conserved	hsa-miR-1233-3p	NA	BICDL1	HMBS
ENSG00000277383	NA	1.27449678195369	0.0273082577168953	M2_vs_M1	HSALNG0126784	anti_sense	Not conserved	hsa-miR-4787-5p,hsa-miR-6803-5p,hsa-miR-7108-3p,hsa-miR-7155-5p	Smoking status measurement	ZNF541	SLC41A1
ENSG00000277423	NA	3.07864462533891	1.67306591894758e-4	M2_vs_M1	HSALNG0094538	sense	Q90	NA	Urinary metabolite measurement,Serum metabolite measurement,-	MLEC	PDE1B
ENSG00000277511	NA	-2.40499888952314	6.1396821801734e-11	M2_vs_M1	HSALNG0115754	integenic	Not conserved	hsa-miR-6089,hsa-miR-7847-3p	-	RHOT1	ENSG00000291263
ENSG00000277559	NA	2.1400012999331	6.76854040829444e-10	M2_vs_M1	HSALNG0111560	anti_sense	Q90	hsa-miR-4456	Tonsillectomy risk measurement,Self reported educational attainment; Intelligence,-	FTO	ENSG00000289589
ENSG00000277566	NA	3.44081764095621	1.47552135782254e-4	M2_vs_M1	HSALNG0094145	sense	Not conserved	NA	NA	TPCN1	SLC4A1AP
ENSG00000277687	NA	-4.81230631852615	0.0357210590071916	M2_vs_M1	HSALNG0080996	sense	Not conserved	NA	NA	CACUL1	ENSG00000223390
ENSG00000277693	NA	-3.0320534002435	0.0207840424025232	M2_vs_M1	HSALNG0131854	integenic	Not conserved	hsa-miR-619-5p	NA	LIPI	MMADHC-DT
ENSG00000277738	NA	5.14133217648933	0.00690696014881744	M2_vs_M1	HSALNG0093017	integenic	Q50	NA	Infant expressive language ability,Leucine measurement,Dna methylation,Sudden cardiac arrest,Facial morphology measurement,Choline measurement,-	PLEKHG7	E2F5
ENSG00000277806	NA	2.68776582028442	0.0315029088389704	M2_vs_M1	HSALNG0126403	sense	Not conserved	NA	NA	ZNF155	H3-3A
ENSG00000277851	LINC02391	2.82074069022962	0.00848771182824273	M2_vs_M1	HSALNG0143695	integenic	Not conserved	NA	Smoking behaviour measurement	BTG1	POMT2
ENSG00000277978	NA	2.35474932443232	2.10738632568014e-11	M2_vs_M1	HSALNG0112104	anti_sense	Q50	hsa-miR-4433a-3p,hsa-miR-4492,hsa-miR-4433b-3p	-	TK2	ENSG00000215835
ENSG00000278017	NA	-2.2056043542797	0.0220821260917758	M2_vs_M1	HSALNG0121991	anti_sense	Q90	NA	NA	PIGN	GATA6
ENSG00000278041	NA	2.53709681607281	0.0360351953504947	M2_vs_M1	HSALNG0129112	integenic	Not conserved	NA	Bone mineral content measurement	NKX2-2	CEACAM21
ENSG00000278058	NA	2.97074586817181	9.57872708897482e-12	M2_vs_M1	HSALNG0112904	anti_sense	Q50	hsa-miR-7109-5p	Eosinophil count,Eosinophil count; Eosinophil percentage of leukocytes,Uric acid measurement,Uric acid measurement; Renal system measurement,-	WWOX	DPP9
ENSG00000278126	NA	2.24898564491268	2.46929066677816e-4	M2_vs_M1	HSALNG0091065	sense	Not conserved	NA	-	POU6F1	MYO1C
ENSG00000278133	NA	1.38877277929381	1.90299053499617e-10	M2_vs_M1	HSALNG0110822	sense	Q90	hsa-miR-4640-3p,hsa-miR-6089,hsa-miR-7704	Smoking behavior; Body mass index,Anxiety; Family history of alzheimers disease,-	KAT8	PSMD2
ENSG00000278376	NA	2.41157701164175	6.41392175759495e-8	M2_vs_M1	HSALNG0087573	anti_sense	Q75	hsa-miR-4749-3p	-	CXCR5	COPS3
ENSG00000278546	NA	2.83075428092769	0.00151019957095797	M2_vs_M1	HSALNG0115707	integenic	Q90	NA	Heel bone mineral density,Body height,Human papilloma virus infection,Myocardial infarction,Systolic blood pressure,Balding measurement,Hippocampal volume,Pulse pressure measurement,Prostate carcinoma,Eosinophil count,Diet measurement; Body mass index,Covid-19; Pneumonia,Coronary artery disease,-	RAB11FIP4	ENSG00000269176
ENSG00000278600	NA	-1.35172075001517	5.3933738958461e-8	M2_vs_M1	HSALNG0144583	sense	Not conserved	NA	Blood protein measurement	ST20-MTHFS	PATL2
ENSG00000278703	NA	4.67006534147515	0.0257263393249085	M2_vs_M1	HSALNG0121773	integenic	Q50	hsa-miR-619-5p	NA	FECH	ENSG00000264666
ENSG00000278709	NKILA	-3.54402292327313	0.00125433986931665	M2_vs_M1	HSALNG0131196	anti_sense	Q50	hsa-miR-6763-3p	-	PCK1	ART3
ENSG00000278768	BACE1-AS	-1.48707901206596	0.0232108486105885	M2_vs_M1	HSALNG0087449	anti_sense	Q90	hsa-miR-6089	Apolipoprotein a 1 measurement,-	RNF214	IFT81
ENSG00000278811	LINC00624	-4.81106097312326	0.0251373956107199	M2_vs_M1	HSALNG0006807	integenic	Not conserved	NA	NA	FMO5	SLC12A5
ENSG00000278910	BANCR	-6.25885297409865	1.76398672264091e-4	M2_vs_M1	HSALNG0071734	integenic	Not conserved	NA	-	APBA1	ENSG00000288954
ENSG00000279159	NA	-2.12020243411019	5.9359594207337e-8	M2_vs_M1	HSALNG0134861	anti_sense	Q75	hsa-miR-671-5p,hsa-miR-6824-3p	Hematocrit,Mean corpuscular hemoglobin,Mean corpuscular volume,Mean reticulocyte volume; Mean corpuscular volume,Breast carcinoma,Hashimoto's thyroiditis,Iga glomerulonephritis; Mean corpuscular volume; Breast carcinoma,Glomerular filtration rate,P-tau measurement,-	ASCC2	FRYL
ENSG00000279277	NA	-2.35086915047147	0.00295094338236429	M2_vs_M1	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47	ENSG00000245025
ENSG00000279345	NA	-6.09028766599558	2.85159222909137e-4	M2_vs_M1	HSALNG0136221	anti_sense	Not conserved	NA	Mean platelet volume	ZBED4	CHRNA1
ENSG00000279516	FAM230C	-1.01478387906225	4.52923123552212e-4	M2_vs_M1	HSALNG0143784	integenic	Not conserved	NA	NA	MPHOSPH8	INVS
ENSG00000279529	NA	-1.47866116028565	0.00167301867203373	M2_vs_M1	HSALNG0124449	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4463,hsa-miR-6746-3p	-	C19orf44	ENSG00000274929
ENSG00000279833	NA	-5.11588611623211	0.0196225484586769	M2_vs_M1	NA	NA	NA	NA	NA	APOBEC3H	DIP2A
ENSG00000279873	LINC01126	-3.2255700841156	0.00704263139498641	M2_vs_M1	HSALNG0014530	anti_sense	Q75	hsa-miR-663a,hsa-miR-4685-3p,hsa-miR-4749-3p,hsa-miR-6819-3p,hsa-miR-8485,hsa-miR-10392-3p	Neutrophil count; Intraocular pressure measurement; Creatinine measurement; Appendicular lean mass; Bmi-adjusted waist-hip ratio; Reticulocyte measurement,Bmi-adjusted waist-hip ratio; Myocardial infarction,-	PLEKHH2	PKD1L1
ENSG00000279968	CCDC28A-AS1	1.33715358667658	0.0341157871054304	M2_vs_M1	HSALNG0053839	sense	Q75	NA	NA	NHSL1	INSIG2
ENSG00000280007	NA	1.03370729053548	0.00302955039591332	M2_vs_M1	HSALNG0133953	anti_sense	Not conserved	hsa-miR-619-5p	Atrial fibrillation,T-tau measurement,Carotid plaque build,-,Mean platelet volume	MICAL3	PALLD
ENSG00000280213	UCKL1-AS1	-1.30905534937392	3.99546062317653e-4	M2_vs_M1	HSALNG0146891	anti_sense	Q75	NA	Urate measurement,-	DNAJC5	SPATA46
ENSG00000280303	ERICD	1.07818782808576	1.5044389850481702e-9	M2_vs_M1	HSALNG0069026	anti_sense	Q50	hsa-miR-4526,hsa-miR-4656,hsa-miR-4749-3p,hsa-miR-6749-3p,hsa-miR-8072	Age-related hearing impairment	CHRAC1	MAP3K5
ENSG00000280486	NA	-3.13342464426095	0.0107345512029027	M2_vs_M1	HSALNG0123021	anti_sense	Not conserved	NA	-	GAMT	ENSG00000260643
ENSG00000280543	ASAP1-IT2	4.17867386911852	3.67701619720638e-5	M2_vs_M1	HSALNG0068611	sense	Not conserved	NA	NA	ASAP1	IMP3
ENSG00000280721	LINC01943	5.89131724705992	2.50419377053455e-28	M2_vs_M1	HSALNG0016641	integenic	Not conserved	hsa-miR-6803-5p	-	RGPD2	EIF4G2
ENSG00000280798	LINC00294	1.59636254386628	6.610584371807011e-15	M2_vs_M1	HSALNG0083507	anti_sense,sense	Not conserved	NA	-	TCP11L1	SYCP2L
ENSG00000280832	GSEC	1.86794699478877	5.66150559050915e-7	M2_vs_M1	HSALNG0088026	anti_sense	Q50	NA	Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3	ENSG00000289586
ENSG00000280927	CTBP1-AS	-1.17444003549646	0.0332293902043844	M2_vs_M1	HSALNG0141602	anti_sense	Q90	NA	-	MAEA	HMCN1
ENSG00000281005	LINC00921	1.19295087417936	0.012016412724103	M2_vs_M1	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	ENSG00000285973
ENSG00000281103	TRG-AS1	2.6919886005611	4.91284987411463e-32	M2_vs_M1	HSALNG0057335	integenic	Not conserved	NA	NA	STARD3NL	ALDH3B1
ENSG00000281162	LINC01127	-2.4645024072444	6.82457205832255e-9	M2_vs_M1	HSALNG0017393	integenic	Q50	hsa-miR-939-3p,hsa-miR-6728-3p,hsa-miR-6737-3p	Eosinophil count,Protein measurement,St2 protein measurement,Neutrophil count,-	IL1R2	NTN1
ENSG00000281183	NPTN-IT1	-7.69756311265383	2.75564590511714e-13	M2_vs_M1	HSALNG0107117	sense	Q75	NA	NA	NPTN	METTL9
ENSG00000281207	SLFNL1-AS1	-1.25819177836703	0.0292871777266229	M2_vs_M1	HSALNG0002926	anti_sense	Not conserved	NA	NA	CTPS1	CALY
ENSG00000281332	LINC00997	1.23734895040073	0.00409764614252349	M2_vs_M1	HSALNG0057093	integenic	Not conserved	NA	NA	AVL9	TRIM23
ENSG00000281333	NA	4.66993697726194	0.0279258978969543	M2_vs_M1	HSALNG0092894	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4463	Hair color,Adolescent idiopathic scoliosis,Mean reticulocyte volume; Lymphocyte percentage of leukocytes; Neutrophil percentage of leukocytes; Monocyte count; Skin pigmentation measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement; Erythrocyte count,Leukocyte count; Myeloid white cell count; Erythrocyte count,Mean corpuscular hemoglobin concentration; Nevus count; Cutaneous melanoma; Leukocyte count; Monocyte count; Mean corpuscular volume,Neutrophil count; Mean corpuscular hemoglobin; Basophil count; Myeloid white cell count; Eosinophil count; Mean corpuscular volume; Granulocyte count,Neutrophil count; Myeloid white cell count; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Hair colour measurement,Skin aging measurement,Nevus count,Mean corpuscular volume,Testicular carcinoma,Testicular germ cell tumor; Testicular carcinoma,Trans fatty acid measurement; Trans/cis-18:2 fatty acid measurement,-,Leukocyte count	TMTC3	ENSG00000264666
ENSG00000281357	ARRDC3-AS1	-1.63232164069172	0.00392017700509315	M2_vs_M1	HSALNG0043456	integenic	Not conserved	NA	NA	ADGRV1	ENSG00000255306
ENSG00000281398	SNHG4	1.84663619919808	1.01810139565352e-29	M2_vs_M1	HSALNG0045213	anti_sense,sense	Q50	hsa-miR-3170,hsa-miR-6089,hsa-miR-6736-5p	-	MATR3	ZNF134
ENSG00000281404	LINC01176	-1.48119330523387	7.64834821270582e-11	M2_vs_M1	HSALNG0149630	sense	Not conserved	NA	NA	NA	NMI
ENSG00000281468	NA	1.68634411496869	0.0385970335929377	M2_vs_M1	HSALNG0125122	integenic	Not conserved	hsa-miR-762,hsa-miR-3155b,hsa-miR-5047,hsa-miR-6797-5p,hsa-miR-6858-3p	-	VSTM2B	ENSG00000253983
ENSG00000281649	EBLN3P	-1.87308610726948	9.624167706857091e-52	M2_vs_M1	HSALNG0071023	sense	Not conserved	NA	Empathy measurement,Bipolar disorder,Sleep duration,Body mass index,Cardiovascular disease,Mean arterial pressure; Body mass index,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Diastolic blood pressure,Chronotype measurement,Body weight,-	ZCCHC7	HIPK2
ENSG00000281756	C2-AS1	-8.06989407219059	3.37349305088085e-17	M2_vs_M1	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	C1R
ENSG00000281903	LINC02246	-5.23917940780565	0.0121546107276437	M2_vs_M1	HSALNG0131961	sense	Q90	hsa-miR-6829-3p	Tuberculosis,Breast carcinoma,Unipolar depression,Reading and spelling ability,Gastroesophageal reflux disease,Serum alanine aminotransferase measurement; Diuretic use measurement; Birth weight; Refractive error; Platelet crit; Hemoglobin measurement; Vitamin d measurement; Systolic blood pressure; Age at onset; Hematocrit; Agents acting on the renin-angiotensin system use measurement; Myopia; Erythrocyte count,Pulse pressure measurement; Systolic blood pressure,Lymphocyte count; Red blood cell distribution width; Leukocyte count; Prostate carcinoma; Platelet count; Monocyte count,Platelet count; Lymphocyte count; Platelet crit; Monocyte count,Monocyte count; Monocyte percentage of leukocytes; Red blood cell distribution width,Platelet component distribution width,Myeloid white cell count; Platelet count; Monocyte count,Myeloid white cell count,High density lipoprotein cholesterol measurement,Response to paliperidone; Schizophrenia symptom severity measurement,Age at onset; Myopia,Response to beta blocker; Heart rate,Hypermetropia; Myopia,Neuropsychological test; Abnormality of refraction,-	NRIP1	ENSG00000279434
ENSG00000281912	LINC01144	2.23285455112182	0.00443180400893974	M2_vs_M1	HSALNG0003233	anti_sense	Not conserved	hsa-miR-320a-5p,hsa-miR-4447	NA	HPDL	HPDL
ENSG00000282508	LINC01002	-2.71718770259414	9.30281261408015e-4	M2_vs_M1	HSALNG0145815	integenic	Not conserved	NA	NA	PLPP2	ENSG00000264769
ENSG00000282851	BISPR	-1.83078271106422	1.8947215454755902e-47	M2_vs_M1	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	R3HCC1L
ENSG00000283031	NA	-5.1609316460387	0.0322766451624089	M2_vs_M1	HSALNG0013552	anti_sense	Q75	NA	-	ATAD2B	RABGAP1L-IT1
ENSG00000283064	NA	-4.96892935099721	0.0170745287546282	M2_vs_M1	HSALNG0048737	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Bmi-adjusted waist circumference; Body height; Bmi-adjusted waist-hip ratio,C-reactive protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking status measurement; Mathematical ability,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Brain volume measurement,-	H4C4	DDX43
ENSG00000283078	NA	2.28127987955441	0.0019839171332415	M2_vs_M1	HSALNG0131475	anti_sense	Not conserved	hsa-miR-6826-3p,hsa-miR-6848-3p	-	LSM14B	RBP4
ENSG00000283360	NA	-2.5256476243354	0.0191766039235885	M2_vs_M1	HSALNG0007943	integenic	Not conserved	NA	Rheumatoid arthritis,Blood protein measurement; Serum non-albumin protein measurement	CFAP126	H4C16
ENSG00000283384	NA	-7.16217552130257	3.7032096765351e-9	M2_vs_M1	HSALNG0099263	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-1207-3p,hsa-miR-4483,hsa-miR-4650-5p,hsa-miR-6763-5p	Granulocyte percentage of myeloid white cells; Leukocyte count; Blood protein measurement; Serum non-albumin protein measurement; Monocyte percentage of leukocytes,Serum non-albumin protein measurement,Monocyte count,Leukocyte count; Neutrophil count; Monocyte count,Venous thromboembolism,Blood protein measurement; Serum non-albumin protein measurement,Tonsillectomy risk measurement,Alcohol dependence measurement,Fev/fec ratio; Response to bronchodilator,-	TNFSF13B	SLC11A1
ENSG00000283504	NA	-7.59853767085915	2.73988870498453e-13	M2_vs_M1	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	USP18
ENSG00000283646	LINC02009	-7.19380286281206	2.9435543162430102e-9	M2_vs_M1	HSALNG0025684	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6786-5p,hsa-miR-6828-3p	Macula measurement; Lymphocyte percentage of leukocytes; Inflammatory bowel disease; Ulcerative colitis; Protein measurement; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Macrophage inflammatory protein 1b measurement,Oral ulcer,Ccl2 measurement,Monocyte count,Monocyte percentage of leukocytes,Eotaxin measurement,Bmi-adjusted hip circumference	LTF	PSEN1
ENSG00000283648	NA	-3.40824773434109	5.17893304864071e-34	M2_vs_M1	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	CCL7
ENSG00000283689	NA	1.6315933064089	0.00788811264269857	M2_vs_M1	HSALNG0111560	anti_sense	Q90	hsa-miR-4456	Tonsillectomy risk measurement,Self reported educational attainment; Intelligence,-	FTO	SETD4
ENSG00000283959	NA	1.23658367930687	0.00444224862628753	M2_vs_M1	HSALNG0067455	integenic	Q75	hsa-miR-30b-3p,hsa-miR-3178,hsa-miR-5787,hsa-miR-6763-5p,hsa-miR-6833-5p	C-reactive protein measurement,Mean reticulocyte volume; Mean corpuscular volume,Susceptibility to common cold measurement,Heart rate variability measurement; Response to antipsychotic drug,Skin pigmentation measurement,-	ODF1	VPS4B
ENSG00000284196	NA	3.93292022575363	1.26413310886745e-6	M2_vs_M1	HSALNG0098167	integenic	Q75	hsa-miR-552-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587	Sleep duration,Cortical surface area measurement,Atopic eczema,Thrombocytopenia,Interleukin-6 measurement,Body height,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Body mass index; Fasting blood insulin measurement,Cleft lip; Cleft palate,-	SPRY2	LNPK
ENSG00000284391	NA	4.29473995514852	8.34691642534251e-8	M2_vs_M1	HSALNG0138430	anti_sense	Q90	NA	NA	TEX11	LAMA4
ENSG00000284633	NA	4.81635435489038	2.64191101399611e-8	M2_vs_M1	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1	IDI1
ENSG00000284669	NA	-1.84222588939525	5.14320933252638e-7	M2_vs_M1	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	NTSR1
ENSG00000284685	NA	-3.03669879799518	0.0175106107532767	M2_vs_M1	HSALNG0110586	integenic	Not conserved	NA	NA	SLX1B	ZNF429
ENSG00000284734	NA	-6.81977266531847	2.50087338943417e-7	M2_vs_M1	HSALNG0005052	anti_sense	Not conserved	NA	NA	GBP6	ENSG00000288765
ENSG00000284968	NA	-1.08070090977711	0.00251743068498375	M2_vs_M1	HSALNG0035672	anti_sense,sense	Q50	NA	Facial hair thickness measurement,Lymphocyte percentage of leukocytes	NA	CEP19
ENSG00000285163	NA	6.77766986846496	4.0135422913058195e-35	M2_vs_M1	HSALNG0113249	integenic	Q50	hsa-miR-92a-2-5p,hsa-miR-525-5p,hsa-miR-4466,hsa-miR-6855-5p	Qrs duration,Monocyte count,Primary biliary cirrhosis,Systemic lupus erythematosus,Monocyte percentage of leukocytes; Monocyte count,Chronic lymphocytic leukemia,Systemic scleroderma,Systemic lupus erythematosus; Systemic scleroderma; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Monocyte percentage of leukocytes,Neutrophil percentage of leukocytes; Neutrophil count,Neutrophil percentage of leukocytes,Bladder exstrophy; Monocyte percentage of leukocytes,Anti-centromere-antibody-positive systemic scleroderma; Limited scleroderma; Systemic scleroderma,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Ulcerative colitis; Monocyte count,Ulcerative colitis; Inflammatory bowel disease,Eosinophil count; Inflammatory bowel disease; Monocyte percentage of leukocytes,Crohn's disease,Systemic lupus erythematosus; Inflammatory bowel disease,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Sclerosing cholangitis,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Lymphocyte count,Eosinophil count,Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes; Eosinophil percentage of granulocytes,Systemic lupus erythematosus; Biliary liver cirrhosis; Primary biliary cirrhosis,Rheumatoid arthritis,Rheumatoid arthritis; Monocyte count,Oral ulcer,Autoimmune disease; Systemic lupus erythematosus; Primary biliary cirrhosis,Behcet's syndrome,Hypothyroidism,Adolescent idiopathic scoliosis,Aspartate aminotransferase measurement,Unipolar depression,Fev/fec ratio,Rheumatoid arthritis; Systemic lupus erythematosus; Myositis; Systemic scleroderma,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-,Leukocyte count; Lymphocyte count	IRF8	RPS29
ENSG00000285280	NA	2.29886658500636	7.14171729704579e-5	M2_vs_M1	HSALNG0142391	integenic	Not conserved	NA	NA	UCHL5	CRIP1
ENSG00000285331	NA	2.63970489485699	1.61011829099214e-61	M2_vs_M1	HSALNG0106164	sense	Not conserved	NA	NA	NA	NEAT1
ENSG00000285410	GABPB1-IT1	1.10444995887304	8.985616570168199e-20	M2_vs_M1	HSALNG0105871	anti_sense,sense	Q90	hsa-miR-5585-3p	Superior frontal gyrus volume measurement,Adolescent idiopathic scoliosis,Testosterone measurement,Platelet crit,Breast carcinoma,Fev/fec ratio,Body height,Blood phosphate measurement,Mean reticulocyte volume,Mean arterial pressure,Systolic blood pressure; Heel bone mineral density,Leukocyte count,Hypertension,Electrocardiography,Granulocyte percentage of myeloid white cells,Intelligence,Eosinophil count,Lymphocyte count,Qt interval,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Lean body mass,Self reported educational attainment,Pulse pressure measurement,Serum alanine aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Pulse pressure measurement; Systolic blood pressure,Aspartate aminotransferase measurement,Coronary artery disease,Uric acid measurement,Urate measurement,Monocyte count,Chronic obstructive pulmonary disease,Hematocrit,Calcium measurement,Fibrinogen measurement,Late-onset alzheimers disease,Lymphocyte count; Myeloid white cell count; Leukocyte count; Calcium measurement; Monocyte count,Sex hormone-binding globulin measurement; Blood phosphate measurement; Serum gamma-glutamyl transferase measurement; Calcium measurement; High density lipoprotein cholesterol measurement,Estradiol measurement,Osteoarthritis, knee,Osteoarthritis, knee; Osteoarthritis, hip, osteoarthritis, knee,Monocyte percentage of leukocytes,-,Neutrophil count; Myeloid white cell count; Leukocyte count; Eosinophil count; Granulocyte count,Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Blood protein measurement; Triglyceride measurement; Serum non-albumin protein measurement; Aspartate aminotransferase measurement,Ankylosing spondylitis; Aspartate aminotransferase to alanine aminotransferase ratio; Total cholesterol measurement,Household income	GABPB1	CPNE8
ENSG00000285517	NA	2.217780336328	9.26755889870827e-22	M2_vs_M1	HSALNG0090154	integenic	Not conserved	hsa-miR-6780a-5p	NA	TSPAN11	SMURF1
ENSG00000285525	NA	5.3278277037372	0.00328168180364688	M2_vs_M1	HSALNG0005545	integenic	Q50	NA	Open-angle glaucoma,Glaucoma,Monocyte count,Leukocyte count,-	VCAM1	SMIM2
ENSG00000285533	RELA-DT	1.98578073677586	3.26358365403319e-10	M2_vs_M1	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1	LNMICC
ENSG00000285554	LINC02988	-2.66385544157528	0.00887854146331424	M2_vs_M1	HSALNG0007003	sense	Q75	hsa-miR-30b-3p	Bipolar disorder,Mathematical ability,Myopathy; Response to simvastatin,-	PLEKHO1	ABCA9
ENSG00000285632	NA	2.48457002956303	2.53197389326366e-5	M2_vs_M1	HSALNG0064623	anti_sense	Not conserved	hsa-miR-619-5p	-	PLPP5	ENSG00000217130
ENSG00000285653	NA	-5.51203144605402	0.00572869745903389	M2_vs_M1	HSALNG0145541	anti_sense	Not conserved	hsa-miR-363-5p,hsa-miR-4463	Drug-induced liver injury; Response to fluoroquinolones	PPP4R1	ENSG00000230325
ENSG00000285675	NA	4.67221884066087	0.026241669665631	M2_vs_M1	HSALNG0063365	anti_sense	Not conserved	NA	Venous thromboembolism	PRSS51	DOC2GP
ENSG00000285684	NA	6.55240623997964	2.1061931442957e-6	M2_vs_M1	HSALNG0098173	integenic	Q75	hsa-miR-671-5p,hsa-miR-6089	Cleft lip,Cleft lip; Oral cleft; Cleft palate,Cleft lip; Cleft palate; Progranulin measurement,Drugs used in diabetes use measurement,Diastolic blood pressure,Fev/fec ratio,Glucose measurement; Hemoglobin a1 measurement,Systolic blood pressure; Mean arterial pressure,Cleft lip; Cleft palate,-	SPRY2	ENSG00000273669
ENSG00000285693	NA	-1.73766449610071	6.96097525065002e-4	M2_vs_M1	HSALNG0085586	sense	Q50	hsa-miR-4279,hsa-miR-4492,hsa-miR-5589-5p	Protein measurement,Platelet count,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement	STARD10	EFCAB2
ENSG00000285722	NA	1.98951446197768	0.021325377649118	M2_vs_M1	HSALNG0136188	integenic	Q50	hsa-miR-4667-5p	-	ZBED4	SLF1
ENSG00000285728	NA	-1.37625809865623	3.29993824570046e-4	M2_vs_M1	HSALNG0003014	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1285-5p	-	CLDN19	BEX1
ENSG00000285744	NA	-11.4798472045376	1.9205498992884797e-150	M2_vs_M1	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	HLA-DOA
ENSG00000285756	NA	2.32811454447464	5.33997522582205e-15	M2_vs_M1	HSALNG0136447	integenic	Not conserved	NA	NA	PRKX	MRPL46
ENSG00000285761	NA	-5.12776858992019	0.0106359918166286	M2_vs_M1	HSALNG0049090	integenic	Not conserved	hsa-miR-6085	Crohn's disease,Small cell lung carcinoma,Sleep duration,Lymphocyte count,Bmi-adjusted waist-hip ratio,-	HLA-F	ENSG00000286616
ENSG00000285793	ANAPC1P2	-2.79760200858308	1.16014081133033e-5	M2_vs_M1	HSALNG0016618	integenic	Not conserved	NA	NA	PLGLB1	ENSG00000275278
ENSG00000285810	NA	-5.0026889199937	0.0300228498693741	M2_vs_M1	HSALNG0078929	anti_sense	Q75	NA	Body weight,Covid-19	KAT6B	ENSG00000287729
ENSG00000285867	NA	3.80319590790584	7.30029787688988e-6	M2_vs_M1	HSALNG0142351	integenic	Not conserved	NA	NA	S100A16	ENSG00000224945
ENSG00000285888	NA	-5.31863443346334	4.95198409078319e-49	M2_vs_M1	HSALNG0149144	anti_sense	Not conserved	hsa-miR-4492	Basophil percentage of leukocytes	RAB44	TMEM170A
ENSG00000285895	NA	-2.66691338683036	0.00723259265058354	M2_vs_M1	HSALNG0143182	integenic	Not conserved	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	NA	OR5B21	SNRNP27
ENSG00000285936	NA	6.01449263724323	1.77039738959067e-5	M2_vs_M1	HSALNG0144120	anti_sense	Q75	NA	NA	RGS6	SEPTIN10
ENSG00000285973	NA	1.85233341636201	0.0453297544096446	M2_vs_M1	HSALNG0081190	anti_sense	Q50	hsa-miR-4277	Pathological myopia	NSMCE4A	CIP2A
ENSG00000285979	NA	-3.985381713693	1.0053282401557e-15	M2_vs_M1	HSALNG0144767	anti_sense	Q75	NA	NA	RSPRY1	ZNF319
ENSG00000286004	NA	-5.28277485801098	1.5930078916569297e-11	M2_vs_M1	HSALNG0031856	anti_sense	Not conserved	NA	Creatinine measurement; Glomerular filtration rate,-	MUC20	DENND2C
ENSG00000286017	NA	2.74014591219675	0.00189962684613335	M2_vs_M1	HSALNG0031982	integenic	Not conserved	NA	NA	NCBP2AS2	SMIM8
ENSG00000286039	NA	1.16586371040313	5.63538828279382e-7	M2_vs_M1	HSALNG0038607	anti_sense	Q75	hsa-miR-1268b,hsa-miR-7106-5p	Lymphocyte count,Platelet count; Platelet crit,Atrial fibrillation,-	SAP30	KDELR1
ENSG00000286062	NA	-1.27569264162729	0.00377793966949109	M2_vs_M1	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB	ENSG00000287263
ENSG00000286122	LINC02964	6.01454921014913	2.06486162922206e-5	M2_vs_M1	HSALNG0068364	integenic	Not conserved	NA	-	TRIB1	SNRPE
ENSG00000286153	NA	-1.92843880022084	7.26262703935542e-10	M2_vs_M1	HSALNG0132875	anti_sense	Not conserved	NA	Erythrocyte count; Response to vaccine; Mean corpuscular hemoglobin; Cognitive decline measurement; Monocyte percentage of leukocytes,Balding measurement,Alopecia,Eosinophil count,Monocyte count,-	CLIC6	METTL17
ENSG00000286162	NA	-1.13580419961367	8.94534689154489e-10	M2_vs_M1	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	PPP5C
ENSG00000286174	NA	-4.81968159623486	0.0332293902043844	M2_vs_M1	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	MGAM2
ENSG00000286196	NA	-5.37511545029496	0.00461219063753494	M2_vs_M1	HSALNG0150729	anti_sense	Not conserved	NA	Blood protein measurement,-	TTC16	GABPB2
ENSG00000286207	NA	-1.73980984085137	1.01542779219626e-5	M2_vs_M1	HSALNG0146630	anti_sense	Q50	NA	NA	PRPF40A	CCSAP
ENSG00000286216	NA	-5.77802162431515	8.90639290669192e-4	M2_vs_M1	HSALNG0012258	integenic	Not conserved	hsa-miR-619-5p	-	ZNF496	HLA-W
ENSG00000286242	NA	-3.31503014913598	0.00560813147934741	M2_vs_M1	HSALNG0148162	anti_sense	Q50	NA	Glomerular filtration rate,Leukocyte count,-	CISD2	ENSG00000272072
ENSG00000286248	NA	-8.83771974815071	6.754673978306269e-28	M2_vs_M1	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	PLSCR1
ENSG00000286333	NA	4.55276395958416	4.28714768773394e-11	M2_vs_M1	HSALNG0102303	anti_sense	Q50	hsa-miR-4254	C-reactive protein measurement; Alkaline phosphatase measurement,C-reactive protein measurement; Sex hormone-binding globulin measurement; Alkaline phosphatase measurement; Testosterone measurement; Aspartate aminotransferase measurement,C-reactive protein measurement,Lysine measurement,-	DPF3	GOLGA8A
ENSG00000286369	NA	-2.48979666781295	4.7106522039254e-5	M2_vs_M1	HSALNG0085227	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4281,hsa-miR-3665,hsa-miR-4443,hsa-miR-4453,hsa-miR-5047,hsa-miR-6089,hsa-miR-6510-5p	Body height	LRP5	TMEM50B
ENSG00000286376	NA	4.66599561102451	0.0399494974417135	M2_vs_M1	HSALNG0056337	integenic	Q75	NA	Susceptibility to childhood ear infection measurement,Fat body mass,Fev/fec ratio,Idiopathic osteonecrosis of the femoral head,High density lipoprotein cholesterol measurement,Sex hormone-binding globulin measurement,Electroencephalogram measurement,Homa-b,Triglyceride measurement,Triglyceride measurement; Total blood protein measurement,Facial morphology measurement,-	MEOX2	ENSG00000286376
ENSG00000286408	NA	2.13883454471475	0.001180216986312	M2_vs_M1	HSALNG0044899	integenic	Q50	NA	NA	ZCCHC10	AP3B1
ENSG00000286431	NA	2.09429485404822	5.87873768162309e-6	M2_vs_M1	HSALNG0136439	integenic	Not conserved	hsa-miR-619-5p	NA	ARSF	ENSG00000274270
ENSG00000286471	NA	-1.09617553488562	0.0200187427224348	M2_vs_M1	HSALNG0065372	integenic	Q50	hsa-miR-619-5p,hsa-miR-1229-5p,hsa-miR-6801-3p	-	SOX17	PGBD1
ENSG00000286475	NA	1.6679479029221	0.0242220201370029	M2_vs_M1	HSALNG0137281	integenic	Not conserved	NA	NA	DYNLT3	PDE5A
ENSG00000286482	NA	-1.93612506776778	0.0217828164305026	M2_vs_M1	HSALNG0054620	integenic	Q50	NA	Mean platelet volume	TMEM242	PIP5K1C
ENSG00000286532	PARTICL	1.83359621238298	7.40048582143051e-8	M2_vs_M1	HSALNG0016500	integenic	Q50	hsa-miR-6721-5p	Myocardial infarction; Body weight,Basophil count,Coronary artery disease,-	GGCX	LINC01962
ENSG00000286548	NA	-5.45194624212804	5.644165835840869e-94	M2_vs_M1	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	APOBEC3A
ENSG00000286555	NA	-2.79253564452962	4.92702337743898e-7	M2_vs_M1	HSALNG0085575	anti_sense	Q90	hsa-miR-6802-5p	Mean platelet volume,Rheumatoid arthritis,-	ATG16L2	PHLDB3
ENSG00000286585	NA	3.64690718657962	0.00285959302483651	M2_vs_M1	HSALNG0030033	anti_sense	Not conserved	hsa-miR-6089	-	GMPS	CYSRT1
ENSG00000286608	NA	3.34894653313693	5.74215217436084e-6	M2_vs_M1	HSALNG0143459	integenic	Q50	hsa-miR-6779-5p	Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Attention deficit hyperactivity disorder; Body fat percentage; Waist-hip ratio; Unipolar depression; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Platelet count; Aspartate aminotransferase measurement,Attention deficit hyperactivity disorder; Cannabis use,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	TMTC3	UQCRC2
ENSG00000286616	NA	-5.50501586980103	0.00609082329491457	M2_vs_M1	HSALNG0052790	integenic	Not conserved	hsa-miR-7846-3p	NA	REV3L	ENSG00000285761
ENSG00000286622	NA	1.8064893330014	0.0432438272870208	M2_vs_M1	HSALNG0150346	anti_sense	Q50	hsa-miR-5787	Neuroticism measurement,-	PRSS51	ENSG00000289091
ENSG00000286646	MAP3K5-AS2	1.91603570632233	5.45491832224684e-59	M2_vs_M1	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p	NA	PEX7	ADRA2B
ENSG00000286654	NA	6.1211275069866	8.62292018922785e-5	M2_vs_M1	HSALNG0146167	anti_sense	Not conserved	hsa-miR-6765-3p	Cortical thickness	CNNM3	CLHC1
ENSG00000286672	NA	-5.0935783841226	0.0281244500438834	M2_vs_M1	HSALNG0149417	anti_sense	Not conserved	NA	NA	TMEM217	LMOD1
ENSG00000286680	NA	1.61831170170288	9.772053486402201e-11	M2_vs_M1	HSALNG0051066	integenic	Q50	hsa-miR-612,hsa-miR-4486	Unipolar depression,Ccl5 measurement,Age-related hearing impairment; Glucose metabolism measurement,-	ADGRB3	MIS18BP1
ENSG00000286694	NA	4.6769437408015	0.0454758393988069	M2_vs_M1	HSALNG0077095	integenic	Not conserved	NA	Uterine fibroid,-	ARHGAP12	RPL23P2
ENSG00000286729	NA	2.16417942521123	0.0354076175689053	M2_vs_M1	HSALNG0028872	anti_sense	Q50	hsa-miR-3198,hsa-miR-6803-5p	NA	H1-10	CTNND1
ENSG00000286755	NA	2.90961951295687	8.208239836570831e-15	M2_vs_M1	HSALNG0032086	anti_sense	Q75	hsa-miR-6873-3p	-	IQCG	MACROD2
ENSG00000286796	NA	6.12192584192391	3.9630906452381e-5	M2_vs_M1	HSALNG0014524	integenic	Q50	hsa-miR-4323,hsa-miR-4472,hsa-miR-6756-3p,hsa-miR-6783-3p,hsa-miR-6836-3p	Gastric carcinoma,Resistin measurement; Monocyte count,Monocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Neutrophil count	MTA3	MAP1LC3C
ENSG00000286940	MICB-DT	-4.70265532685841	1.13951145416744e-8	M2_vs_M1	HSALNG0049272	anti_sense	Not conserved	hsa-miR-4701-3p,hsa-miR-6089	Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Eosinophil percentage of leukocytes,Bmi-adjusted hip circumference,Eosinophil count,Susceptibility to childhood ear infection measurement,Body height,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Ulcerative colitis,Atopic asthma,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to plantar warts measurement,Mhc class i polypeptide-related sequence a measurement,Mhc class i polypeptide-related sequence b measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Alcohol use disorder measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Cytokine measurement,Testosterone measurement,Monocyte count,Platelet crit,Lobe attachment; Lymphocyte count,Bmi-adjusted waist circumference,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Human papilloma virus infection; Oropharynx cancer,Blood protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	ATP6V1G2-DDX39B	PIK3R5-DT
ENSG00000286986	NA	-2.55693791095376	3.16657393111538e-5	M2_vs_M1	HSALNG0039860	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6769b-3p	Gut microbiome measurement	ICE1	RHBDL1
ENSG00000286989	NA	1.65911022237711	0.00141783193896161	M2_vs_M1	HSALNG0000179	overlap_antisense	Q50	hsa-miR-338-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-5572,hsa-miR-5587-3p,hsa-miR-6511b-3p,hsa-miR-6754-5p,hsa-miR-6803-5p,hsa-miR-6804-3p,hsa-miR-6890-3p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	MIB2	PNMA1
ENSG00000287024	NA	1.88744406363641	0.00467182135934197	M2_vs_M1	HSALNG0140088	integenic	Q75	hsa-miR-3960,hsa-miR-6724-5p,hsa-miR-6773-5p	NA	APLN	SMG6
ENSG00000287064	NA	-1.97598908540738	0.00239919010398276	M2_vs_M1	HSALNG0007424	integenic	Not conserved	NA	C-reactive protein measurement	CHRNB2	ENSG00000289401
ENSG00000287069	NA	-2.92881682893443	8.44039990696195e-9	M2_vs_M1	HSALNG0024559	anti_sense	Q50	hsa-miR-615-3p,hsa-miR-619-5p,hsa-miR-3135b,hsa-miR-6763-5p,hsa-miR-6825-5p,hsa-miR-10392-3p	Body mass index,Protein measurement,-	EFHB	MORF4L1
ENSG00000287097	NA	-7.08901237369389	1.14220077889127e-40	M2_vs_M1	HSALNG0052955	integenic	Q50	NA	Serum igg glycosylation measurement,Dna methylation,Carotid artery intima media thickness,-	MARCKS	KRT18P22
ENSG00000287100	NA	-1.99015983512626	4.5726409650688e-4	M2_vs_M1	HSALNG0149240	integenic	Q75	NA	Stem cell growth factor beta measurement,-	ASF1A	DMGDH
ENSG00000287115	LINC02993	2.44232842747564	1.24158323057315e-7	M2_vs_M1	HSALNG0019363	integenic	Q90	hsa-miR-4472,hsa-miR-6803-5p,hsa-miR-7108-3p	-	ZEB2	STAM
ENSG00000287188	NA	-2.60675490387812	3.04978045111832e-16	M2_vs_M1	HSALNG0038414	anti_sense	Q50	NA	-	DDX60	ZNF354B
ENSG00000287200	NA	1.63319195745497	0.00698785237824386	M2_vs_M1	HSALNG0091617	anti_sense	Q75	hsa-miR-6796-5p	Red blood cell distribution width,-	ARHGAP9	EFCAB14
ENSG00000287202	NA	-6.10337934771585	1.71048930652647e-4	M2_vs_M1	HSALNG0143498	anti_sense	Q75	NA	-	FICD	SEC16A
ENSG00000287203	NA	4.47168270015699	1.50654863284313e-10	M2_vs_M1	HSALNG0045515	integenic	Not conserved	hsa-miR-619-5p	Diabetic retinopathy	FGF1	KIF25
ENSG00000287216	NA	-4.02308351016376	5.6236024272921e-8	M2_vs_M1	HSALNG0037966	anti_sense	Not conserved	hsa-miR-28-3p,hsa-miR-204-5p,hsa-miR-211-5p,hsa-miR-6784-5p	Mean reticulocyte volume; Platelet crit; Body height; Platelet count; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement,-	RNF175	PCOLCE
ENSG00000287222	NA	-1.00358781133548	0.0181957491374403	M2_vs_M1	HSALNG0069338	anti_sense	Q75	hsa-miR-331-3p,hsa-miR-1237-5p,hsa-miR-3186-3p,hsa-miR-4508,hsa-miR-4734	-	IQANK1	ENSG00000289504
ENSG00000287235	NA	4.67025919369512	0.0228457857047606	M2_vs_M1	HSALNG0075873	integenic	Q50	hsa-miR-198,hsa-miR-619-5p,hsa-miR-920,hsa-miR-6764-5p	Interleukin 2 receptor antagonist measurement,Sporadic amyotrophic lateral sclerosis,-	CALML5	XPNPEP2
ENSG00000287245	NA	1.39934278951781	0.0249440372550268	M2_vs_M1	HSALNG0087038	anti_sense	Not conserved	NA	NA	ZC3H12C	ENSG00000237529
ENSG00000287250	NA	2.15490789646599	0.02069289672023	M2_vs_M1	HSALNG0015993	anti_sense	Q75	hsa-miR-6807-3p	Serum metabolite measurement,-	DUSP11	ENSG00000217801
ENSG00000287252	NA	4.89806712261856	6.48134877883574e-14	M2_vs_M1	HSALNG0048904	integenic	Not conserved	hsa-miR-6089	NA	H2AC13	ENSG00000287616
ENSG00000287259	NA	5.32785559015439	0.00500593778579313	M2_vs_M1	HSALNG0011112	integenic	Not conserved	hsa-miR-194-3p	Skin conductance response amplitude; Electrodermal activity measurement,-	NA	RPS4XP3
ENSG00000287265	NA	-4.96839814239023	0.0178218629375167	M2_vs_M1	HSALNG0047279	integenic	Not conserved	NA	NA	EXOC2	NOTCH2NLC
ENSG00000287278	NA	-2.75409084678711	2.50927161644255e-4	M2_vs_M1	HSALNG0077187	integenic	Q50	hsa-miR-6848-5p	Triglyceride measurement; High density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Intelligence; Mathematical ability,Crohn's disease; Disease progression measurement,-	CCDC7	NFKB2
ENSG00000287287	NA	3.64458999573252	0.0021201938567889	M2_vs_M1	HSALNG0150805	intronic_antisense	Q50	hsa-miR-30b-3p	NA	FAM166B	VTI1BP2
ENSG00000287299	NA	-7.05546628887603	2.41468754918697e-8	M2_vs_M1	HSALNG0021467	anti_sense	Q75	hsa-miR-7703	Reaction time measurement,Urinary albumin to creatinine ratio,Alcoholic pancreatitis; Alcoholic liver cirrhosis,-	KCTD18	ANKFY1
ENSG00000287301	NA	-3.85475029342944	1.56526655753768e-4	M2_vs_M1	HSALNG0065526	integenic	Not conserved	hsa-miR-505-5p	-	FAM110B	ZNF493
ENSG00000287335	NA	-4.41634894308722	6.06332469312876e-12	M2_vs_M1	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	TLX2
ENSG00000287356	NA	2.5367809037357	0.00744473220241785	M2_vs_M1	HSALNG0000242	integenic	Not conserved	hsa-miR-3178,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4732-3p,hsa-miR-6837-5p	NA	SKI	GARRE1
ENSG00000287367	NA	5.77903398899781	2.29730403268197e-4	M2_vs_M1	HSALNG0041841	integenic	Q50	NA	-	SNX18	DAPL1
ENSG00000287385	NA	3.52448611090715	0.018394998337498	M2_vs_M1	HSALNG0102098	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-4308,hsa-miR-6869-3p	Cognitive function measurement,Monoclonal gammopathy,Prostate carcinoma,Body height,Coronary artery calcification,Bmi-adjusted waist-hip ratio; Gut microbiome measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Balding measurement,High density lipoprotein cholesterol measurement,Diabetic nephropathy,-	ZFP36L1	ZNF785
ENSG00000287401	NA	-4.62852562717858	0.0440280915195782	M2_vs_M1	HSALNG0035305	anti_sense	Q90	NA	NA	CCDC158	TG
ENSG00000287407	NA	1.23130138274594	6.979376456261859e-11	M2_vs_M1	HSALNG0055418	integenic	Not conserved	hsa-miR-920,hsa-miR-6848-3p	Intraocular pressure measurement,Glaucoma; Intraocular pressure measurement,Prostate carcinoma,-	DLL1	DDB1
ENSG00000287485	NA	-5.49039001600143	0.00252481273005758	M2_vs_M1	HSALNG0050410	integenic	Q75	NA	NA	TNFRSF21	ENSG00000287485
ENSG00000287494	NA	1.56211001094619	0.00249917798397563	M2_vs_M1	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1	TAF10
ENSG00000287510	NA	-4.97390749189908	0.0135702459391489	M2_vs_M1	HSALNG0002188	anti_sense	Q50	hsa-miR-6749-5p,hsa-miR-6791-5p,hsa-miR-6803-5p	Body height,-	ZCCHC17	KRBOX5
ENSG00000287538	NA	-1.07138662680876	0.0488731299738367	M2_vs_M1	HSALNG0084155	integenic	Not conserved	hsa-miR-6779-5p	NA	OR4C45	ARHGAP45
ENSG00000287543	NA	-5.44780812090303	2.45154880143517e-27	M2_vs_M1	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	LRRC3B
ENSG00000287557	NA	1.05172202113435	1.23088369049922e-4	M2_vs_M1	HSALNG0051066	integenic	Q50	hsa-miR-612,hsa-miR-4486	Unipolar depression,Ccl5 measurement,Age-related hearing impairment; Glucose metabolism measurement,-	ADGRB3	ANXA2R-OT1
ENSG00000287576	NA	-1.53113080166621	0.0191177138379756	M2_vs_M1	HSALNG0150312	integenic	Not conserved	NA	Leukocyte count	GSDMD	ENSG00000286086
ENSG00000287584	NA	-4.62820776041037	0.0430623620149183	M2_vs_M1	HSALNG0057374	integenic	Q50	NA	Intelligence,-	MPLKIP	ENSG00000235121
ENSG00000287599	NA	4.92290590622486	0.0114229927372174	M2_vs_M1	HSALNG0097000	anti_sense,sense	Q50	NA	NA	RB1	SYT10
ENSG00000287616	NA	4.69832329794379	2.99782580180284e-7	M2_vs_M1	HSALNG0052338	integenic	Q50	NA	-	HACE1	ENSG00000287252
ENSG00000287626	NA	-3.59171722095179	4.05021889971252e-16	M2_vs_M1	HSALNG0048279	anti_sense	Not conserved	hsa-miR-6089,hsa-miR-6763-5p	Alkaline phosphatase measurement,Squamous cell carcinoma,Body height,-	JARID2	ENSG00000266947
ENSG00000287680	NA	1.35173820498018	0.025654656641654	M2_vs_M1	HSALNG0122604	anti_sense	Q75	hsa-miR-6764-5p	Interleukin 16 measurement,Lymphocyte count,Response to paclitaxel,Qt interval,Total blood protein measurement; Insomnia,Brain volume measurement; Neuroimaging measurement,-	ZNF236	ENSG00000263017
ENSG00000287710	NA	1.93950345119637	0.00245831110709604	M2_vs_M1	HSALNG0116546	anti_sense	Not conserved	NA	NA	MLX	ENSG00000289436
ENSG00000287721	NA	-3.13474947692225	0.0113979214603958	M2_vs_M1	HSALNG0115443	integenic	Not conserved	NA	NA	NLK	ENSG00000279520
ENSG00000287729	NA	-5.00553295348591	0.0347349550438479	M2_vs_M1	HSALNG0137338	anti_sense	Q90	hsa-miR-4508,hsa-miR-6089,hsa-miR-6728-3p	NA	RPGR	ENSG00000287729
ENSG00000287733	NA	-4.97776563164147	3.5663163816047296e-145	M2_vs_M1	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	TDO2
ENSG00000287787	NA	3.21731038025411	4.5645815422786e-5	M2_vs_M1	HSALNG0113198	sense	Not conserved	NA	Balding measurement,Alopecia,Systolic blood pressure,Body weight,Triglyceride measurement; Response to diuretic	GSE1	ENSG00000260949
ENSG00000287789	NA	4.86648925171993	1.88857241318095e-7	M2_vs_M1	HSALNG0149201	anti_sense	Q75	NA	NA	GJA10	RASGRP4
ENSG00000287825	NA	2.05462997251313	2.91697223053179e-16	M2_vs_M1	HSALNG0050133	anti_sense	Q75	hsa-miR-619-5p	-	PEX6	ADCY6
ENSG00000287838	NA	6.22168053386256	9.1103152962445e-5	M2_vs_M1	HSALNG0071161	integenic	Not conserved	hsa-miR-4650-5p	NA	SPATA31A1	CBR4
ENSG00000287875	NA	-4.98195472615086	0.0288573930669686	M2_vs_M1	HSALNG0015111	anti_sense	Q90	hsa-miR-8485	Cortical thickness,Epithelial cell adhesion molecule measurement,Autism spectrum disorder,Bmi-adjusted waist circumference,Depressive symptom measurement; Mathematical ability; Wellbeing measurement; Mood instability measurement; Neuroticism measurement,Intelligence,Neuroticism measurement,Smoking initiation; Smoking status measurement,Daytime rest measurement,Neuroticism measurement; Depressive symptom measurement,Wellbeing measurement,Irritability measurement,Mood disorder; Neuroticism measurement; Unipolar depression,Chronotype measurement,Wellbeing measurement; Unipolar depression; Neurotic disorder,Depressive symptom measurement; Unipolar depression,Diet measurement,Handedness,Waist-hip ratio,Feeling miserable measurement,Epithelioid cell uveal melanoma,Body height,Age at first sexual intercourse measurement; Bmi-adjusted hip circumference,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder,Cortical surface area measurement; Neuroimaging measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	FANCL	ENSG00000287875
ENSG00000287878	NA	-2.55541607607269	2.08077660407471e-5	M2_vs_M1	HSALNG0024042	overlap_antisense,anti_sense	Q50	hsa-miR-1304-5p,hsa-miR-6747-3p	-	CAMK1	ZNF713
ENSG00000287895	NA	-4.81166320924214	0.0294312141668679	M2_vs_M1	HSALNG0142441	integenic	Not conserved	NA	NA	MRPL55	DFFBP1
ENSG00000287910	NA	4.67299500340241	0.0423660355602315	M2_vs_M1	HSALNG0114911	integenic	Q75	hsa-miR-619-5p	Cortical surface area measurement,-	TNFRSF13B	LINC01649
ENSG00000287935	NA	-1.73064028656523	6.77848819541454e-4	M2_vs_M1	HSALNG0143115	integenic	Not conserved	NA	Susceptibility to childhood ear infection measurement	TOLLIP	H4C9
ENSG00000287981	NA	4.6724853990096	0.0305023413238703	M2_vs_M1	HSALNG0025092	integenic	Q50	NA	-	PDCD6IP	ENSG00000287981
ENSG00000287993	NA	5.90336586303329	1.78288870209078e-4	M2_vs_M1	HSALNG0122517	integenic	Q75	NA	-	TSHZ1	GAS6-DT
ENSG00000288018	NA	1.79957843413763	6.252356821170889e-11	M2_vs_M1	HSALNG0086321	integenic	Not conserved	NA	-	TYR	RPL7AP6
ENSG00000288065	NA	-5.4903487018545	0.00290090470815455	M2_vs_M1	HSALNG0146128	intronic_antisense	Not conserved	NA	NA	MPHOSPH10	ENSG00000261204
ENSG00000288066	NA	1.33222778948836	3.94599948923674e-4	M2_vs_M1	HSALNG0019641	anti_sense	Q90	NA	-	RIF1	DNAI4
ENSG00000288156	NA	1.18839941156138	1.0852300008827402e-15	M2_vs_M1	HSALNG0123151	intronic_sense	Not conserved	NA	-	NA	SERTAD2
ENSG00000288162	NA	1.72444493897253	4.25530419388613e-17	M2_vs_M1	HSALNG0055417	integenic	Not conserved	hsa-miR-1233-5p	Balding measurement,Glaucoma; Open-angle glaucoma; Lymphocyte count,-	FAM120B	OGFRL1
ENSG00000288573	NA	1.90376870137132	6.3739898418704e-4	M2_vs_M1	HSALNG0003131	integenic	Q50	hsa-miR-619-5p,hsa-miR-1587,hsa-miR-4638-5p,hsa-miR-4695-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Intelligence; Cognitive function measurement	SLC6A9	PCED1A
ENSG00000288714	NA	3.87221442265037	1.19238075799281e-6	M2_vs_M1	HSALNG0149266	integenic	Not conserved	NA	-	HECA	LINC00862
ENSG00000288741	NA	-1.07155403296416	0.0360893637271452	M2_vs_M1	HSALNG0042976	anti_sense	Q50	NA	Body height,-	SPZ1	ENSG00000287557
ENSG00000288746	NA	1.03327898471507	4.70866967645885e-4	M2_vs_M1	HSALNG0057615	integenic	Not conserved	NA	NA	PGAM2	GTF3C3
ENSG00000288765	NA	-7.23124265858421	1.15803481850713e-9	M2_vs_M1	NA	NA	NA	NA	NA	PCDH17	ENSG00000284734
ENSG00000288771	NA	3.72970238511087	6.1128930640949e-8	M2_vs_M1	HSALNG0071712	anti_sense	Q50	NA	Fasting blood glucose measurement	PRKACG	PSMD7
ENSG00000288792	NA	-2.10125176490037	0.00240417409309147	M2_vs_M1	HSALNG0055740	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4701-5p	NA	TTYH3	C2orf49-DT
ENSG00000288803	NA	-5.60495985392342	0.00364782918466589	M2_vs_M1	HSALNG0005997	integenic	Q90	hsa-miR-619-5p	-	CD53	H1-3
ENSG00000288806	NA	3.19980037226962	0.0228780856865057	M2_vs_M1	HSALNG0028550	anti_sense	Q75	hsa-miR-1178-5p,hsa-miR-4267,hsa-miR-6165,hsa-miR-7113-3p	Adolescent idiopathic scoliosis,-	KALRN	DDX23
ENSG00000288807	NA	6.1189496136707	1.62071143755073e-5	M2_vs_M1	NA	NA	NA	NA	NA	METRNL	ENSG00000288807
ENSG00000288817	NA	4.42358331381133	3.81528598780315e-6	M2_vs_M1	HSALNG0136685	integenic	Q75	NA	NA	FAM9C	TMEM42
ENSG00000288818	NA	2.27695026798603	3.90447967086856e-8	M2_vs_M1	HSALNG0065278	anti_sense	Q50	NA	Leptin measurement,Mitochondrial dna measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Quality of life during menstruation measurement; Dysmenorrheic pain measurement,-	NPBWR1	SRPK1
ENSG00000288827	NA	-3.89888963909542	7.897833979474069e-18	M2_vs_M1	NA	NA	NA	NA	NA	DHX34	ZIC5
ENSG00000288831	NA	3.36395574556199	0.00909878977476734	M2_vs_M1	HSALNG0023820	anti_sense	Q75	hsa-miR-762,hsa-miR-5787,hsa-miR-6857-5p	Blood protein measurement,-	IL5RA	ENSG00000283041
ENSG00000288838	NA	-1.09330362120996	6.45890779898491e-7	M2_vs_M1	HSALNG0071452	integenic	Not conserved	NA	-	FOXD4L5	YIPF1
ENSG00000288839	NA	-2.92902938585645	0.0292317539836437	M2_vs_M1	HSALNG0120196	sense	Q90	NA	Dna methylation,-	RNMT	MPP3
ENSG00000288851	NA	-3.75697019611405	3.43153426785067e-58	M2_vs_M1	HSALNG0048627	integenic	Q90	hsa-miR-4281,hsa-miR-4447,hsa-miR-4467,hsa-miR-4492	NA	ACOT13	CNOT1
ENSG00000288852	NA	1.66246739963521	1.11233450226839e-4	M2_vs_M1	HSALNG0084751	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6803-5p	Lymphocyte count,Dna methylation,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Urate measurement,Monocyte count,-	MACROD1	TPT1P9
ENSG00000288856	NA	1.64807249826895	1.36625173180963e-8	M2_vs_M1	HSALNG0137398	anti_sense	Q50	NA	NA	ATP6AP2	SNORD48
ENSG00000288858	NA	3.16157922668787	0.00157736607318773	M2_vs_M1	HSALNG0016508	anti_sense	Q75	hsa-miR-331-3p,hsa-miR-4292,hsa-miR-6809-3p	Adolescent idiopathic scoliosis,Body height,-	TMEM150A	AGRP
ENSG00000288885	NA	2.31333399621374	0.00285645659082194	M2_vs_M1	HSALNG0133657	anti_sense	Not conserved	NA	NA	COL18A1	C10orf88B
ENSG00000288888	NA	3.19350824369506	0.0396266018617564	M2_vs_M1	NA	NA	NA	NA	NA	SEPTIN11	SLC26A9
ENSG00000288924	NA	2.65794870031617	4.86634648286055e-16	M2_vs_M1	HSALNG0074774	intronic_sense	Q50	hsa-miR-8485	NA	FNBP1	CALM2
ENSG00000288927	NA	1.4381595652178	2.81671266865093e-5	M2_vs_M1	HSALNG0000949	anti_sense	Q90	NA	-	AADACL4	SNHG32
ENSG00000288928	NA	-5.9975066289586	0.00125683395360179	M2_vs_M1	NA	NA	NA	NA	NA	HIF1A	ENSG00000254691
ENSG00000288934	NA	1.27223150675003	0.00533357166530265	M2_vs_M1	HSALNG0009875	integenic	Q50	NA	NA	MDM4	GATAD2A
ENSG00000288935	NA	2.17820762437432	6.12926218170543e-5	M2_vs_M1	HSALNG0109228	integenic	Not conserved	hsa-miR-331-3p	Mean platelet volume; Bmi-adjusted waist-hip ratio,Cortical thickness,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Platelet count,Alkaline phosphatase measurement,Fev/fec ratio; Bmi-adjusted hip circumference,Puberty onset measurement,Prostate specific antigen measurement,Neuroimaging measurement; Brain measurement,-	PAM16	ENSG00000290374
ENSG00000288940	NA	6.55434625977291	2.1605218235254e-6	M2_vs_M1	HSALNG0148071	integenic	Q90	hsa-miR-4268,hsa-miR-6089	-	PCDH7	GYS1
ENSG00000288947	NA	-5.33993341673484	4.7755623723844905e-13	M2_vs_M1	NA	NA	NA	NA	NA	TBX20	TMEM123-DT
ENSG00000288951	NA	-2.06442041232941	0.0469053528594074	M2_vs_M1	HSALNG0033010	integenic	Not conserved	NA	NA	BOD1L1	SLC22A1
ENSG00000288952	NA	-2.53440480885095	2.37016349126876e-4	M2_vs_M1	HSALNG0024203	integenic	Q50	NA	NA	TIMP4	CA12
ENSG00000288954	NA	-5.80455649436522	0.00148381888286749	M2_vs_M1	HSALNG0089060	integenic	Not conserved	hsa-miR-211-3p	Blood protein measurement,-	CLEC4E	BANCR
ENSG00000288966	NA	2.35823732779979	0.00594282091009448	M2_vs_M1	HSALNG0066049	integenic	Q75	hsa-miR-149-3p,hsa-miR-3943,hsa-miR-4710,hsa-miR-4743-5p	Alkaline phosphatase measurement,-	XKR9	MRPL38
ENSG00000288973	NA	-1.41158750185807	0.0157158986616408	M2_vs_M1	HSALNG0056961	integenic	Q50	NA	Facial emotion recognition measurement,Periprosthetic osteolysis,-	SCRN1	ENSG00000288061
ENSG00000288983	NA	2.34526220326047	2.56104833035796e-9	M2_vs_M1	HSALNG0110765	integenic	Not conserved	hsa-miR-619-5p	-	PRR14	TAFA3
ENSG00000288990	NA	1.4130704432833	2.16113749891121e-25	M2_vs_M1	HSALNG0031952	anti_sense	Q50	NA	Inhalant adrenergic use measurement,Respiratory system disease,-	CEP19	TMSB4X
ENSG00000289007	NA	-1.64816229400303	5.97394731578365e-11	M2_vs_M1	HSALNG0136377	integenic	Not conserved	hsa-miR-370-3p,hsa-miR-1228-5p,hsa-miR-6769b-5p	NA	DHRSX	UBQLN4
ENSG00000289043	NA	1.38834075051774	0.0375615379882907	M2_vs_M1	HSALNG0025824	anti_sense	Not conserved	NA	NA	ZNF589	TMEM167A
ENSG00000289050	NA	1.65397346322945	0.0161750509131142	M2_vs_M1	NA	NA	NA	NA	NA	ST3GAL1	ENSG00000253671
ENSG00000289070	NA	3.92781198665731	1.7044812352446397e-30	M2_vs_M1	HSALNG0118660	anti_sense	Q50	hsa-miR-619-5p	Blood protein measurement,-	CD300A	YARS2
ENSG00000289089	NA	-1.58965308034752	0.00166163078587573	M2_vs_M1	NA	NA	NA	NA	NA	TBX20	ENSG00000252274
ENSG00000289092	NA	1.59056530788835	2.12660504745051e-4	M2_vs_M1	HSALNG0077924	anti_sense	Not conserved	hsa-miR-1273h-5p	Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Erythrocyte count	TIMM23	SPCS2
ENSG00000289104	NA	4.69646986222034	1.43676103558333e-7	M2_vs_M1	HSALNG0064676	integenic	Q75	NA	Pancreatic carcinoma; Chronic mountain sickness; Platelet aggregation,-	TACC1	ZNF558
ENSG00000289106	NA	1.45670863531129	2.48198316002087e-5	M2_vs_M1	NA	NA	NA	NA	NA	SDHC	ENSG00000253106
ENSG00000289110	NA	-4.98933789997517	0.0244479118495436	M2_vs_M1	NA	NA	NA	NA	NA	SYNRG	SLC10A6
ENSG00000289123	NA	4.5485804295415	1.6460526323457e-9	M2_vs_M1	HSALNG0072704	integenic	Q50	hsa-miR-619-5p,hsa-miR-644a,hsa-miR-4258,hsa-miR-4466,hsa-miR-4685-3p,hsa-miR-6803-5p,hsa-miR-6837-3p,hsa-miR-7704,hsa-miR-8069	Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Leukocyte count,-	SYK	CCDC3
ENSG00000289127	NA	2.46656245045718	8.48706891130569e-4	M2_vs_M1	HSALNG0137342	integenic	Q90	NA	NA	MID1IP1	PSMD9
ENSG00000289135	NA	1.5874203048248	1.34575162247875e-4	M2_vs_M1	HSALNG0017086	anti_sense	Q50	hsa-miR-4488,hsa-miR-9899	Parental genotype effect measurement; Birth weight,-	ANKRD23	PPP5C
ENSG00000289161	NA	-2.07282899808485	3.21084578798353e-88	M2_vs_M1	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	MRPL44
ENSG00000289164	NA	2.31448154692125	0.00396979435744348	M2_vs_M1	NA	NA	NA	NA	NA	RANBP10	SLC39A5
ENSG00000289177	NA	-4.80584281738574	0.0297694272563038	M2_vs_M1	HSALNG0058624	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-1268b,hsa-miR-4478,hsa-miR-6089	Covid-19,Response to triptolide; Cytotoxicity measurement,-	RABGEF1	CDCA4P4
ENSG00000289182	NA	1.54334614881259	1.86127195505271e-7	M2_vs_M1	HSALNG0119279	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-615-5p,hsa-miR-661,hsa-miR-4257,hsa-miR-4472,hsa-miR-4685-3p,hsa-miR-1199-3p,hsa-miR-6826-3p,hsa-miR-6886-5p,hsa-miR-7113-3p	Serum alanine aminotransferase measurement; Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Serum gamma-glutamyl transferase measurement,Protein measurement,Testosterone measurement,Sex hormone-binding globulin measurement,-	FSCN2	ZBTB48
ENSG00000289194	NA	2.08344675681341	4.03667665149626e-4	M2_vs_M1	NA	NA	NA	NA	NA	INCENP	ENSG00000287910
ENSG00000289198	NA	-4.81229907945163	0.0356341104881784	M2_vs_M1	HSALNG0052920	integenic	Q90	NA	-	MARCKS	NME8
ENSG00000289206	NA	-2.65849478225628	0.0122734832489549	M2_vs_M1	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	CHRNA2
ENSG00000289210	NA	-4.62370346055317	0.0420978883070404	M2_vs_M1	HSALNG0038631	integenic	Q90	NA	-	FBXO8	ZNF611
ENSG00000289234	ZNF496-DT	-1.03525396073291	3.19033215373775e-12	M2_vs_M1	HSALNG0012257	integenic	Not conserved	hsa-miR-7156-3p	NA	NLRP3	OPLAH
ENSG00000289250	NA	2.61704380504991	8.64312334596882e-4	M2_vs_M1	HSALNG0015751	anti_sense,sense	Q50	NA	-	ANXA4	SMYD5
ENSG00000289263	NA	5.13929577328701	0.0067453163500285	M2_vs_M1	HSALNG0069085	integenic	Not conserved	hsa-miR-6848-3p	Systolic blood pressure,-	PTP4A3	RCOR2
ENSG00000289293	NA	-6.10051235755489	1.9045835857491e-22	M2_vs_M1	HSALNG0117931	integenic	Q90	hsa-miR-4296,hsa-miR-4322,hsa-miR-4265,hsa-miR-3960	NA	MED13	ENSG00000280054
ENSG00000289294	NA	1.42654539414172	1.60965477670061e-6	M2_vs_M1	HSALNG0021663	anti_sense	Q50	hsa-miR-4488,hsa-miR-4734	-	RAPH1	INKA2-AS1
ENSG00000289296	NA	-7.32349098846336	1.87077092092446e-10	M2_vs_M1	HSALNG0146266	integenic	Q50	NA	NA	SP9	WDFY3
ENSG00000289298	NA	2.11993263984059	2.3457840276614997e-26	M2_vs_M1	HSALNG0126206	integenic	Not conserved	NA	NA	CEACAM4	BTBD7
ENSG00000289306	NA	-5.49045773938078	0.00204949481126189	M2_vs_M1	HSALNG0045492	sense	Q90	NA	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Platelet count,Eosinophil count; Adult onset asthma; Eosinophil percentage of leukocytes,Basophil count,Platelet count; Platelet crit,-	NDFIP1	DNAH7
ENSG00000289317	NA	-3.389698650124	0.00305263699911015	M2_vs_M1	HSALNG0042985	integenic	Not conserved	hsa-miR-328-5p	NA	ANKRD34B	TENM4
ENSG00000289318	NA	-5.06034256855503	1.8169588444108197e-19	M2_vs_M1	HSALNG0006635	integenic	Not conserved	hsa-miR-4258,hsa-miR-4492,hsa-miR-3960,hsa-miR-6826-3p	NA	PPIAL4F	GON4L
ENSG00000289339	NA	1.81537792279729	1.15026713758451e-4	M2_vs_M1	HSALNG0084919	integenic	Not conserved	NA	Total hip arthroplasty	LTBP3	ENSG00000273483
ENSG00000289350	NA	5.14310107288183	0.00612575981817128	M2_vs_M1	HSALNG0142735	integenic	Not conserved	NA	Fev/fec ratio; Response to bronchodilator,-	ABI1	ATP5MC2P4
ENSG00000289365	NA	-1.17512618287372	3.91907332679176e-5	M2_vs_M1	HSALNG0139497	integenic	Q50	NA	NA	NXT2	PAIP1
ENSG00000289378	NA	-6.01831094084117	2.09612589100527e-4	M2_vs_M1	HSALNG0125414	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-1285-3p,hsa-miR-3178,hsa-miR-4508	-	SLC7A10	ENSG00000291145
ENSG00000289384	NA	-6.31084070320577	4.5828934089869e-5	M2_vs_M1	HSALNG0143688	integenic	Q50	NA	-	KITLG	JAK3
ENSG00000289396	NA	-5.25947337903716	0.00702687729870564	M2_vs_M1	HSALNG0031996	sense	Q90	NA	Pr interval,Bmi-adjusted waist-hip ratio,Cleft lip; Cleft palate,-	DLG1	ENSG00000267011
ENSG00000289425	NA	-5.12749529858024	0.0103988495747395	M2_vs_M1	NA	NA	NA	NA	NA	RABGAP1L	TP53TG1
ENSG00000289426	NA	-1.50416089600466	0.00986361755883384	M2_vs_M1	HSALNG0008532	anti_sense	Q50	NA	Intelligence,-	TEX50	HMGB1P3
ENSG00000289440	NA	1.63285359992018	0.00930954886220523	M2_vs_M1	HSALNG0072095	anti_sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p	-	GNAQ	CNTD1
ENSG00000289443	NA	-4.45739365375953	1.8752926984837e-7	M2_vs_M1	NA	NA	NA	NA	NA	SEPTIN11	NAXE
ENSG00000289463	NA	-6.15733439621909	1.03552710943393e-4	M2_vs_M1	HSALNG0015879	sense	Q90	NA	Mean reticulocyte volume,Bmi-adjusted hip circumference; Aspartate aminotransferase measurement,-	ZNF638	ENSG00000287216
ENSG00000289465	NA	-6.18355789086577	1.49953411089323e-4	M2_vs_M1	HSALNG0087040	sense	Q50	hsa-miR-619-5p	NA	RDX	ADORA2A-AS1
ENSG00000289470	NA	-10.855718818858	1.4028865768235898e-77	M2_vs_M1	HSALNG0062298	integenic	Not conserved	hsa-miR-4483	Testosterone measurement; Sex hormone-binding globulin measurement,-	TMEM176B	ENSG00000237927
ENSG00000289483	NA	5.77587608333249	2.12495979887561e-4	M2_vs_M1	HSALNG0005183	anti_sense	Q90	NA	-	SETSIP	ENSG00000272482
ENSG00000289515	NA	2.14591859370216	1.74569311301697e-8	M2_vs_M1	HSALNG0035305	anti_sense	Q90	NA	NA	CCDC158	ENSG00000279821
ENSG00000289523	NA	1.64707366576557	1.32896859108437e-4	M2_vs_M1	NA	NA	NA	NA	NA	MAPK1IP1L	LEPROT
ENSG00000289582	NA	-8.64415001788965	1.26346269870785e-26	M2_vs_M1	NA	NA	NA	NA	NA	GBP2	CLEC4E
ENSG00000289588	NA	-2.65896904635306	2.7355548738521997e-24	M2_vs_M1	HSALNG0062635	integenic	Not conserved	hsa-miR-4731-5p	Caudate nucleus measurement; Functional brain measurement; Response to reward	SHH	AZIN2
ENSG00000289589	NA	-1.72564258063937	0.00355471438874005	M2_vs_M1	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	MTHFD1
ENSG00000289597	NA	6.55623164541555	1.70777707544569e-6	M2_vs_M1	HSALNG0075642	integenic	Not conserved	NA	NA	PFKP	ENSG00000272990
ENSG00000289602	NA	7.65566449077451	3.37629485166017e-14	M2_vs_M1	HSALNG0011006	integenic	Q75	hsa-miR-619-5p	NA	SRP9	NUP205
ENSG00000289634	NA	-2.56036831928812	0.00180268676714631	M2_vs_M1	NA	NA	NA	NA	NA	SLCO4A1	NUDT6
ENSG00000289829	NA	-4.80263952571286	0.0437839909859143	M2_vs_M1	NA	NA	NA	NA	NA	HSPA1L	ENSG00000258424
ENSG00000289839	NA	-5.38618543159277	0.00587510618812061	M2_vs_M1	HSALNG0047169	integenic	Q50	NA	Ovarian carcinoma,-	CNOT6	RASEF
ENSG00000289880	NA	-6.73693792107463	1.26061205844376e-5	M2_vs_M1	NA	NA	NA	NA	NA	FAM177B	HKDC1
ENSG00000289912	NA	-3.7476386745581	4.75234821443765e-4	M2_vs_M1	HSALNG0043768	overlap_antisense	Q75	hsa-miR-619-5p	Systemic lupus erythematosus; Lymphocyte count,Lymphocyte count,Monocyte count,Systemic lupus erythematosus,Leukocyte count,Primary biliary cirrhosis,Serum igg glycosylation measurement,Myeloid white cell count,-	FAM174A	ENSG00000264769
ENSG00000289915	NA	-2.413704401714	5.35509556761403e-7	M2_vs_M1	HSALNG0126752	integenic	Q75	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6726-3p,hsa-miR-6763-3p,hsa-miR-6873-3p	Body mass index,Leukocyte count,-	BBC3	RALGDS
ENSG00000289932	NA	6.69949625717367	1.78785489637987e-7	M2_vs_M1	HSALNG0113246	integenic	Not conserved	NA	Monocyte count,Monocyte percentage of leukocytes,Triglyceride measurement; Response to hydrochlorothiazide,-	IRF8	TNFRSF10A-DT
ENSG00000289947	NA	-5.49309232065827	0.0020778003436111	M2_vs_M1	NA	NA	NA	NA	NA	ODF3B	LINC02100
ENSG00000289971	NA	2.9421771484225	0.00705217707918087	M2_vs_M1	HSALNG0031394	integenic	Not conserved	hsa-miR-3196,hsa-miR-4447,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6717-5p	Adiponectin measurement,-	RFC4	ENSG00000280231
ENSG00000289979	NA	-2.44043946885132	0.00605073663484309	M2_vs_M1	HSALNG0100117	anti_sense	Q75	NA	-	GMPR2	AMPH
ENSG00000289984	NA	1.63741928062224	4.48327132352898e-4	M2_vs_M1	NA	NA	NA	NA	NA	ARHGEF15	CYB5B
ENSG00000289995	NA	1.22184688069641	9.494382309054029e-23	M2_vs_M1	HSALNG0009283	integenic	Not conserved	NA	Colonic neoplasm; Overall survival	RGS13	CYTIP
ENSG00000290021	NA	-2.8639773813149	2.49558823408054e-8	M2_vs_M1	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	HLA-L
ENSG00000290041	NA	-6.35778738994548	1.37851441876167e-5	M2_vs_M1	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19	LINC01506
ENSG00000290060	NA	-5.11958882431211	0.00933914139932176	M2_vs_M1	HSALNG0022124	integenic	Q75	NA	NA	SMARCAL1	FRMD6
ENSG00000290082	NA	-2.61500807836549	0.00154791937972615	M2_vs_M1	HSALNG0115585	anti_sense	Not conserved	NA	NA	ABHD15	ENSG00000236529
ENSG00000290085	NA	1.1766556074476	0.0398399047378888	M2_vs_M1	HSALNG0016448	integenic	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-3960,hsa-miR-1199-3p,hsa-miR-6085	NA	TRABD2A	DRC7
ENSG00000290086	NA	-5.24850426615893	0.00912882627850004	M2_vs_M1	HSALNG0022720	anti_sense	Not conserved	hsa-miR-619-5p	Leucine measurement	IRS1	TRO
ENSG00000290105	NA	2.05431946598747	0.0143909723799657	M2_vs_M1	HSALNG0007790	anti_sense	Q90	hsa-miR-574-5p,hsa-miR-5586-5p,hsa-miR-6878-3p	Red blood cell density measurement,C-reactive protein measurement,Bilirubin measurement,-	SLAMF8	SERPINF1
ENSG00000290374	FAM86EP	2.44241254313566	1.49286377407511e-9	M2_vs_M1	HSALNG0032504	integenic	Not conserved	hsa-miR-1228-5p,hsa-miR-5698,hsa-miR-8485	Lung carcinoma,Visual perception measurement,-	OTOP1	NUFIP1
ENSG00000290394	NA	-6.53120226522895	1.75392840943487e-6	M2_vs_M1	HSALNG0109791	anti_sense	Not conserved	hsa-miR-6837-5p	-	RRN3	PDCD6
ENSG00000290404	NA	2.8254875124023	0.0224074822361555	M2_vs_M1	NA	NA	NA	NA	NA	GOSR1	PAQR6
ENSG00000290427	NA	-1.52912135504326	2.1588423256455898e-11	M2_vs_M1	HSALNG0123614	integenic	Not conserved	NA	Susceptibility to chronic sinus infection measurement	MBD3L2B	RPUSD1
ENSG00000290441	NA	-6.94129734959643	4.91537586324273e-8	M2_vs_M1	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587	NA	TLR2	TEF
ENSG00000290525	GBP1P1	-9.2220835796646	7.564024447317838e-157	M2_vs_M1	NA	NA	NA	NA	NA	GBP6	ENSG00000258521
ENSG00000290535	NA	-1.09344605329223	0.00116774168981394	M2_vs_M1	HSALNG0077424	integenic	Not conserved	hsa-miR-4453,hsa-miR-4763-3p,hsa-miR-4436b-3p,hsa-miR-6089	-	PLD5P1	NUP42
ENSG00000290578	NA	-3.61078007489263	6.80105742267106e-4	M2_vs_M1	HSALNG0142325	integenic	Not conserved	hsa-miR-4492,hsa-miR-6873-5p,hsa-miR-6873-3p	NA	PPIAL4H	ENG
ENSG00000290682	STAG3L5P	-1.13040078608471	0.0249843365629567	M2_vs_M1	HSALNG0059997	integenic	Q50	NA	NA	PILRB	RAB11FIP1P1
ENSG00000290683	NA	-4.36697832630726	9.203450143705439e-97	M2_vs_M1	HSALNG0012244	integenic	Not conserved	NA	-	ZNF124	ZNF592
ENSG00000290720	ZNF542P	1.91974646516124	0.0255674401005569	M2_vs_M1	HSALNG0127752	anti_sense	Not conserved	hsa-miR-939-3p	NA	ZNF583	WFS1
ENSG00000290727	ALMS1P1	-7.93890212162265	8.50991514477931e-15	M2_vs_M1	HSALNG0015975	anti_sense	Not conserved	NA	Serum metabolite measurement; Urinary metabolite measurement,-	ALMS1	FGF10-AS1
ENSG00000290728	NA	-5.2551526183022	0.00507467768681167	M2_vs_M1	HSALNG0109047	anti_sense	Q75	hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Intraocular pressure measurement,Aspartate aminotransferase measurement,-	PRSS27	ENSG00000287735
ENSG00000290735	NA	-2.96741031200119	3.37037036482189e-5	M2_vs_M1	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	CLIC2
ENSG00000290758	NA	1.44607339845666	1.97236676367795e-5	M2_vs_M1	HSALNG0057612	integenic	Not conserved	hsa-miR-1268b	NA	PGAM2	ZMAT5
ENSG00000290762	NA	-1.27629875543713	0.00758899261912233	M2_vs_M1	HSALNG0031865	integenic	Not conserved	hsa-miR-6736-3p	-	TNK2	PLA2G4A
ENSG00000290763	SDHAP1	1.19090491801077	0.00304518042613812	M2_vs_M1	HSALNG0031873	integenic	Not conserved	NA	NA	TFRC	PSME3
ENSG00000290767	NA	-2.52565839629935	0.0191939685691874	M2_vs_M1	NA	NA	NA	NA	NA	LYSMD4	ENSG00000267102
ENSG00000290790	NA	-2.64876055391641	1.2036018934603e-7	M2_vs_M1	HSALNG0006964	integenic	Not conserved	hsa-miR-6743-5p	NA	H2BC18	TFAP2A
ENSG00000290791	NA	-2.2142727024863	2.06584975945287e-7	M2_vs_M1	HSALNG0006974	integenic	Not conserved	NA	Age at menopause	H4C14	ZNF83
ENSG00000290792	NA	-1.57847998525691	3.6742504459837795e-12	M2_vs_M1	HSALNG0006976	integenic	Not conserved	NA	NA	H2AC18	TIGD5
ENSG00000290793	NA	-1.02311570241621	0.0136419307467523	M2_vs_M1	NA	NA	NA	NA	NA	AMZ2	FLVCR2
ENSG00000290796	NA	-1.72350280323508	2.18646796931959e-4	M2_vs_M1	HSALNG0134568	sense	Not conserved	hsa-miR-328-3p	NA	LHFPL7	BRCC3
ENSG00000290835	NA	-1.74501125774004	4.50807046096649e-10	M2_vs_M1	HSALNG0056000	integenic	Not conserved	hsa-miR-619-5p	Neutrophil count,Leukocyte count; Myeloid white cell count,Ejection fraction measurement,Hematocrit; Hemoglobin measurement,Apoe carrier status,-	RSPH10B2	CAMKK2
ENSG00000290838	NCF1B	-7.54707755175046	2.55362881981618e-12	M2_vs_M1	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	SDAD1-AS1
ENSG00000290853	NA	1.01012507522269	0.041058378528549	M2_vs_M1	HSALNG0141243	integenic	Not conserved	NA	NA	TMSB4Y	BEST4
ENSG00000290862	NMRAL2P	-4.62880490302977	0.0449313151714852	M2_vs_M1	NA	NA	NA	NA	NA	SENP2	H1-3
ENSG00000290866	OTOAP1	6.3087017461797	1.28252833859087e-5	M2_vs_M1	NA	NA	NA	NA	NA	NPIPB5	PSPHP1
ENSG00000290867	LINC01145	-1.67518670166961	3.78585843796689e-7	M2_vs_M1	HSALNG0142314	integenic	Not conserved	NA	-	PPIAL4D	KCTD18
ENSG00000290872	NA	1.75645855705297	2.1413384707655e-7	M2_vs_M1	NA	NA	NA	NA	NA	PGAM2	MRPL3
ENSG00000290879	NA	3.39526889850409	8.18004365709206e-8	M2_vs_M1	NA	NA	NA	NA	NA	APBA2	KLC1
ENSG00000290880	NA	3.18758862220517	4.079966935394e-12	M2_vs_M1	NA	NA	NA	NA	NA	APBA2	ENSG00000290979
ENSG00000290882	NA	1.40706150630246	0.0160460855767576	M2_vs_M1	NA	NA	NA	NA	NA	CDK20	CXXC5
ENSG00000290907	NA	2.53995502431497	0.00224756356891349	M2_vs_M1	HSALNG0071140	sense	Not conserved	hsa-miR-143-5p	Ischemic stroke,-	ANKRD18A	TRGV5
ENSG00000290927	NA	-2.88253450536229	5.8634043141712e-39	M2_vs_M1	HSALNG0110892	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-320a-5p,hsa-miR-4289,hsa-miR-6132,hsa-miR-6722-3p,hsa-miR-6776-5p	-	KRBOX5	ENSG00000279861
ENSG00000290947	NA	-5.11887364370772	0.0105446333467971	M2_vs_M1	NA	NA	NA	NA	NA	GOLGA6L9	ENSG00000273066
ENSG00000290965	OR7E47P	4.6704527363683	0.0204319299208462	M2_vs_M1	NA	NA	NA	NA	NA	SMIM41	FUT11
ENSG00000290979	NA	4.8091730887269	3.35114236315516e-24	M2_vs_M1	NA	NA	NA	NA	NA	TNFRSF13B	ENSG00000290880
ENSG00000290994	FAM86C2P	2.38001709090332	2.67421771661677e-10	M2_vs_M1	HSALNG0085186	integenic	Not conserved	hsa-miR-619-5p	Hair colour measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Body height,Interleukin 18 measurement,Qrs duration,Sex interaction measurement,-	ALDH3B2	EXOSC7
ENSG00000291003	NA	1.40957519833286	2.60633680165142e-21	M2_vs_M1	HSALNG0104483	integenic	Not conserved	NA	NA	GOLGA6L22	GOSR2
ENSG00000291006	NA	1.60374076138967	1.7939364184694998e-12	M2_vs_M1	NA	NA	NA	NA	NA	TMEM14A	ABCC5
ENSG00000291019	AACSP1	-3.03902923488496	0.0198057999314599	M2_vs_M1	HSALNG0149043	integenic	Not conserved	NA	-	ZNF354A	CCDC125
ENSG00000291034	NA	-5.1296623440757	0.0126044934253571	M2_vs_M1	HSALNG0141205	integenic	Not conserved	hsa-miR-1273h-5p	NA	UTY	ACAN
ENSG00000291038	NA	4.66371353456824	1.53486710112076e-12	M2_vs_M1	NA	NA	NA	NA	NA	APEX1	PCYOX1L
ENSG00000291043	GLUD1P3	3.25094813807804	6.262383265612019e-75	M2_vs_M1	HSALNG0078866	integenic	Not conserved	NA	-	SEC24C	SOD1
ENSG00000291049	FAM86B3P	1.27001984842418	1.96783504370978e-5	M2_vs_M1	NA	NA	NA	NA	NA	ZNF705B	FXN
ENSG00000291050	TEKT4P2	-1.25855674007017	0.0249752616141172	M2_vs_M1	HSALNG0131780	integenic	Not conserved	NA	NA	LIPI	PLGLB2
ENSG00000291057	ABCC6P1	-4.79413170930988	0.0405395887739128	M2_vs_M1	HSALNG0109951	integenic	Not conserved	NA	-	TMC7	ABCC6P1
ENSG00000291058	NA	2.07016193396003	1.75389748144632e-6	M2_vs_M1	HSALNG0104695	integenic	Not conserved	NA	-	APBA2	TTLL5
ENSG00000291063	NA	1.6155167092042	5.35871486197106e-8	M2_vs_M1	HSALNG0145041	integenic	Not conserved	NA	NA	NF1	DPH5
ENSG00000291064	RPL23AP7	1.49191552879433	2.2443453303314303e-9	M2_vs_M1	HSALNG0136334	anti_sense	Not conserved	hsa-miR-4469	NA	ACR	LINC02937
ENSG00000291069	BMS1P1	3.81467727100822	2.01702518917093e-5	M2_vs_M1	HSALNG0077766	integenic	Not conserved	NA	NA	PTPN20	FIZ1
ENSG00000291073	NA	-3.25672729008763	1.05460360940585e-6	M2_vs_M1	HSALNG0110122	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4673	NA	NPIPB3	PIGC
ENSG00000291074	CCDC144NL	-2.46382419043058	1.84727703632456e-21	M2_vs_M1	HSALNG0145242	sense	Not conserved	NA	NA	USP22	ZNF765
ENSG00000291075	NA	-1.17767139442699	2.49165698625247e-7	M2_vs_M1	HSALNG0071578	integenic	Not conserved	NA	NA	SPATA31A6	HOXB3
ENSG00000291077	NA	-3.73595143063364	4.83028339367118e-38	M2_vs_M1	NA	NA	NA	NA	NA	ARHGEF19	YIPF4
ENSG00000291086	LGALS17A	-5.68918618955075	0.00109575171544757	M2_vs_M1	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	PRKCG
ENSG00000291090	CCDC144BP	-5.37584396876489	0.00374026873612423	M2_vs_M1	HSALNG0115060	integenic	Not conserved	NA	-	TBC1D28	NADSYN1
ENSG00000291097	HLA-L	-2.20029055419956	0.0162762013664129	M2_vs_M1	HSALNG0049134	integenic	Not conserved	NA	NA	TRIM39	ENSG00000290021
ENSG00000291099	NA	5.31946456079463	0.00854610934431102	M2_vs_M1	HSALNG0055915	integenic	Not conserved	NA	NA	OCM	CLEC1B
ENSG00000291100	NA	-1.00230454682227	8.30555602645005e-8	M2_vs_M1	NA	NA	NA	NA	NA	DEFB116	PURA
ENSG00000291102	GUSBP1	1.06404945290141	6.65434255554201e-7	M2_vs_M1	HSALNG0040560	integenic	Not conserved	NA	NA	PRDM9	ZNF701
ENSG00000291113	NA	2.63954289455779	2.62512527647812e-17	M2_vs_M1	HSALNG0046977	integenic	Not conserved	hsa-miR-202-3p,hsa-miR-619-5p,hsa-miR-4727-5p,hsa-miR-6089	Cleft lip; Cleft palate,-	N4BP3	PLXNA1
ENSG00000291114	SIGLEC17P	3.43529026546658	3.00895624886673e-33	M2_vs_M1	NA	NA	NA	NA	NA	SIGLEC7	PPCDC
ENSG00000291122	CASTOR3P	1.08962755616454	0.00133157206621577	M2_vs_M1	HSALNG0150011	sense	Not conserved	hsa-miR-125a-3p	NA	GPC2	PTPN2
ENSG00000291129	PPIEL	-1.31972894023103	1.79899979907967e-17	M2_vs_M1	HSALNG0002774	anti_sense	Q90	hsa-miR-631,hsa-miR-3135b,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-8485	Forced expiratory volume; Red blood cell distribution width; Traffic air pollution measurement; Fev/fec ratio; Peak expiratory flow; Peripheral arterial disease,Peripheral arterial disease; Alkaline phosphatase measurement; Traffic air pollution measurement,Testosterone measurement,Diastolic blood pressure,Triglyceride measurement; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin,High density lipoprotein cholesterol measurement; Waist-hip ratio,Triglyceride measurement; C-reactive protein measurement; Waist-hip ratio,Chronic obstructive pulmonary disease; Resting heart rate,-	PABPC4	DEF6
ENSG00000291134	WASH2P	-1.25688410609283	0.0202047146262802	M2_vs_M1	HSALNG0018076	integenic	Q90	hsa-miR-663b,hsa-miR-6748-3p	-	RABL2A	MBIP
ENSG00000291141	EMBP1	1.14621768379287	3.82114852695592e-4	M2_vs_M1	HSALNG0006567	integenic	Not conserved	NA	NA	SRGAP2C	BORA
ENSG00000291143	NA	-3.96241126578442	7.88973715722473e-5	M2_vs_M1	NA	NA	NA	NA	NA	OR2AG2	ZDBF2
ENSG00000291144	NA	-3.1457738062186	7.47234093945651e-45	M2_vs_M1	HSALNG0082349	overlap_sense	Not conserved	NA	Lung carcinoma,Mean corpuscular hemoglobin concentration,Hip bone mineral density; Hip bone size,Diastolic blood pressure,-	OR52K1	SLIT2
ENSG00000291147	NA	-2.4403857054029	0.00524406652805575	M2_vs_M1	HSALNG0146386	integenic	Not conserved	hsa-miR-4463	Vitamin b12 measurement	RTP5	UQCC1
ENSG00000291155	CT75	-5.87182164285407	2.47771984728827e-4	M2_vs_M1	HSALNG0022522	integenic	Q50	hsa-miR-4308,hsa-miR-4467,hsa-miR-3960	Susceptibility to scarlet fever measurement,-	SGPP2	TDRD3
ENSG00000291176	NA	1.80198077666062	0.00160456817243494	M2_vs_M1	HSALNG0017006	integenic	Q75	NA	NA	CIAO1	HSD17B6
ENSG00000291178	NA	1.16150220359384	9.6361844386937e-5	M2_vs_M1	HSALNG0059995	anti_sense	Not conserved	hsa-miR-619-5p	Hemoglobin measurement,Family history of alzheimers disease; Late-onset alzheimers disease; Red blood cell distribution width,Platelet count; Platelet crit,-	ZCWPW1	BCL9
ENSG00000291192	ANKRD18DP	3.63060191025211	1.36537471128573e-7	M2_vs_M1	NA	NA	NA	NA	NA	IQCG	GPR84-AS1
ENSG00000291201	NA	-2.62569935444945	2.31276502125039e-34	M2_vs_M1	HSALNG0036674	integenic	Not conserved	hsa-miR-6089	NA	METTL14	KCNJ10
ENSG00000291202	NA	-1.52006395425117	5.03662299523362e-6	M2_vs_M1	HSALNG0036725	integenic	Not conserved	hsa-miR-1285-3p	NA	PDE5A	EML1
ENSG00000291214	NA	-2.6270953035378	6.42002907358153e-20	M2_vs_M1	HSALNG0118342	integenic	Not conserved	NA	NA	AMZ2	WRN
ENSG00000291215	NA	-2.69233983715355	5.30070063444022e-8	M2_vs_M1	HSALNG0000033	integenic	Not conserved	hsa-miR-4453,hsa-miR-4763-3p	-	OR4F16	ENSG00000253683
ENSG00000291223	FAM86DP	2.12455841634412	6.15621749464966e-32	M2_vs_M1	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p	NA	ZNF717	ZBTB48
ENSG00000291228	NA	-1.39628476211419	0.0461294280913033	M2_vs_M1	HSALNG0109038	integenic	Not conserved	hsa-miR-4257,hsa-miR-4287	-	PDPK1	ENSG00000242198
ENSG00000291230	NA	4.91747634145231	0.0297319472919063	M2_vs_M1	NA	NA	NA	NA	NA	KCNC3	MYH15
ENSG00000291233	NA	-3.54403440553589	0.00125683395360179	M2_vs_M1	NA	NA	NA	NA	NA	NBPF9	ENSG00000290021
ENSG00000291236	NA	-4.75858694005806	4.98515403118224e-16	M2_vs_M1	NA	NA	NA	NA	NA	TNS1	C4B
ENSG00000291263	SMG1P7	-1.71329998523598	6.49131596448007e-6	M2_vs_M1	NA	NA	NA	NA	NA	EXOSC6	ENSG00000277511
ENSG00000291266	SMG1P5	-2.18691712811859	0.00110412031009841	M2_vs_M1	HSALNG0110714	integenic	Not conserved	NA	Nicotine dependence symptom count,-	CD2BP2	DNAJC27-AS1
ENSG00000291272	NA	-2.93144381067006	6.89579991878589e-5	M2_vs_M1	HSALNG0109788	anti_sense,sense	Not conserved	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-6089	Body height,Obsessive-compulsive trait,Parental longevity,Blood metabolite measurement; Glycerophospholipid measurement,Reticulocyte count; Reticulocyte measurement,-	RRN3	ENSG00000290907
ENSG00000291273	NA	-6.17170120819834	3.13038028611468e-5	M2_vs_M1	HSALNG0109788	anti_sense,sense	Not conserved	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-6089	Body height,Obsessive-compulsive trait,Parental longevity,Blood metabolite measurement; Glycerophospholipid measurement,Reticulocyte count; Reticulocyte measurement,-	RRN3	ITPR3
